Unnamed: 0,activity_comment,activity_id,assay_chembl_id,assay_description,assay_type,bao_endpoint,bao_format,bao_label,canonical_smiles,document_chembl_id,document_journal,document_year,molecule_chembl_id,molecule_pref_name,parent_molecule_chembl_id,potential_duplicate,qudt_units,record_id,relation,src_id,standard_flag,standard_relation,standard_type,standard_units,standard_value,target_chembl_id,target_organism,target_pref_name,target_tax_id,toid,type,units,uo_units,value
56000,,5184678,CHEMBL1653034,Antimicrobial activity against erythromycin-susceptible Streptococcus Group F clinical isolates assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,Activity,%,0.0,CHEMBL612313,Streptococcus,Streptococcus,1301.0,,Activity,%,UO_0000187,0.0
56001,,5184682,CHEMBL1653033,Antimicrobial activity against Streptococcus Group F clinical isolates assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,Activity,%,0.0,CHEMBL612313,Streptococcus,Streptococcus,1301.0,,Activity,%,UO_0000187,0.0
56002,,5184686,CHEMBL1653044,Antimicrobial activity against erythromycin-nonsusceptible Streptococcus Group G clinical isolates assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,Activity,%,0.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,Activity,%,UO_0000187,0.0
56003,,5184690,CHEMBL1653045,Antimicrobial activity against erythromycin-susceptible Streptococcus Group G clinical isolates assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,Activity,%,0.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,Activity,%,UO_0000187,0.0
56004,,5184694,CHEMBL1653046,Antimicrobial activity against Streptococcus Group G clinical isolates assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,Activity,%,0.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,Activity,%,UO_0000187,0.0
56005,,5184698,CHEMBL1653047,Antimicrobial activity against erythromycin-nonsusceptible Streptococcus Group C clinical isolates assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,Activity,%,0.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,Activity,%,UO_0000187,0.0
56006,,5184702,CHEMBL1653818,Antimicrobial activity against erythromycin-susceptible Streptococcus Group C clinical isolates assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,Activity,%,0.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,Activity,%,UO_0000187,0.0
56007,,5184706,CHEMBL1653819,Antimicrobial activity against Streptococcus Group C clinical isolates assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,Activity,%,0.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,Activity,%,UO_0000187,0.0
56008,,5184710,CHEMBL1653820,Antimicrobial activity against erythromycin-nonsusceptible Streptococcus pyogenes clinical isolates assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,Activity,%,0.8,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,Activity,%,UO_0000187,0.8
56009,,5184714,CHEMBL1653821,Antimicrobial activity against erythromycin-susceptible Streptococcus pyogenes clinical isolates assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,Activity,%,0.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,Activity,%,UO_0000187,0.0
56010,,5184718,CHEMBL1653822,Antimicrobial activity against Streptococcus pyogenes clinical isolates assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,Activity,%,0.1,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,Activity,%,UO_0000187,0.1
56011,,5184723,CHEMBL1653823,Antimicrobial activity against erythromycin-nonsusceptible Streptococcus agalactiae clinical isolates assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,Activity,%,4.1,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,Activity,%,UO_0000187,4.1
56012,,5184728,CHEMBL1653824,Antimicrobial activity against erythromycin-susceptible Streptococcus agalactiae clinical isolates assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,Activity,%,1.4,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,Activity,%,UO_0000187,1.4
56013,,5184733,CHEMBL1653825,Antimicrobial activity against Streptococcus agalactiae clinical isolates assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,Activity,%,2.2,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,Activity,%,UO_0000187,2.2
56014,,5184739,CHEMBL1653826,Antimicrobial activity against Enterococcus faecium expressing VanB gene clinical isolates assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,Activity,%,100.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,Activity,%,UO_0000187,100.0
56015,,5184745,CHEMBL1653827,Antimicrobial activity against Enterococcus faecium expressing VanA gene clinical isolates assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,Activity,%,99.8,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,Activity,%,UO_0000187,99.8
56016,,5184751,CHEMBL1653828,Antimicrobial activity against vancomycin-nonsusceptible Enterococcus faecium clinical isolates assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,Activity,%,99.8,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,Activity,%,UO_0000187,99.8
56017,,5184757,CHEMBL1653829,Antimicrobial activity against vancomycin-susceptible Enterococcus faecium clinical isolates assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,Activity,%,66.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,Activity,%,UO_0000187,66.0
56018,,5184763,CHEMBL1653830,Antimicrobial activity against Enterococcus faecium clinical isolates assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,Activity,%,85.3,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,Activity,%,UO_0000187,85.3
56019,,5184769,CHEMBL1653831,Antimicrobial activity against Enterococcus faecalis expressing VanB gene clinical isolates assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,Activity,%,100.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Activity,%,UO_0000187,100.0
56020,,5184775,CHEMBL1653832,Antimicrobial activity against Enterococcus faecalis expressing VanA gene clinical isolates assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,Activity,%,100.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Activity,%,UO_0000187,100.0
56021,,5184781,CHEMBL1653833,Antimicrobial activity against vancomycin-nonsusceptible Enterococcus faecalis clinical isolates assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,Activity,%,100.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Activity,%,UO_0000187,100.0
56022,,5184787,CHEMBL1653834,Antimicrobial activity against vancomycin-susceptible Enterococcus faecalis clinical isolates assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,Activity,%,35.2,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Activity,%,UO_0000187,35.2
56023,,5184793,CHEMBL1653835,Antimicrobial activity against Enterococcus faecalis clinical isolates assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,Activity,%,38.4,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Activity,%,UO_0000187,38.4
56024,,5184837,CHEMBL1653845,Antimicrobial activity against Streptococcus pneumoniae clinical isolates assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,Activity,%,0.9,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,0.9
56025,,5184845,CHEMBL1653847,Antimicrobial activity against penicillin-susceptible Streptococcus pneumoniae clinical isolates assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,Activity,%,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,0.5
56026,,5184853,CHEMBL1653849,Antimicrobial activity against penicillin-intermediate Streptococcus pneumoniae clinical isolates assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,Activity,%,2.3,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,2.3
56027,,5184861,CHEMBL1653951,Antimicrobial activity against penicillin-resistant Streptococcus pneumoniae clinical isolates assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,Activity,%,0.7,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,0.7
56028,,5184918,CHEMBL1660375,Antimicrobial activity against Streptococcus Group C clinical isolates by broth microdilution method,F,BAO_0000179,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,0.5
56029,,5184919,CHEMBL1660372,Antimicrobial activity against Streptococcus Group G clinical isolates by broth microdilution method,F,BAO_0000179,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,0.5
56030,,5184920,CHEMBL1660369,Antimicrobial activity against Streptococcus Group F clinical isolates by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL612313,Streptococcus,Streptococcus,1301.0,,MIC90,ug ml-1,UO_0000274,0.5
56031,,5184930,CHEMBL1660374,Antimicrobial activity against erythromycin-susceptible Streptococcus Group C clinical isolates by broth microdilution method,F,BAO_0000179,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,0.5
56032,,5184931,CHEMBL1660371,Antimicrobial activity against erythromycin-susceptible Streptococcus Group G clinical isolates by broth microdilution method,F,BAO_0000179,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,0.5
56033,,5184932,CHEMBL1660368,Antimicrobial activity against erythromycin-susceptible Streptococcus Group F clinical isolates by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL612313,Streptococcus,Streptococcus,1301.0,,MIC90,ug ml-1,UO_0000274,0.5
56034,,5184933,CHEMBL1660373,Antimicrobial activity against erythromycin-nonsusceptible Streptococcus Group C clinical isolates by broth microdilution method,F,BAO_0000179,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,0.5
56035,,5184934,CHEMBL1660370,Antimicrobial activity against erythromycin-nonsusceptible Streptococcus Group G clinical isolates by broth microdilution method,F,BAO_0000179,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,0.5
56036,,5184935,CHEMBL1660367,Antimicrobial activity against erythromycin-nonsusceptible Streptococcus Group F clinical isolates by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL612313,Streptococcus,Streptococcus,1301.0,,MIC90,ug ml-1,UO_0000274,0.5
56037,,5184983,CHEMBL1652892,Antimicrobial activity against Streptococcus pneumoniae clinical isolates by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,1.0
56038,,5184984,CHEMBL1652894,Antimicrobial activity against penicillin-susceptible Streptococcus pneumoniae clinical isolates by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,1.0
56039,,5184985,CHEMBL1652896,Antimicrobial activity against penicillin-intermediate Streptococcus pneumoniae clinical isolates by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,1.0
56040,,5184986,CHEMBL1652898,Antimicrobial activity against penicillin-resistant Streptococcus pneumoniae clinical isolates by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,1.0
56041,,5186017,CHEMBL1652898,Antimicrobial activity against penicillin-resistant Streptococcus pneumoniae clinical isolates by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,>,1,1,>,MIC,ug.mL-1,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.25
56042,,5194872,CHEMBL1671526,Antibacterial activity against Streptococcus hemolyticus 1002 after 18 to 24 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1667809,Bioorg Med Chem Lett,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1329322,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,32.0
56043,,5194893,CHEMBL1671527,Antibacterial activity against Escherichia coli ATCC 25922 after 18 to 24 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1667809,Bioorg Med Chem Lett,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1329322,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.015
56044,,5194914,CHEMBL1671528,Antibacterial activity against Escherichia coli 10-02 after 18 to 24 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1667809,Bioorg Med Chem Lett,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1329322,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.5
56045,,5194935,CHEMBL1671529,Antibacterial activity against Klebsiella pneumoniae 10-1 after 18 to 24 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1667809,Bioorg Med Chem Lett,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1329322,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,32.0
56046,,5194956,CHEMBL1671530,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 18 to 24 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1667809,Bioorg Med Chem Lett,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1329322,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,4.0
56047,,5194977,CHEMBL1671531,Antibacterial activity against Pseudomonas aeruginosa 10-1 after 18 to 24 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1667809,Bioorg Med Chem Lett,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1329322,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,2.0
56048,,5206323,CHEMBL1671222,Antibacterial activity against Staphylococcus aureus ATCC 25923 after 18 to 24 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1667809,Bioorg Med Chem Lett,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1329322,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.125
56049,,5206344,CHEMBL1671223,Antibacterial activity against methicillin-sensitive Staphylococcus aureus 10-04 after 18 to 24 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1667809,Bioorg Med Chem Lett,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1329322,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
56050,,5206365,CHEMBL1671224,Antibacterial activity against methicillin-resistant Staphylococcus aureus 10-05 after 18 to 24 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1667809,Bioorg Med Chem Lett,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1329322,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,32.0
56051,,5206386,CHEMBL1671225,Antibacterial activity against methicillin-sensitive Staphylococcus epidermidis 10-4 after 18 to 24 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1667809,Bioorg Med Chem Lett,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1329322,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,2.0
56052,,5206407,CHEMBL1671226,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis 10-5 after 18 to 24 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1667809,Bioorg Med Chem Lett,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1329322,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,8.0
56053,,5206428,CHEMBL1671525,Antibacterial activity against Streptococcus pneumoniae 1001 after 18 to 24 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1667809,Bioorg Med Chem Lett,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1329322,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.015
56054,,5209464,CHEMBL1678307,Antimicrobial activity against Escherichia coli MG1655 after 24 hrs by modified broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671737,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332588,=,1,1,=,MIC,ug.mL-1,0.016,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,mg/L,UO_0000274,0.016
56055,,5209465,CHEMBL1678305,Antimicrobial activity against methicillin-resistant Staphylococcus aureus ASAU021 after 24 hrs by modified broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671737,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332588,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,1.0
56056,,5209466,CHEMBL1678306,Antimicrobial activity against recA-deficient Staphylococcus aureus ASAU022 after 24 hrs by modified broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671737,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332588,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,0.25
56057,,5209467,CHEMBL1678308,Antimicrobial activity against recA-deficient Escherichia coli MG1655 after 24 hrs by modified broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671737,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332588,=,1,1,=,MIC,ug.mL-1,0.004,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,mg/L,UO_0000274,0.004
56058,,5209468,CHEMBL1678309,"Antimicrobial activity methicillin-resistant against Staphylococcus aureus ASAU021 harboring gyrA S84A, S84L, S84P, E88G and E88K mutant recovered from compound supplemented plates after 24 hrs by modified broth macrodilution method relative to wild type",F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671737,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1332588,>,1,0,>,FC,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,FC,,,4.0
56059,,5209469,CHEMBL1678310,"Antimicrobial activity against Escherichia coli MG1655 harboring gyrA S84A, S83L, D87G, D87Y mutant recovered from compound supplemented plates after 24 hrs by modified broth macrodilution method relative to wild type",F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671737,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1332588,=,1,0,=,FC,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,FC,,,8.0
56060,Active,5209470,CHEMBL1678311,Bactericidal activity against recA-deficient Staphylococcus aureus ASAU022 assessed as induction of slow growth rate at 0.5 times MIC by time kill study,F,BAO_0000201,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671737,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332588,,1,0,,Inhibition,%,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,INH,,UO_0000187,
56061,Active,5209471,CHEMBL1678312,Bactericidal activity against recA-deficient Staphylococcus aureus ASAU022 assessed as induction of increase bacterial kill rate at 2 times MIC by time kill study,F,BAO_0000201,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671737,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332588,,1,0,,Inhibition,%,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,INH,,UO_0000187,
56062,Active,5209472,CHEMBL1678313,Antimicrobial activity against methicillin-resistant Staphylococcus aureus ASAU021 infected in in vitro hollow fiber infection model assessed as suppression of microbial resistance at AUC/MIC ratio of >32,F,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671737,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1332588,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
56063,Active,5209473,CHEMBL1678314,Antimicrobial activity against recA-deficient Staphylococcus aureus ASAU022 infected in in vitro hollow fiber infection model assessed as suppression of microbial resistance at AUC/MIC ratio of >23,F,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671737,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1332588,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
56064,Active,5209474,CHEMBL1678315,Antimicrobial activity against recA-deficient Staphylococcus aureus ASAU022 infected in in vitro hollow fiber infection model assessed as suppression of microbial resistance at AUC/MIC ratio of 31,F,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671737,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1332588,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
56065,,5209824,CHEMBL1678977,Antimicrobial activity against ESBL producing Escherichia coli isolated from patient bloodstream assessed as resistant isolate by Etest method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671616,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1331735,=,1,0,=,Activity,%,92.2,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,92.2
56066,,5210727,CHEMBL1676035,Ratio of MIC for wild type Pseudomonas aeruginosa PAO1 to Pseudomonas aeruginosa PAO1 horboring gabD mutant gene,F,BAO_0000193,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671741,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1332597,=,1,0,=,Ratio,,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Ratio,,,8.0
56067,,5210728,CHEMBL1676036,Ratio of MIC for wild type Pseudomonas aeruginosa PAO1 to Pseudomonas aeruginosa PAO1 horboring yaaA mutant gene,F,BAO_0000193,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671741,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1332597,=,1,0,=,Ratio,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Ratio,,,2.0
56068,,5210741,CHEMBL1677626,Antibacterial activity against wild type Pseudomonas aeruginosa PAO1 assessed as viable bacterial count by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671741,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332597,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,2.0
56069,,5210742,CHEMBL1676040,Antibacterial activity against Pseudomonas aeruginosa PAO1 harboring gatA::ISphoA/haha mutation by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671741,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332597,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.5
56070,,5210743,CHEMBL1676041,Antibacterial activity against Pseudomonas aeruginosa PAO1 harboring phoU::ISphoA/haha mutation by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671741,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332597,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,1.0
56071,,5210744,CHEMBL1676042,Antibacterial activity against Pseudomonas aeruginosa PAO1 harboring gabD::ISphoA/haha mutation by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671741,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332597,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.25
56072,,5210745,CHEMBL1676043,Antibacterial activity against Pseudomonas aeruginosa PAO1 harboring mmsA::ISphoA/haha mutation by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671741,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332597,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.25
56073,,5210746,CHEMBL1676044,Antibacterial activity against Pseudomonas aeruginosa PAO1 harboring yaaA::ISphoA/haha mutation by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671741,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332597,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.25
56074,,5210747,CHEMBL1676045,Antibacterial activity against Pseudomonas aeruginosa PAO1 harboring gabD::ISlacZ/haha mutation by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671741,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332597,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.25
56075,,5210779,CHEMBL1676046,Antibacterial activity against intI1-positive tigecycline-susceptible Acinetobacter baumannii AB018 with PFGE subgroup G containing carbapenemase OXA-58 and OXA-51 by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332606,=,1,1,=,MIC,ug.mL-1,6.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,mg/L,UO_0000274,6.0
56076,,5210785,CHEMBL1676047,Antibacterial activity against intI1-positive tigecycline-susceptible Acinetobacter baumannii AB039 with PFGE subgroup B1 containing carbapenemase OXA-23 and OXA-51 by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332606,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,mg/L,UO_0000274,8.0
56077,,5210791,CHEMBL1676048,Antibacterial activity against intI1-positive tigecycline-susceptible Acinetobacter baumannii AB095 with PFGE subgroup E containing carbapenemase OXA-23 and OXA-51 by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332606,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,mg/L,UO_0000274,32.0
56078,,5210797,CHEMBL1676049,Antibacterial activity against intI1-positive tigecycline-susceptible Acinetobacter baumannii AB110 with PFGE subgroup C containing carbapenemase OXA-51 by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332606,=,1,1,=,MIC,ug.mL-1,12.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,mg/L,UO_0000274,12.0
56079,,5210803,CHEMBL1676050,Antibacterial activity against intI1-positive tigecycline-intermediate Acinetobacter baumannii AB127 with PFGE subgroup I containing carbapenemase OXA-23 and OXA-51 by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332606,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,mg/L,UO_0000274,32.0
56080,,5210809,CHEMBL1676051,Antibacterial activity against intI1-positive tigecycline-intermediate Acinetobacter baumannii AB166 with PFGE subgroup A3 containing carbapenemase OXA-51 by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332606,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,mg/L,UO_0000274,32.0
56081,,5210815,CHEMBL1676052,Antibacterial activity against intI1-negative tigecycline-intermediate Acinetobacter baumannii AB098 with PFGE subgroup F containing carbapenemase OXA-23 and OXA-51 by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332606,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,mg/L,UO_0000274,32.0
56082,,5210821,CHEMBL1676053,Antibacterial activity against intI1-positive tigecycline-intermediate Acinetobacter baumannii AB099 with PFGE subgroup H containing carbapenemase OXA-23 and OXA-51 by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332606,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,mg/L,UO_0000274,32.0
56083,,5210827,CHEMBL1676054,Antibacterial activity against intI1-positive tigecycline-resistant Acinetobacter baumannii AB106 with PFGE subgroup B1 containing carbapenemase OXA-23 and OXA-51 by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332606,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,mg/L,UO_0000274,32.0
56084,,5210833,CHEMBL1676055,Antibacterial activity against intI1-positive tigecycline-resistant Acinetobacter baumannii AB113 with PFGE subgroup B1 containing carbapenemase OXA-23 and OXA-51 by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332606,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,mg/L,UO_0000274,32.0
56085,,5210839,CHEMBL1676056,Antibacterial activity against intI1-positive tigecycline-resistant Acinetobacter baumannii AB118 with PFGE subgroup B2 containing carbapenemase OXA-23 and OXA-51 by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332606,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,mg/L,UO_0000274,32.0
56086,,5210845,CHEMBL1676057,Antibacterial activity against intI1-positive tigecycline-resistant Acinetobacter baumannii AB125 with PFGE subgroup A1 containing carbapenemase OXA-23 and OXA-51 by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332606,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,mg/L,UO_0000274,32.0
56087,,5210851,CHEMBL1676058,Antibacterial activity against intI1-positive tigecycline-resistant Acinetobacter baumannii AB134 with PFGE subgroup A2 containing carbapenemase OXA-23 and OXA-51 by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332606,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,mg/L,UO_0000274,32.0
56088,,5210857,CHEMBL1676059,Antibacterial activity against intI1-positive tigecycline-resistant Acinetobacter baumannii AB168 with PFGE subgroup A1 containing carbapenemase OXA-23 and OXA-51 by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332606,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,mg/L,UO_0000274,32.0
56089,,5210863,CHEMBL1676060,Antibacterial activity against intI1-positive tigecycline-resistant Acinetobacter baumannii AB173 with PFGE subgroup B1 containing carbapenemase OXA-23 and OXA-51 by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332606,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,mg/L,UO_0000274,32.0
56090,,5210869,CHEMBL1676061,Antibacterial activity against intI1-positive tigecycline-resistant Acinetobacter baumannii AB097 with PFGE subgroup B1 containing carbapenemase OXA-23 and OXA-51 by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332606,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,mg/L,UO_0000274,32.0
56091,,5210875,CHEMBL1676062,Antibacterial activity against intI1-positive tigecycline-resistant Acinetobacter baumannii AB096 with PFGE subgroup B1 containing carbapenemase OXA-23 and OXA-51 by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332606,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,mg/L,UO_0000274,32.0
56092,,5210987,CHEMBL1679717,"Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii beta clonal group isolate 9 expressing ampC, ompA, adeB, adeM by Etest method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331742,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,32.0
56093,,5210988,CHEMBL1679719,"Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii beta clonal group isolate 10 expressing ompA, adeB, adeM, aacA4, blaSHV-5 by Etest method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331742,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,32.0
56094,,5210989,CHEMBL1679721,"Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii beta clonal group isolate 11 expressing ompA, adeB, adeM, blaSHV-5 by Etest method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331742,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,32.0
56095,,5210990,CHEMBL1679723,"Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii beta clonal group isolate 12 expressing ompA, adeB, adeM, aacA4, aacC2, blaSHV-5 by Etest method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331742,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,32.0
56096,,5210991,CHEMBL1679725,"Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii beta clonal group isolate 13 expressing ompA, adeB, adeM, aacA4, blaSHV-5 by Etest method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331742,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,32.0
56097,,5210992,CHEMBL1679727,"Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii beta clonal group isolate 14 expressing ompA, adeB, adeM, aacA4, blaSHV-5 by Etest method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331742,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,32.0
56098,,5210993,CHEMBL1679729,"Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii beta clonal group isolate 15 expressing ompA, adeB, adeM, aacA4, blaSHV-5 by Etest method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331742,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,32.0
56099,,5210994,CHEMBL1679731,"Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii beta clonal group isolate 16 expressing ompA, adeB, adeM, aacA4, blaSHV-5 by Etest method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331742,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,32.0
56100,,5210995,CHEMBL1679733,"Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii beta clonal group isolate 17 expressing ompA, adeB, adeM, aacA4, blaSHV-5 by Etest method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331742,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,32.0
56101,,5210996,CHEMBL1679863,"Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii beta clonal group isolate 18 expressing ompA, adeB, adeM, aacA4, blaSHV-5 by Etest method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331742,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,32.0
56102,,5210997,CHEMBL1679869,"Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii zeta clonal group isolate 21 expressing ampC, ompA, adeB, adeM, aacC2, blaSHV-5 by Etest method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331742,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,32.0
56103,,5210998,CHEMBL1680767,"Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii unique clonal group isolate 40 expressing ampC, ompA, adeB, adeM, aadA1, aacA4, aacC2, blaSHV-5 by Etest method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331742,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,32.0
56104,,5211027,CHEMBL1678986,"Antimicrobial activity against Acinetobacter baumannii alpha clonal group isolate 2 expressing ampC, ompA, adeB, adeM, aacC1, aadA1 by Etest method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331742,>,1,1,>,MIC,ug.mL-1,12.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,12.0
56105,,5211028,CHEMBL1678987,"Antimicrobial activity against Acinetobacter baumannii alpha clonal group isolate 3 expressing ampC, ompA, adeB, adeM, aacC1, aadA1 by Etest method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331742,>,1,1,>,MIC,ug.mL-1,12.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,12.0
56106,,5211029,CHEMBL1678988,"Antimicrobial activity against Acinetobacter baumannii alpha clonal group isolate 4 expressing ampC, ompA, adeB, adeM, aacC1, aadA1 by Etest method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331742,>,1,1,>,MIC,ug.mL-1,12.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,12.0
56107,,5211030,CHEMBL1678989,"Antimicrobial activity against Acinetobacter baumannii alpha clonal group isolate 5 expressing ampC, ompA, adeB, adeM, aacC1, aadA1 by Etest method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331742,>,1,1,>,MIC,ug.mL-1,12.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,12.0
56108,,5211031,CHEMBL1680749,"Antimicrobial activity against Acinetobacter baumannii nu clonal group isolate 31 expressing ampC, ompA, adeB, adeM, aadB, aadA2 by Etest method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331742,>,1,1,>,MIC,ug.mL-1,12.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,12.0
56109,,5211032,CHEMBL1680751,"Antimicrobial activity against Acinetobacter baumannii nu clonal group isolate 32 expressing ampC, ompA, adeB, adeM, aadB, aadA2 by Etest method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331742,>,1,1,>,MIC,ug.mL-1,12.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,12.0
56110,,5211065,CHEMBL1680757,"Antimicrobial activity against Acinetobacter baumannii eta clonal group isolate 35 expressing ampC, ompA, adeB, adeM by Etest method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331742,>,1,1,>,MIC,ug.mL-1,6.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,6.0
56111,,5211066,CHEMBL1680759,"Antimicrobial activity against Acinetobacter baumannii eta clonal group isolate 36 expressing ampC, ompA, adeB, adeM by Etest method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331742,>,1,1,>,MIC,ug.mL-1,6.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,6.0
56112,,5211075,CHEMBL1680765,"Antimicrobial activity against Acinetobacter baumannii unique clonal group isolate 39 expressing ampC, ompA, adeM by Etest method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331742,=,1,1,=,MIC,ug.mL-1,0.09,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,0.09
56113,,5211077,CHEMBL1680763,"Antimicrobial activity against Acinetobacter baumannii unique clonal group isolate 38 expressing ampC, ompA, adeB, adeM by Etest method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331742,=,1,1,=,MIC,ug.mL-1,0.13,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,0.13
56114,,5211134,CHEMBL1680600,"Antimicrobial activity against Acinetobacter baumannii lambda clonal group isolate 27 expressing ampC, ompA, adeB, adeM, aadB, aadA1 by Etest method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331742,=,1,1,=,MIC,ug.mL-1,3.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,3.0
56115,,5211155,CHEMBL1678991,"Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii alpha clonal group isolate 6 expressing ampC, ompA, adeB, adeM, aacC1, aadA1 by Etest method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331742,=,1,1,=,MIC,ug.mL-1,6.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,6.0
56116,,5211156,CHEMBL1679713,"Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii alpha clonal group isolate 7 expressing ampC, ompA, adeB, adeM, blaSHV-5 by Etest method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331742,=,1,1,=,MIC,ug.mL-1,6.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,6.0
56117,,5211157,CHEMBL1680761,"Antimicrobial activity against Acinetobacter baumannii unique clonal group isolate 37 expressing ampC, ompA, adeB, adeM by Etest method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331742,=,1,1,=,MIC,ug.mL-1,6.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,6.0
56118,,5211160,CHEMBL1680602,"Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii lambda clonal group isolate 28 expressing ampC, ompA, adeM, aadB, aadA1 by Etest method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331742,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,8.0
56119,,5211161,CHEMBL1680745,"Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii lambda clonal group isolate 29 expressing ampC, ompA, adeM, aadB, aadA1 by Etest method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331742,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,8.0
56120,,5211166,CHEMBL1679873,"Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii zeta clonal group isolate 23 expressing ampC, ompA, adeB, adeM, aadA1, aacA4, aacC2, aphA6 by Etest method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331742,=,1,1,=,MIC,ug.mL-1,12.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,12.0
56121,,5211176,CHEMBL1678981,"Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii alpha clonal group isolate 1 expressing ampC, ompA, adeB, adeM by Etest method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331742,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,16.0
56122,,5211177,CHEMBL1679871,"Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii zeta clonal group isolate 22 expressing ampC, ompA, adeB, adeM, aadA1, aacA4, aacC2, blaSHV-5 by Etest method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331742,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,16.0
56123,,5211178,CHEMBL1680747,"Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii lambda clonal group isolate 30 expressing ampC, ompA, adeB, adeM, aadB, aadA1 by Etest method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331742,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,16.0
56124,,5211198,CHEMBL1679715,"Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii alpha clonal group isolate 8 expressing ampC, ompA, adeB, adeM, aacC1, aadA1 by Etest method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331742,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,32.0
56125,,5211278,CHEMBL1679865,"Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii zeta clonal group isolate 19 expressing ampC, ompA, adeB, adeM, aacC2 by Etest method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331742,=,1,1,=,MIC,ug.mL-1,12.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,12.0
56126,,5211279,CHEMBL1679867,"Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii zeta clonal group isolate 20 expressing ampC, ompA, adeB, adeM, aacC2 by Etest method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331742,=,1,1,=,MIC,ug.mL-1,12.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,12.0
56127,,5211290,CHEMBL1679875,"Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii zeta clonal group isolate 24 expressing ampC, ompA, adeB, adeM, aadA1, aacA4, aacC2, blaSHV-5 by Etest method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331742,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,16.0
56128,,5211291,CHEMBL1679877,"Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii zeta clonal group isolate 25 expressing ampC, ompA, adeB, adeM, aadA1, aacA4, aacC2, blaSHV-5 by Etest method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331742,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,16.0
56129,,5211292,CHEMBL1679879,"Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii zeta clonal group isolate 26 expressing ampC, ompA, adeB, adeM, aadA1, aacA4, aacC2, blaSHV-5 by Etest method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331742,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,16.0
56130,,5211828,CHEMBL1678783,"Antimicrobial activity against Escherichia coli isolate 157 expressing beta-lactamase KPC2, CTX-M-15, TEM and PFGE cluster 3 isolated from urine of patient by vitek-2 method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671686,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332142,>,1,1,>,MIC,ug.mL-1,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,8.0
56131,,5211829,CHEMBL1678784,Antimicrobial activity against Escherichia coli isolate 157T expressing beta-lactamase KPC2 and PFGE cluster 3 isolated from urine of patient by vitek-2 method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671686,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332142,<,1,1,<,MIC,ug.mL-1,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.25
56132,,5211830,CHEMBL1678785,"Antimicrobial activity against Escherichia coli isolate 329 expressing beta-lactamase KPC2, CTX-M-2, TEM and PFGE cluster 2 isolated from blood of patient by vitek-2 method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671686,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332142,>,1,1,>,MIC,ug.mL-1,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,8.0
56133,,5211831,CHEMBL1678786,Antimicrobial activity against Escherichia coli isolate 329T expressing beta-lactamase KPC2 and PFGE cluster 2 isolated from blood of patient by vitek-2 method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671686,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332142,<,1,1,<,MIC,ug.mL-1,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.25
56134,,5211832,CHEMBL1674594,"Antimicrobial activity against Escherichia coli isolate 339 expressing beta-lactamase KPC2, TEM and PFGE cluster 5 isolated from peritoneal fluid of patient by vitek-2 method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671686,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332142,>,1,1,>,MIC,ug.mL-1,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,8.0
56135,,5211833,CHEMBL1674595,Antimicrobial activity against Escherichia coli isolate 339T expressing beta-lactamase KPC2 and PFGE cluster 5 isolated from peritoneal fluid of patient by vitek-2 method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671686,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332142,<,1,1,<,MIC,ug.mL-1,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.25
56136,,5211834,CHEMBL1674596,"Antimicrobial activity against Escherichia coli isolate 360 expressing beta-lactamase KPC2, CTX-M-15, OXA-9, TEM and PFGE cluster 1 isolated from urine of patient by vitek-2 method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671686,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332142,>,1,1,>,MIC,ug.mL-1,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,8.0
56137,,5211835,CHEMBL1674597,"Antimicrobial activity against Escherichia coli isolate 360T expressing beta-lactamase KPC2, OXA-9 and PFGE cluster 1 isolated from urine of patient by vitek-2 method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671686,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332142,<,1,1,<,MIC,ug.mL-1,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.25
56138,,5211836,CHEMBL1674598,"Antimicrobial activity against Escherichia coli isolate 386 expressing beta-lactamase KPC2, CTX-M-15, OXA-9, TEM and PFGE cluster 1 isolated from wound of patient by vitek-2 method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671686,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332142,>,1,1,>,MIC,ug.mL-1,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,8.0
56139,,5211837,CHEMBL1674599,"Antimicrobial activity against Escherichia coli isolate 386T expressing beta-lactamase KPC2, OXA-9 and PFGE cluster 1 isolated from wound of patient by vitek-2 method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671686,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332142,<,1,1,<,MIC,ug.mL-1,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.25
56140,,5211838,CHEMBL1674600,"Antimicrobial activity against Escherichia coli isolate 540 expressing beta-lactamase KPC2, TEM and PFGE cluster 4 isolated from synovial fluid of patient by vitek-2 method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671686,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332142,>,1,1,>,MIC,ug.mL-1,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,8.0
56141,,5211839,CHEMBL1674601,"Antimicrobial activity against Escherichia coli isolate 543 expressing beta-lactamase KPC2, CTX-M-15, TEM and PFGE cluster 4 isolated from synovial fluid of patient by vitek-2 method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671686,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332142,>,1,1,>,MIC,ug.mL-1,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,8.0
56142,,5211840,CHEMBL1674602,Antimicrobial activity against Escherichia coli isolate 543T expressing beta-lactamase KPC2 and PFGE cluster 4 isolated from synovial fluid of patient by vitek-2 method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671686,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332142,<,1,1,<,MIC,ug.mL-1,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.25
56143,,5211841,CHEMBL1674603,"Antimicrobial activity against Escherichia coli isolate 544 expressing beta-lactamase KPC2, TEM and PFGE cluster 4 isolated from abscess of patient by vitek-2 method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671686,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332142,>,1,1,>,MIC,ug.mL-1,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,8.0
56144,,5211842,CHEMBL1674604,"Antimicrobial activity against Escherichia coli isolate 547 expressing beta-lactamase KPC2, TEM and PFGE cluster 4 isolated from blood of patient by vitek-2 method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671686,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332142,>,1,1,>,MIC,ug.mL-1,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,8.0
56145,,5211843,CHEMBL1674605,Antimicrobial activity against Escherichia coli isolate 547T expressing beta-lactamase KPC2 and PFGE cluster 4 isolated from blood of patient by vitek-2 method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671686,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332142,<,1,1,<,MIC,ug.mL-1,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.25
56146,,5211844,CHEMBL1674606,"Antimicrobial activity against Escherichia coli isolate 1679 expressing beta-lactamase KPC2, SHV-12, TEM and PFGE cluster 6 isolated from peritoneal fluid of patient by vitek-2 method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671686,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332142,>,1,1,>,MIC,ug.mL-1,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,8.0
56147,,5211845,CHEMBL1674607,"Antimicrobial activity against Escherichia coli isolate 1679T expressing beta-lactamase KPC2, TEM and PFGE cluster 6 isolated from peritoneal fluid of patient by vitek-2 method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671686,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332142,<,1,1,<,MIC,ug.mL-1,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.25
56148,,5211846,CHEMBL1674608,Antimicrobial activity against Escherichia coli DH10B by vitek-2 method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671686,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332142,<,1,1,<,MIC,ug.mL-1,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.25
56149,,5212012,CHEMBL1676501,Antimicrobial activity against Streptococcus pneumoniae serotype 7F by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332160,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,1.0
56150,Not Active,5212326,CHEMBL1673527,Antimycobacterial activity against extensively drug-resistant Mycobacterium tuberculosis isolate 2301 obtained from sputum of patient at 2 ug/ml by Bactec MGIT960 modified proportion method,F,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671750,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1332671,,1,0,,Activity,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,Activity,,,
56151,Not Active,5212336,CHEMBL1673521,Antimycobacterial activity against extensively drug-resistant Mycobacterium tuberculosis isolate 2403 obtained from sputum of patient at 2 ug/ml by Bactec MGIT960 modified proportion method,F,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671750,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1332671,,1,0,,Activity,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,Activity,,,
56152,Not Active,5212343,CHEMBL1675242,Antimycobacterial activity against extensively drug-resistant Mycobacterium tuberculosis isolate 761 obtained from pus of patient at 2 ug/ml by Bactec MGIT960 modified proportion method,F,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671750,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1332671,,1,0,,Activity,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,Activity,,,
56153,Not Determined,5212353,CHEMBL1675236,Antimycobacterial activity against extensively drug-resistant Mycobacterium tuberculosis isolate 625 obtained from sputum of patient at 2 ug/ml by Bactec MGIT960 modified proportion method,F,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671750,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1332671,,1,0,,Activity,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,Activity,,,
56154,Not Active,5212363,CHEMBL1673533,Antimycobacterial activity against extensively drug-resistant Mycobacterium tuberculosis isolate 2911 obtained from sputum of patient at 2 ug/ml by Bactec MGIT960 modified proportion method,F,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671750,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1332671,,1,0,,Activity,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,Activity,,,
56155,,5212370,CHEMBL1680753,"Antimicrobial activity against Acinetobacter baumannii nu clonal group isolate 33 expressing ampC, ompA, adeB, adeM by Etest method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331742,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,4.0
56156,,5212371,CHEMBL1680755,"Antimicrobial activity against Acinetobacter baumannii nu clonal group isolate 34 expressing ampC, ompA, adeB, adeM by Etest method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331742,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,4.0
56157,,5213059,CHEMBL1676500,Antimicrobial activity against Streptococcus pneumoniae serotype 35B by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332160,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,1.0
56158,,5213069,CHEMBL1676500,Antimicrobial activity against Streptococcus pneumoniae serotype 35B by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332160,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,1.0
56159,,5213079,CHEMBL1676499,Antimicrobial activity against Streptococcus pneumoniae serotype 3 by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332160,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,1.0
56160,,5213082,CHEMBL1676499,Antimicrobial activity against Streptococcus pneumoniae serotype 3 by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332160,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,1.0
56161,,5213090,CHEMBL1676498,Antimicrobial activity against Streptococcus pneumoniae serotype 19A by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332160,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,1.0
56162,,5213095,CHEMBL1676498,Antimicrobial activity against Streptococcus pneumoniae serotype 19A by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332160,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,1.0
56163,,5213114,CHEMBL1676501,Antimicrobial activity against Streptococcus pneumoniae serotype 7F by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332160,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,1.0
56164,,5213116,CHEMBL1676618,Antimicrobial activity against Streptococcus pneumoniae serotype 11A by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332160,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,1.0
56165,,5213119,CHEMBL1676619,Antimicrobial activity against Streptococcus pneumoniae serotype 6C by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332160,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,1.0
56166,,5213123,CHEMBL1676619,Antimicrobial activity against Streptococcus pneumoniae serotype 6C by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332160,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,1.0
56167,,5213126,CHEMBL1676620,Antimicrobial activity against multiple drug resistant Streptococcus pneumoniae serotype 19A by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332160,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,1.0
56168,,5213128,CHEMBL1676620,Antimicrobial activity against multiple drug resistant Streptococcus pneumoniae serotype 19A by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332160,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,1.0
56169,,5213131,CHEMBL1676621,Antimicrobial activity against multiple drug resistant Streptococcus pneumoniae serotype 19F by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332160,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,1.0
56170,,5213133,CHEMBL1676621,Antimicrobial activity against multiple drug resistant Streptococcus pneumoniae serotype 19F by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332160,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,1.0
56171,,5213136,CHEMBL1676622,Antimicrobial activity against multiple drug resistant Streptococcus pneumoniae serotype 6B by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332160,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,1.0
56172,,5213138,CHEMBL1676622,Antimicrobial activity against multiple drug resistant Streptococcus pneumoniae serotype 6B by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332160,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,1.0
56173,,5213146,CHEMBL1676618,Antimicrobial activity against Streptococcus pneumoniae serotype 11A by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332160,=,1,1,=,MIC90,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,2.0
56174,,5213260,CHEMBL1676498,Antimicrobial activity against Streptococcus pneumoniae serotype 19A by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332160,<=,1,1,<=,MIC,ug.mL-1,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.25
56175,,5213288,CHEMBL1676619,Antimicrobial activity against Streptococcus pneumoniae serotype 6C by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332160,<=,1,1,<=,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
56176,,5213289,CHEMBL1676499,Antimicrobial activity against Streptococcus pneumoniae serotype 3 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332160,<=,1,1,<=,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
56177,,5213290,CHEMBL1676501,Antimicrobial activity against Streptococcus pneumoniae serotype 7F by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332160,<=,1,1,<=,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
56178,,5213291,CHEMBL1676618,Antimicrobial activity against Streptococcus pneumoniae serotype 11A by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332160,<=,1,1,<=,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
56179,,5213292,CHEMBL1676500,Antimicrobial activity against Streptococcus pneumoniae serotype 35B by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332160,<=,1,1,<=,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
56180,Not Determined,5213398,CHEMBL1673539,Antimycobacterial activity against extensively drug-resistant Mycobacterium tuberculosis isolate 2474 obtained from sputum of patient at 2 ug/ml by Bactec MGIT960 modified proportion method,F,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671750,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1332671,,1,0,,Activity,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,Activity,,,
56181,,5214019,CHEMBL1674079,Antibacterial activity against methicillin-susceptible Staphylococcus aureus by CLSI M7-A7 broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,MIC50,ug.mL-1,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,0.12
56182,,5214029,CHEMBL1674080,Antibacterial activity against methicillin-susceptible Staphylococcus aureus assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,Activity,%,83.9,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,83.9
56183,,5214038,CHEMBL1674081,Antibacterial activity against methicillin-susceptible Staphylococcus aureus assessed as resistant isolates by CLSI M7-A7 broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,Activity,%,15.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,15.2
56184,,5214048,CHEMBL1674082,Antibacterial activity against methicillin-resistant Staphylococcus aureus by CLSI M7-A7 broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,MIC50,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,8.0
56185,,5214058,CHEMBL1674083,Antibacterial activity against methicillin-resistant Staphylococcus aureus assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,Activity,%,25.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,25.6
56186,,5214067,CHEMBL1674198,Antibacterial activity against methicillin-resistant Staphylococcus aureus assessed as resistant isolates by CLSI M7-A7 broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,Activity,%,73.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,73.2
56187,,5214077,CHEMBL1674199,Antibacterial activity against coagulase-negative and oxacillin-susceptible Staphylococcus aureus by CLSI M7-A7 broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,MIC50,ug.mL-1,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,0.12
56188,,5214087,CHEMBL1674200,Antibacterial activity against coagulase-negative and oxacillin-susceptible Staphylococcus aureus assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,Activity,%,81.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,81.6
56189,,5214448,CHEMBL1677043,Antimicrobial activity against Streptococcus pneumoniae serotype 19A assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332160,=,1,0,=,Activity,%,100.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,100.0
56190,,5214459,CHEMBL1677044,Antimicrobial activity against Streptococcus pneumoniae serotype 3 assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332160,=,1,0,=,Activity,%,100.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,100.0
56191,,5214470,CHEMBL1677045,Antimicrobial activity against Streptococcus pneumoniae serotype 35B assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332160,=,1,0,=,Activity,%,98.3,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,98.3
56192,,5214481,CHEMBL1677046,Antimicrobial activity against Streptococcus pneumoniae serotype 7F assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332160,=,1,0,=,Activity,%,98.3,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,98.3
56193,,5214493,CHEMBL1677047,Antimicrobial activity against Streptococcus pneumoniae serotype 11A assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332160,=,1,0,=,Activity,%,100.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,100.0
56194,,5214505,CHEMBL1677048,Antimicrobial activity against Streptococcus pneumoniae serotype 6C assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332160,=,1,0,=,Activity,%,100.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,100.0
56195,,5214517,CHEMBL1677049,Antimicrobial activity against multiple drug resistant Streptococcus pneumoniae serotype 19A assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332160,=,1,0,=,Activity,%,99.2,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,99.2
56196,,5214529,CHEMBL1677050,Antimicrobial activity against multiple drug resistant Streptococcus pneumoniae serotype 19F assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332160,=,1,0,=,Activity,%,99.2,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,99.2
56197,,5214541,CHEMBL1677051,Antimicrobial activity against multiple drug resistant Streptococcus pneumoniae serotype 6B assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332160,=,1,0,=,Activity,%,99.2,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,99.2
56198,,5214584,CHEMBL1677175,Antimicrobial activity against Streptococcus pneumoniae serotype 15A assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332160,=,1,0,=,Activity,%,100.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,100.0
56199,,5214585,CHEMBL1677176,Antimicrobial activity against Streptococcus pneumoniae serotype 22F assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332160,=,1,0,=,Activity,%,100.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,100.0
56200,,5214586,CHEMBL1677179,Antimicrobial activity against Streptococcus pneumoniae serotype 23A assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332160,=,1,0,=,Activity,%,100.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,100.0
56201,,5214587,CHEMBL1677177,Antimicrobial activity against Streptococcus pneumoniae serotype 23B assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332160,=,1,0,=,Activity,%,97.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,97.0
56202,,5214588,CHEMBL1677178,Antimicrobial activity against Streptococcus pneumoniae serotype 19F assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332160,=,1,0,=,Activity,%,96.6,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,96.6
56203,,5214889,CHEMBL1677458,Antimicrobial activity against Chlamydia trachomatis serovar F infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332745,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,MIC,ug ml-1,UO_0000274,0.5
56204,,5214890,CHEMBL1677457,Antimicrobial activity against Chlamydia trachomatis serovar E infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332745,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,MIC,ug ml-1,UO_0000274,0.5
56205,,5214891,CHEMBL1677456,Antimicrobial activity against Chlamydia trachomatis serovar D infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332745,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,MIC,ug ml-1,UO_0000274,0.5
56206,,5214892,CHEMBL1677459,Antimicrobial activity against Chlamydia trachomatis serovar G infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332745,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,MIC,ug ml-1,UO_0000274,0.25
56207,,5214893,CHEMBL1677460,Antimicrobial activity against Chlamydia trachomatis serovar H infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332745,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,MIC,ug ml-1,UO_0000274,0.5
56208,,5214894,CHEMBL1677461,Antimicrobial activity against Chlamydia trachomatis serovar I infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332745,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,MIC,ug ml-1,UO_0000274,0.5
56209,,5214895,CHEMBL1677462,Antimicrobial activity against Chlamydia trachomatis serovar J infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332745,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,MIC,ug ml-1,UO_0000274,0.5
56210,,5214896,CHEMBL1677463,Antimicrobial activity against Chlamydia trachomatis serovar K infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332745,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,MIC,ug ml-1,UO_0000274,0.5
56211,,5214897,CHEMBL1677464,Bactericidal activity against Chlamydia trachomatis serovar D infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332745,=,1,0,=,MBC,ug ml-1,0.5,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,MBC,ug ml-1,UO_0000274,0.5
56212,,5214898,CHEMBL1677465,Bactericidal activity against Chlamydia trachomatis serovar E infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332745,=,1,0,=,MBC,ug ml-1,0.5,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,MBC,ug ml-1,UO_0000274,0.5
56213,,5214899,CHEMBL1677466,Bactericidal activity against Chlamydia trachomatis serovar F infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332745,=,1,0,=,MBC,ug ml-1,0.5,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,MBC,ug ml-1,UO_0000274,0.5
56214,,5214900,CHEMBL1677467,Bactericidal activity against Chlamydia trachomatis serovar G infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332745,=,1,0,=,MBC,ug ml-1,0.25,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,MBC,ug ml-1,UO_0000274,0.25
56215,,5214901,CHEMBL1677468,Bactericidal activity against Chlamydia trachomatis serovar H infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332745,=,1,0,=,MBC,ug ml-1,0.5,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,MBC,ug ml-1,UO_0000274,0.5
56216,,5214902,CHEMBL1677469,Bactericidal activity against Chlamydia trachomatis serovar I infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332745,=,1,0,=,MBC,ug ml-1,0.5,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,MBC,ug ml-1,UO_0000274,0.5
56217,,5214903,CHEMBL1677470,Bactericidal activity against Chlamydia trachomatis serovar J infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332745,=,1,0,=,MBC,ug ml-1,0.5,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,MBC,ug ml-1,UO_0000274,0.5
56218,,5214904,CHEMBL1677471,Bactericidal activity against Chlamydia trachomatis serovar K infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332745,=,1,0,=,MBC,ug ml-1,0.5,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,MBC,ug ml-1,UO_0000274,0.5
56219,,5214905,CHEMBL1677472,Antimicrobial activity against Chlamydia trachomatis Ic Cal-8 serovar D infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332745,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,MIC,ug ml-1,UO_0000274,0.5
56220,,5214906,CHEMBL1677473,Antimicrobial activity against Chlamydia trachomatis Bour serovar E infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,BAO_0002146,BAO_0000219,cell-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332745,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,MIC,ug ml-1,UO_0000274,0.5
56221,,5214907,CHEMBL1677474,Antimicrobial activity against Chlamydia trachomatis 580 serovar H infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332745,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,MIC,ug ml-1,UO_0000274,0.5
56222,,5214908,CHEMBL1677475,Antimicrobial activity against Chlamydia trachomatis UW-36 serovar J infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,BAO_0002146,BAO_0000219,cell-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332745,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,MIC,ug ml-1,UO_0000274,0.5
56223,,5214989,CHEMBL1677472,Antimicrobial activity against Chlamydia trachomatis Ic Cal-8 serovar D infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332745,=,1,0,=,MBC,ug ml-1,0.5,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,MBC,ug ml-1,UO_0000274,0.5
56224,,5214990,CHEMBL1677473,Antimicrobial activity against Chlamydia trachomatis Bour serovar E infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,BAO_0000179,BAO_0000219,cell-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332745,=,1,0,=,MBC,ug ml-1,0.5,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,MBC,ug ml-1,UO_0000274,0.5
56225,,5214991,CHEMBL1677474,Antimicrobial activity against Chlamydia trachomatis 580 serovar H infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332745,=,1,0,=,MBC,ug ml-1,0.5,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,MBC,ug ml-1,UO_0000274,0.5
56226,,5214992,CHEMBL1677475,Antimicrobial activity against Chlamydia trachomatis UW-36 serovar J infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,BAO_0000179,BAO_0000219,cell-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332745,=,1,0,=,MBC,ug ml-1,0.5,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,MBC,ug ml-1,UO_0000274,0.5
56227,,5215130,CHEMBL1674201,Antibacterial activity against coagulase-negative and oxacillin-susceptible Staphylococcus aureus assessed as resistant isolates by CLSI M7-A7 broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,Activity,%,17.9,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,17.9
56228,,5215140,CHEMBL1674202,Antibacterial activity against coagulase-negative and oxacillin-resistant Staphylococcus aureus by CLSI M7-A7 broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,MIC50,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,8.0
56229,,5215150,CHEMBL1674203,Antibacterial activity against coagulase-negative and oxacillin-resistant Staphylococcus aureus assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,Activity,%,21.7,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,21.7
56230,,5215159,CHEMBL1674204,Antibacterial activity against coagulase-negative and oxacillin-resistant Staphylococcus aureus assessed as resistant isolates by CLSI M7-A7 broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,Activity,%,73.9,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,73.9
56231,,5215169,CHEMBL1674205,Antibacterial activity against penicillin-susceptible Streptococcus pneumoniae by CLSI M7-A7 broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,0.5
56232,,5215175,CHEMBL1674206,Antibacterial activity against penicillin-susceptible Streptococcus pneumoniae assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,Activity,%,98.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,98.5
56233,,5215181,CHEMBL1674207,Antibacterial activity against penicillin-susceptible Streptococcus pneumoniae assessed as resistant isolates by CLSI M7-A7 broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,Activity,%,1.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,1.5
56234,,5215188,CHEMBL1674208,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae by CLSI M7-A7 broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,0.5
56235,,5215194,CHEMBL1674209,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,Activity,%,99.3,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,99.3
56236,,5215200,CHEMBL1674210,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae assessed as resistant isolates by CLSI M7-A7 broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,Activity,%,0.7,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,0.7
56237,,5215207,CHEMBL1674211,Antibacterial activity against erythromycin-susceptible Streptococcus pyogenes by CLSI M7-A7 broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC50,ug ml-1,UO_0000274,0.5
56238,,5215214,CHEMBL1674212,Antibacterial activity against erythromycin-susceptible Streptococcus pyogenes assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,Activity,%,100.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,Activity,%,UO_0000187,100.0
56239,,5215219,CHEMBL1674213,Antibacterial activity against erythromycin-susceptible Streptococcus pyogenes assessed as resistant isolates by CLSI M7-A7 broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,Activity,%,0.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,Activity,%,UO_0000187,0.0
56240,,5215226,CHEMBL1674214,Antibacterial activity against erythromycin-nonsusceptible Streptococcus pyogenes by CLSI M7-A7 broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC50,ug ml-1,UO_0000274,0.5
56241,,5215233,CHEMBL1674215,Antibacterial activity against erythromycin-nonsusceptible Streptococcus pyogenes assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,Activity,%,100.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,Activity,%,UO_0000187,100.0
56242,,5215238,CHEMBL1674216,Antibacterial activity against erythromycin-nonsusceptible Streptococcus pyogenes assessed as resistant isolates by CLSI M7-A7 broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,Activity,%,0.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,Activity,%,UO_0000187,0.0
56243,,5215242,CHEMBL1674217,Antibacterial activity against erythromycin-susceptible Streptococcus agalactiae assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,Activity,%,100.0,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,Activity,%,UO_0000187,100.0
56244,,5215252,CHEMBL1674218,Antibacterial activity against erythromycin-susceptible Streptococcus agalactiae by CLSI M7-A7 broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,MIC50,ug ml-1,UO_0000274,0.5
56245,,5215256,CHEMBL1674219,Antibacterial activity against erythromycin-susceptible Streptococcus agalactiae assessed as resistant isolates by CLSI M7-A7 broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,Activity,%,0.0,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,Activity,%,UO_0000187,0.0
56246,,5215260,CHEMBL1674220,Antibacterial activity against erythromycin-nonsusceptible Streptococcus agalactiae assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,Activity,%,97.6,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,Activity,%,UO_0000187,97.6
56247,,5215270,CHEMBL1674221,Antibacterial activity against erythromycin-nonsusceptible Streptococcus agalactiae by CLSI M7-A7 broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,MIC50,ug ml-1,UO_0000274,1.0
56248,,5215275,CHEMBL1674222,Antibacterial activity against erythromycin-nonsusceptible Streptococcus agalactiae assessed as resistant isolates by CLSI M7-A7 broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,Activity,%,2.4,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,Activity,%,UO_0000187,2.4
56249,,5215282,CHEMBL1674223,Antibacterial activity against penicillin-susceptible Streptococcus viridans by CLSI M7-A7 broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,MIC50,ug ml-1,UO_0000274,1.0
56250,,5215289,CHEMBL1674224,Antibacterial activity against penicillin-susceptible Streptococcus viridans assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,Activity,%,100.0,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,Activity,%,UO_0000187,100.0
56251,,5215295,CHEMBL1674225,Antibacterial activity against penicillin-susceptible Streptococcus viridans assessed as resistant isolates by CLSI M7-A7 broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,Activity,%,0.0,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,Activity,%,UO_0000187,0.0
56252,,5215304,CHEMBL1674226,Antibacterial activity against penicillin-nonsusceptible Streptococcus viridans by CLSI M7-A7 broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,MIC50,ug ml-1,UO_0000274,1.0
56253,,5215311,CHEMBL1674227,Antibacterial activity against penicillin-nonsusceptible Streptococcus viridans assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,Activity,%,92.9,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,Activity,%,UO_0000187,92.9
56254,,5215318,CHEMBL1674228,Antibacterial activity against penicillin-nonsusceptible Streptococcus viridans assessed as resistant isolates by CLSI M7-A7 broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,Activity,%,7.1,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,Activity,%,UO_0000187,7.1
56255,,5215327,CHEMBL1674229,Antibacterial activity against vancomycin-susceptible Enterococcus faecalis by CLSI M7-A7 broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC50,ug ml-1,UO_0000274,1.0
56256,,5215334,CHEMBL1674230,Antibacterial activity against vancomycin-susceptible Enterococcus faecalis assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,Activity,%,59.2,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Activity,%,UO_0000187,59.2
56257,,5215340,CHEMBL1674231,Antibacterial activity against vancomycin-susceptible Enterococcus faecalis assessed as resistant isolates by CLSI M7-A7 broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,Activity,%,40.8,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Activity,%,UO_0000187,40.8
56258,,5215350,CHEMBL1674232,Antibacterial activity against vancomycin-resistant Enterococcus faecalis by CLSI M7-A7 broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,>,1,1,>,MIC50,ug.mL-1,16.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC50,ug ml-1,UO_0000274,16.0
56259,,5215357,CHEMBL1674233,Antibacterial activity against vancomycin-resistant Enterococcus faecalis assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,Activity,%,4.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Activity,%,UO_0000187,4.0
56260,,5215363,CHEMBL1674234,Antibacterial activity against vancomycin-resistant Enterococcus faecalis assessed as resistant isolates by CLSI M7-A7 broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,Activity,%,96.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Activity,%,UO_0000187,96.0
56261,,5215373,CHEMBL1674235,Antibacterial activity against vancomycin-resistant Enterococcus faecium by CLSI M7-A7 broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,>,1,1,>,MIC50,ug.mL-1,16.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC50,ug ml-1,UO_0000274,16.0
56262,,5215380,CHEMBL1674236,Antibacterial activity against vancomycin-resistant Enterococcus faecium assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,Activity,%,0.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,Activity,%,UO_0000187,0.0
56263,,5215386,CHEMBL1674237,Antibacterial activity against vancomycin-resistant Enterococcus faecium assessed as resistant isolates by CLSI M7-A7 broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,Activity,%,100.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,Activity,%,UO_0000187,100.0
56264,,5215394,CHEMBL1674989,Antibacterial activity against ceftazidime-susceptible Enterobacteriaceae by CLSI M7-A7 broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,MIC50,ug.mL-1,0.06,CHEMBL614436,Enterobacteriaceae,Enterobacteriaceae,543.0,,MIC50,ug ml-1,UO_0000274,0.06
56265,,5215402,CHEMBL1674990,Antibacterial activity against ceftazidime-susceptible Enterobacteriaceae assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,Activity,%,89.6,CHEMBL614436,Enterobacteriaceae,Enterobacteriaceae,543.0,,Activity,%,UO_0000187,89.6
56266,,5215410,CHEMBL1674991,Antibacterial activity against ceftazidime-susceptible Enterobacteriaceae assessed as resistant isolates by CLSI M7-A7 broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,Activity,%,9.4,CHEMBL614436,Enterobacteriaceae,Enterobacteriaceae,543.0,,Activity,%,UO_0000187,9.4
56267,,5215419,CHEMBL1674992,Antibacterial activity against ceftazidime-nonsusceptible Enterobacteriaceae by CLSI M7-A7 broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,MIC50,ug.mL-1,8.0,CHEMBL614436,Enterobacteriaceae,Enterobacteriaceae,543.0,,MIC50,ug ml-1,UO_0000274,8.0
56268,,5215427,CHEMBL1674993,Antibacterial activity against ceftazidime-nonsusceptible Enterobacteriaceae assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,Activity,%,41.8,CHEMBL614436,Enterobacteriaceae,Enterobacteriaceae,543.0,,Activity,%,UO_0000187,41.8
56269,,5215435,CHEMBL1674994,Antibacterial activity against ceftazidime-nonsusceptible Enterobacteriaceae assessed as resistant isolates by CLSI M7-A7 broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,Activity,%,51.4,CHEMBL614436,Enterobacteriaceae,Enterobacteriaceae,543.0,,Activity,%,UO_0000187,51.4
56270,,5215444,CHEMBL1674995,Antibacterial activity against ceftazidime-susceptible Citrobacter freundii by CLSI M7-A7 broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,<=,1,1,<=,MIC50,ug.mL-1,0.03,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,MIC50,ug ml-1,UO_0000274,0.03
56271,,5215452,CHEMBL1674996,Antibacterial activity against ceftazidime-susceptible Citrobacter freundii assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,Activity,%,98.0,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,Activity,%,UO_0000187,98.0
56272,,5215460,CHEMBL1674997,Antibacterial activity against ceftazidime-susceptible Citrobacter freundii assessed as resistant isolates by CLSI M7-A7 broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,Activity,%,0.0,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,Activity,%,UO_0000187,0.0
56273,,5215469,CHEMBL1674998,Antibacterial activity against ceftazidime-nonsusceptible Citrobacter freundii by CLSI M7-A7 broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,MIC50,ug ml-1,UO_0000274,0.25
56274,,5216501,CHEMBL1674999,Antibacterial activity against ceftazidime-nonsusceptible Citrobacter freundii assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,Activity,%,72.7,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,Activity,%,UO_0000187,72.7
56275,,5216509,CHEMBL1675000,Antibacterial activity against ceftazidime-nonsusceptible Citrobacter freundii assessed as resistant isolates by CLSI M7-A7 broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,Activity,%,24.2,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,Activity,%,UO_0000187,24.2
56276,,5216518,CHEMBL1675001,Antibacterial activity against ceftazidime-susceptible Enterobacter cloacae by CLSI M7-A7 broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,<=,1,1,<=,MIC50,ug.mL-1,0.03,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC50,ug ml-1,UO_0000274,0.03
56277,,5216526,CHEMBL1675002,Antibacterial activity against ceftazidime-susceptible Enterobacter cloacae assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,Activity,%,94.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,Activity,%,UO_0000187,94.0
56278,,5216534,CHEMBL1675003,Antibacterial activity against ceftazidime-susceptible Enterobacter cloacae assessed as resistant isolates by CLSI M7-A7 broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,Activity,%,2.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,Activity,%,UO_0000187,2.0
56279,,5216543,CHEMBL1675004,Antibacterial activity against ceftazidime-nonsusceptible Enterobacter cloacae by CLSI M7-A7 broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,MIC50,ug.mL-1,0.12,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC50,ug ml-1,UO_0000274,0.12
56280,,5216551,CHEMBL1675005,Antibacterial activity against ceftazidime-nonsusceptible Enterobacter cloacae assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,Activity,%,62.9,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,Activity,%,UO_0000187,62.9
56281,,5216559,CHEMBL1675006,Antibacterial activity against ceftazidime-nonsusceptible Enterobacter cloacae assessed as resistant isolates by CLSI M7-A7 broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,Activity,%,25.7,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,Activity,%,UO_0000187,25.7
56282,,5216568,CHEMBL1675007,Antibacterial activity against ceftazidime-susceptible Escherichia coli by CLSI M7-A7 broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,<=,1,1,<=,MIC50,ug.mL-1,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC50,ug ml-1,UO_0000274,0.03
56283,,5216576,CHEMBL1675008,Antibacterial activity against ceftazidime-susceptible Escherichia coli assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,Activity,%,86.4,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,86.4
56284,,5216584,CHEMBL1675009,Antibacterial activity against ceftazidime-susceptible Escherichia coli assessed as resistant isolates by CLSI M7-A7 broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,Activity,%,13.6,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,13.6
56285,,5216593,CHEMBL1675143,Antibacterial activity against ceftazidime-nonsusceptible Escherichia coli by CLSI M7-A7 broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,>,1,1,>,MIC50,ug.mL-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC50,ug ml-1,UO_0000274,16.0
56286,,5216601,CHEMBL1675144,Antibacterial activity against ceftazidime-nonsusceptible Escherichia coli assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,Activity,%,14.3,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,14.3
56287,,5216609,CHEMBL1675145,Antibacterial activity against ceftazidime-nonsusceptible Escherichia coli assessed as resistant isolates by CLSI M7-A7 broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,Activity,%,85.7,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,85.7
56288,,5216618,CHEMBL1675146,Antibacterial activity against ceftazidime-susceptible Klebsiella pneumoniae by CLSI M7-A7 broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,MIC50,ug.mL-1,0.06,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC50,ug ml-1,UO_0000274,0.06
56289,,5216626,CHEMBL1675147,Antibacterial activity against ceftazidime-susceptible Klebsiella pneumoniae assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,Activity,%,98.1,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,Activity,%,UO_0000187,98.1
56290,,5216634,CHEMBL1675148,Antibacterial activity against ceftazidime-susceptible Klebsiella pneumoniae assessed as resistant isolates by CLSI M7-A7 broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,Activity,%,1.4,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,Activity,%,UO_0000187,1.4
56291,,5216643,CHEMBL1675149,Antibacterial activity against ceftazidime-nonsusceptible Klebsiella pneumoniae by CLSI M7-A7 broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,MIC50,ug.mL-1,8.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC50,ug ml-1,UO_0000274,8.0
56292,,5216651,CHEMBL1675150,Antibacterial activity against ceftazidime-nonsusceptible Klebsiella pneumoniae assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,Activity,%,37.9,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,Activity,%,UO_0000187,37.9
56293,,5216659,CHEMBL1675151,Antibacterial activity against ceftazidime-nonsusceptible Klebsiella pneumoniae assessed as resistant isolates by CLSI M7-A7 broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,Activity,%,54.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,Activity,%,UO_0000187,54.5
56294,,5216668,CHEMBL1675152,Antibacterial activity against ceftazidime-susceptible Morganella morganii by CLSI M7-A7 broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,<=,1,1,<=,MIC50,ug.mL-1,0.03,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,MIC50,ug ml-1,UO_0000274,0.03
56295,,5216676,CHEMBL1675153,Antibacterial activity against ceftazidime-susceptible Morganella morganii assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,Activity,%,76.5,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,Activity,%,UO_0000187,76.5
56296,,5216684,CHEMBL1675154,Antibacterial activity against ceftazidime-susceptible Morganella morganii assessed as resistant isolates by CLSI M7-A7 broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,Activity,%,20.6,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,Activity,%,UO_0000187,20.6
56297,,5216693,CHEMBL1675155,Antibacterial activity against ceftazidime-susceptible Proteus mirabilis by CLSI M7-A7 broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,MIC50,ug.mL-1,0.06,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,MIC50,ug ml-1,UO_0000274,0.06
56298,,5216701,CHEMBL1675156,Antibacterial activity against ceftazidime-susceptible Proteus mirabilis assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,Activity,%,75.9,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,Activity,%,UO_0000187,75.9
56299,,5216709,CHEMBL1675157,Antibacterial activity against ceftazidime-susceptible Proteus mirabilis assessed as resistant isolates by CLSI M7-A7 broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,Activity,%,20.7,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,Activity,%,UO_0000187,20.7
56300,,5216718,CHEMBL1675158,Antibacterial activity against ceftazidime-susceptible Serratia marcescens by CLSI M7-A7 broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,MIC50,ug.mL-1,0.12,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,MIC50,ug ml-1,UO_0000274,0.12
56301,,5216726,CHEMBL1675159,Antibacterial activity against ceftazidime-susceptible Serratia marcescens assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,Activity,%,98.3,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,Activity,%,UO_0000187,98.3
56302,,5216734,CHEMBL1675160,Antibacterial activity against ceftazidime-susceptible Serratia marcescens assessed as resistant isolates by CLSI M7-A7 broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,Activity,%,1.7,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,Activity,%,UO_0000187,1.7
56303,,5216743,CHEMBL1675161,Antibacterial activity against multidrug-resistant Acinetobacter by CLSI M7-A7 broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,MIC50,ug.mL-1,16.0,CHEMBL614424,Acinetobacter,Acinetobacter,469.0,,MIC50,ug ml-1,UO_0000274,16.0
56304,,5216751,CHEMBL1675162,Antibacterial activity against multidrug-resistant Acinetobacter assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,Activity,%,6.3,CHEMBL614424,Acinetobacter,Acinetobacter,469.0,,Activity,%,UO_0000187,6.3
56305,,5216758,CHEMBL1675163,Antibacterial activity against multidrug-resistant Acinetobacter assessed as resistant isolates by CLSI M7-A7 broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,Activity,%,87.5,CHEMBL614424,Acinetobacter,Acinetobacter,469.0,,Activity,%,UO_0000187,87.5
56306,,5216766,CHEMBL1675164,Antibacterial activity against imipenem-susceptible Acinetobacter by CLSI M7-A7 broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL614424,Acinetobacter,Acinetobacter,469.0,,MIC50,ug ml-1,UO_0000274,0.5
56307,,5216774,CHEMBL1675165,Antibacterial activity against imipenem-susceptible Acinetobacter assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,Activity,%,51.1,CHEMBL614424,Acinetobacter,Acinetobacter,469.0,,Activity,%,UO_0000187,51.1
56308,,5216781,CHEMBL1675166,Antibacterial activity against imipenem-susceptible Acinetobacter assessed as resistant isolates by CLSI M7-A7 broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,Activity,%,36.2,CHEMBL614424,Acinetobacter,Acinetobacter,469.0,,Activity,%,UO_0000187,36.2
56309,,5216789,CHEMBL1675167,Antibacterial activity against beta lactamase-negative Haemophilus influenzae by CLSI M7-A7 broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,MIC50,ug.mL-1,0.015,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC50,ug ml-1,UO_0000274,0.015
56310,,5216797,CHEMBL1675168,Antibacterial activity against beta lactamase-negative Haemophilus influenzae assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,Activity,%,100.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,Activity,%,UO_0000187,100.0
56311,,5216807,CHEMBL1675170,Antibacterial activity against beta lactamase-positive Haemophilus influenzae by CLSI M7-A7 broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,MIC50,ug.mL-1,0.015,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC50,ug ml-1,UO_0000274,0.015
56312,,5216815,CHEMBL1675171,Antibacterial activity against beta lactamase-positive Haemophilus influenzae assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,Activity,%,100.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,Activity,%,UO_0000187,100.0
56313,,5216827,CHEMBL1675173,Antibacterial activity against beta lactamase-positive Moraxella catarrhalis by CLSI M7-A7 broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,<=,1,1,<=,MIC50,ug.mL-1,0.03,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,MIC50,ug ml-1,UO_0000274,0.03
56314,,5216834,CHEMBL1675174,Antibacterial activity against beta lactamase-positive Moraxella catarrhalis assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,Activity,%,100.0,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,Activity,%,UO_0000187,100.0
56315,,5216841,CHEMBL1675176,Antibacterial activity against Pasteurella multocida by CLSI M7-A7 broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,<=,1,1,<=,MIC50,ug.mL-1,0.015,CHEMBL614409,Pasteurella multocida,Pasteurella multocida,747.0,,MIC50,ug ml-1,UO_0000274,0.015
56316,,5217882,CHEMBL1675177,Antibacterial activity against Pasteurella multocida assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,Activity,%,95.5,CHEMBL614409,Pasteurella multocida,Pasteurella multocida,747.0,,Activity,%,UO_0000187,95.5
56317,,5217888,CHEMBL1675179,Antibacterial activity against ceftazidime-susceptible Providencia sp. by CLSI M7-A7 broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL612538,Providencia sp.,Providencia sp.,589.0,,MIC50,ug ml-1,UO_0000274,0.25
56318,,5217896,CHEMBL1675180,Antibacterial activity against ceftazidime-susceptible Providencia sp. assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,Activity,%,66.7,CHEMBL612538,Providencia sp.,Providencia sp.,589.0,,Activity,%,UO_0000187,66.7
56319,,5217904,CHEMBL1675181,Antibacterial activity against ceftazidime-susceptible Providencia sp. assessed as resistant isolates by CLSI M7-A7 broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,Activity,%,25.9,CHEMBL612538,Providencia sp.,Providencia sp.,589.0,,Activity,%,UO_0000187,25.9
56320,,5217915,CHEMBL1674079,Antibacterial activity against methicillin-susceptible Staphylococcus aureus by CLSI M7-A7 broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,MIC90,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,16.0
56321,,5217926,CHEMBL1674079,Antibacterial activity against methicillin-susceptible Staphylococcus aureus by CLSI M7-A7 broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,>,1,1,>,MIC,ug.mL-1,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.06
56322,,5217937,CHEMBL1674082,Antibacterial activity against methicillin-resistant Staphylococcus aureus by CLSI M7-A7 broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,>,1,1,>,MIC90,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,16.0
56323,,5217948,CHEMBL1674082,Antibacterial activity against methicillin-resistant Staphylococcus aureus by CLSI M7-A7 broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,>,1,1,>,MIC,ug.mL-1,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.12
56324,,5217959,CHEMBL1674199,Antibacterial activity against coagulase-negative and oxacillin-susceptible Staphylococcus aureus by CLSI M7-A7 broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,8.0
56325,,5217970,CHEMBL1674199,Antibacterial activity against coagulase-negative and oxacillin-susceptible Staphylococcus aureus by CLSI M7-A7 broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,>=,1,1,>=,MIC,ug.mL-1,0.03,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.03
56326,,5217981,CHEMBL1674202,Antibacterial activity against coagulase-negative and oxacillin-resistant Staphylococcus aureus by CLSI M7-A7 broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,>,1,1,>,MIC90,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,16.0
56327,,5217992,CHEMBL1674202,Antibacterial activity against coagulase-negative and oxacillin-resistant Staphylococcus aureus by CLSI M7-A7 broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,>,1,1,>,MIC,ug.mL-1,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.12
56328,,5218003,CHEMBL1674205,Antibacterial activity against penicillin-susceptible Streptococcus pneumoniae by CLSI M7-A7 broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,1.0
56329,,5218012,CHEMBL1674205,Antibacterial activity against penicillin-susceptible Streptococcus pneumoniae by CLSI M7-A7 broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.25
56330,,5218021,CHEMBL1674208,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae by CLSI M7-A7 broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,1.0
56331,,5218030,CHEMBL1674208,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae by CLSI M7-A7 broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.12
56332,,5218039,CHEMBL1674211,Antibacterial activity against erythromycin-susceptible Streptococcus pyogenes by CLSI M7-A7 broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC90,ug ml-1,UO_0000274,1.0
56333,,5218049,CHEMBL1674211,Antibacterial activity against erythromycin-susceptible Streptococcus pyogenes by CLSI M7-A7 broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,0.03
56334,,5218059,CHEMBL1674214,Antibacterial activity against erythromycin-nonsusceptible Streptococcus pyogenes by CLSI M7-A7 broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC90,ug ml-1,UO_0000274,1.0
56335,,5218069,CHEMBL1674214,Antibacterial activity against erythromycin-nonsusceptible Streptococcus pyogenes by CLSI M7-A7 broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,0.25
56336,,5218079,CHEMBL1674218,Antibacterial activity against erythromycin-susceptible Streptococcus agalactiae by CLSI M7-A7 broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,MIC90,ug ml-1,UO_0000274,1.0
56337,,5218089,CHEMBL1674218,Antibacterial activity against erythromycin-susceptible Streptococcus agalactiae by CLSI M7-A7 broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,MIC,ug ml-1,UO_0000274,0.12
56338,,5218099,CHEMBL1674221,Antibacterial activity against erythromycin-nonsusceptible Streptococcus agalactiae by CLSI M7-A7 broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,MIC90,ug ml-1,UO_0000274,1.0
56339,,5218109,CHEMBL1674221,Antibacterial activity against erythromycin-nonsusceptible Streptococcus agalactiae by CLSI M7-A7 broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,>,1,1,>,MIC,ug.mL-1,0.5,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,MIC,ug ml-1,UO_0000274,0.5
56340,,5218119,CHEMBL1674223,Antibacterial activity against penicillin-susceptible Streptococcus viridans by CLSI M7-A7 broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,MIC90,ug ml-1,UO_0000274,1.0
56341,,5218129,CHEMBL1674223,Antibacterial activity against penicillin-susceptible Streptococcus viridans by CLSI M7-A7 broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,<=,1,1,<=,MIC,ug.mL-1,0.015,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,MIC,ug ml-1,UO_0000274,0.015
56342,,5218139,CHEMBL1674226,Antibacterial activity against penicillin-nonsusceptible Streptococcus viridans by CLSI M7-A7 broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,MIC90,ug.mL-1,2.0,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,MIC90,ug ml-1,UO_0000274,2.0
56343,,5218149,CHEMBL1674226,Antibacterial activity against penicillin-nonsusceptible Streptococcus viridans by CLSI M7-A7 broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,>,1,1,>,MIC,ug.mL-1,0.12,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,MIC,ug ml-1,UO_0000274,0.12
56344,,5218159,CHEMBL1674229,Antibacterial activity against vancomycin-susceptible Enterococcus faecalis by CLSI M7-A7 broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,>,1,1,>,MIC90,ug.mL-1,16.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC90,ug ml-1,UO_0000274,16.0
56345,,5218170,CHEMBL1674229,Antibacterial activity against vancomycin-susceptible Enterococcus faecalis by CLSI M7-A7 broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,>,1,1,>,MIC,ug.mL-1,0.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,0.5
56346,,5218181,CHEMBL1674232,Antibacterial activity against vancomycin-resistant Enterococcus faecalis by CLSI M7-A7 broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,>,1,1,>,MIC90,ug.mL-1,16.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC90,ug ml-1,UO_0000274,16.0
56347,,5218192,CHEMBL1674232,Antibacterial activity against vancomycin-resistant Enterococcus faecalis by CLSI M7-A7 broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,>,1,1,>,MIC,ug.mL-1,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,1.0
56348,,5218203,CHEMBL1674235,Antibacterial activity against vancomycin-resistant Enterococcus faecium by CLSI M7-A7 broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,>,1,1,>,MIC90,ug.mL-1,16.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC90,ug ml-1,UO_0000274,16.0
56349,,5218214,CHEMBL1674235,Antibacterial activity against vancomycin-resistant Enterococcus faecium by CLSI M7-A7 broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,>,1,1,>,MIC,ug.mL-1,16.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,16.0
56350,,5218863,CHEMBL1678578,Antimicrobial activity against Staphylococcus aureus USA300 isolate harboring pSK41 plasmid assessed resistant isolates,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671712,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332354,=,1,0,=,Activity,%,45.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,45.0
56351,,5219281,CHEMBL1674989,Antibacterial activity against ceftazidime-susceptible Enterobacteriaceae by CLSI M7-A7 broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL614436,Enterobacteriaceae,Enterobacteriaceae,543.0,,MIC90,ug ml-1,UO_0000274,4.0
56352,,5219290,CHEMBL1674989,Antibacterial activity against ceftazidime-susceptible Enterobacteriaceae by CLSI M7-A7 broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,>=,1,1,>=,MIC,ug.mL-1,0.03,CHEMBL614436,Enterobacteriaceae,Enterobacteriaceae,543.0,,MIC,ug ml-1,UO_0000274,0.03
56353,,5219299,CHEMBL1674992,Antibacterial activity against ceftazidime-nonsusceptible Enterobacteriaceae by CLSI M7-A7 broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,>,1,1,>,MIC90,ug.mL-1,16.0,CHEMBL614436,Enterobacteriaceae,Enterobacteriaceae,543.0,,MIC90,ug ml-1,UO_0000274,16.0
56354,,5219308,CHEMBL1674992,Antibacterial activity against ceftazidime-nonsusceptible Enterobacteriaceae by CLSI M7-A7 broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,>=,1,1,>=,MIC,ug.mL-1,0.03,CHEMBL614436,Enterobacteriaceae,Enterobacteriaceae,543.0,,MIC,ug ml-1,UO_0000274,0.03
56355,,5219317,CHEMBL1674995,Antibacterial activity against ceftazidime-susceptible Citrobacter freundii by CLSI M7-A7 broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,MIC90,ug ml-1,UO_0000274,1.0
56356,,5219326,CHEMBL1674995,Antibacterial activity against ceftazidime-susceptible Citrobacter freundii by CLSI M7-A7 broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,MIC,ug ml-1,UO_0000274,0.03
56357,,5219335,CHEMBL1674998,Antibacterial activity against ceftazidime-nonsusceptible Citrobacter freundii by CLSI M7-A7 broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,MIC90,ug.mL-1,16.0,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,MIC90,ug ml-1,UO_0000274,16.0
56358,,5219344,CHEMBL1674998,Antibacterial activity against ceftazidime-nonsusceptible Citrobacter freundii by CLSI M7-A7 broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,>=,1,1,>=,MIC,ug.mL-1,0.03,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,MIC,ug ml-1,UO_0000274,0.03
56359,,5219353,CHEMBL1675001,Antibacterial activity against ceftazidime-susceptible Enterobacter cloacae by CLSI M7-A7 broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC90,ug ml-1,UO_0000274,0.5
56360,,5219362,CHEMBL1675001,Antibacterial activity against ceftazidime-susceptible Enterobacter cloacae by CLSI M7-A7 broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,0.03
56361,,5219371,CHEMBL1675004,Antibacterial activity against ceftazidime-nonsusceptible Enterobacter cloacae by CLSI M7-A7 broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC90,ug ml-1,UO_0000274,1.0
56362,,5219380,CHEMBL1675004,Antibacterial activity against ceftazidime-nonsusceptible Enterobacter cloacae by CLSI M7-A7 broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,>=,1,1,>=,MIC,ug.mL-1,0.03,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,0.03
56363,,5219389,CHEMBL1675007,Antibacterial activity against ceftazidime-susceptible Escherichia coli by CLSI M7-A7 broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,MIC90,ug.mL-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC90,ug ml-1,UO_0000274,16.0
56364,,5219398,CHEMBL1675007,Antibacterial activity against ceftazidime-susceptible Escherichia coli by CLSI M7-A7 broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,>=,1,1,>=,MIC,ug.mL-1,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.03
56365,,5219407,CHEMBL1675143,Antibacterial activity against ceftazidime-nonsusceptible Escherichia coli by CLSI M7-A7 broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,>,1,1,>,MIC90,ug.mL-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC90,ug ml-1,UO_0000274,16.0
56366,,5219416,CHEMBL1675143,Antibacterial activity against ceftazidime-nonsusceptible Escherichia coli by CLSI M7-A7 broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,>=,1,1,>=,MIC,ug.mL-1,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.03
56367,,5219425,CHEMBL1675146,Antibacterial activity against ceftazidime-susceptible Klebsiella pneumoniae by CLSI M7-A7 broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,MIC90,ug.mL-1,0.25,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC90,ug ml-1,UO_0000274,0.25
56368,,5219434,CHEMBL1675146,Antibacterial activity against ceftazidime-susceptible Klebsiella pneumoniae by CLSI M7-A7 broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,>=,1,1,>=,MIC,ug.mL-1,0.03,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.03
56369,,5219443,CHEMBL1675149,Antibacterial activity against ceftazidime-nonsusceptible Klebsiella pneumoniae by CLSI M7-A7 broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,>,1,1,>,MIC90,ug.mL-1,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC90,ug ml-1,UO_0000274,16.0
56370,,5219452,CHEMBL1675149,Antibacterial activity against ceftazidime-nonsusceptible Klebsiella pneumoniae by CLSI M7-A7 broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,>=,1,1,>=,MIC,ug.mL-1,0.03,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.03
56371,,5219461,CHEMBL1675152,Antibacterial activity against ceftazidime-susceptible Morganella morganii by CLSI M7-A7 broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,MIC90,ug ml-1,UO_0000274,8.0
56372,,5219470,CHEMBL1675152,Antibacterial activity against ceftazidime-susceptible Morganella morganii by CLSI M7-A7 broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,>=,1,1,>=,MIC,ug.mL-1,0.03,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,MIC,ug ml-1,UO_0000274,0.03
56373,,5219479,CHEMBL1675155,Antibacterial activity against ceftazidime-susceptible Proteus mirabilis by CLSI M7-A7 broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,MIC90,ug.mL-1,16.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,MIC90,ug ml-1,UO_0000274,16.0
56374,,5219488,CHEMBL1675155,Antibacterial activity against ceftazidime-susceptible Proteus mirabilis by CLSI M7-A7 broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,>=,1,1,>=,MIC,ug.mL-1,0.03,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,MIC,ug ml-1,UO_0000274,0.03
56375,,5219497,CHEMBL1675158,Antibacterial activity against ceftazidime-susceptible Serratia marcescens by CLSI M7-A7 broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,MIC90,ug ml-1,UO_0000274,1.0
56376,,5219506,CHEMBL1675158,Antibacterial activity against ceftazidime-susceptible Serratia marcescens by CLSI M7-A7 broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,MIC,ug ml-1,UO_0000274,0.03
56377,,5219515,CHEMBL1675161,Antibacterial activity against multidrug-resistant Acinetobacter by CLSI M7-A7 broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,>,1,1,>,MIC90,ug.mL-1,16.0,CHEMBL614424,Acinetobacter,Acinetobacter,469.0,,MIC90,ug ml-1,UO_0000274,16.0
56378,,5219524,CHEMBL1675161,Antibacterial activity against multidrug-resistant Acinetobacter by CLSI M7-A7 broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,>,1,1,>,MIC,ug.mL-1,2.0,CHEMBL614424,Acinetobacter,Acinetobacter,469.0,,MIC,ug ml-1,UO_0000274,2.0
56379,,5219533,CHEMBL1675164,Antibacterial activity against imipenem-susceptible Acinetobacter by CLSI M7-A7 broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,>,1,1,>,MIC90,ug.mL-1,16.0,CHEMBL614424,Acinetobacter,Acinetobacter,469.0,,MIC90,ug ml-1,UO_0000274,16.0
56380,,5219542,CHEMBL1675164,Antibacterial activity against imipenem-susceptible Acinetobacter by CLSI M7-A7 broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,>=,1,1,>=,MIC,ug.mL-1,0.03,CHEMBL614424,Acinetobacter,Acinetobacter,469.0,,MIC,ug ml-1,UO_0000274,0.03
56381,,5219551,CHEMBL1675167,Antibacterial activity against beta lactamase-negative Haemophilus influenzae by CLSI M7-A7 broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,MIC90,ug.mL-1,0.03,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC90,ug ml-1,UO_0000274,0.03
56382,,5219560,CHEMBL1675167,Antibacterial activity against beta lactamase-negative Haemophilus influenzae by CLSI M7-A7 broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,<=,1,1,<=,MIC,ug.mL-1,0.004,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug ml-1,UO_0000274,0.004
56383,,5219569,CHEMBL1675170,Antibacterial activity against beta lactamase-positive Haemophilus influenzae by CLSI M7-A7 broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,MIC90,ug.mL-1,0.03,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC90,ug ml-1,UO_0000274,0.03
56384,,5219578,CHEMBL1675170,Antibacterial activity against beta lactamase-positive Haemophilus influenzae by CLSI M7-A7 broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,<=,1,1,<=,MIC,ug.mL-1,0.004,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug ml-1,UO_0000274,0.004
56385,,5219588,CHEMBL1675173,Antibacterial activity against beta lactamase-positive Moraxella catarrhalis by CLSI M7-A7 broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,<=,1,1,<=,MIC90,ug.mL-1,0.03,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,MIC90,ug ml-1,UO_0000274,0.03
56386,,5219597,CHEMBL1675173,Antibacterial activity against beta lactamase-positive Moraxella catarrhalis by CLSI M7-A7 broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,MIC,ug ml-1,UO_0000274,0.03
56387,,5220663,CHEMBL1675176,Antibacterial activity against Pasteurella multocida by CLSI M7-A7 broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,MIC90,ug.mL-1,0.03,CHEMBL614409,Pasteurella multocida,Pasteurella multocida,747.0,,MIC90,ug ml-1,UO_0000274,0.03
56388,,5220671,CHEMBL1675176,Antibacterial activity against Pasteurella multocida by CLSI M7-A7 broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,>=,1,1,>=,MIC,ug.mL-1,0.015,CHEMBL614409,Pasteurella multocida,Pasteurella multocida,747.0,,MIC,ug ml-1,UO_0000274,0.015
56389,,5220678,CHEMBL1675179,Antibacterial activity against ceftazidime-susceptible Providencia sp. by CLSI M7-A7 broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,>,1,1,>,MIC90,ug.mL-1,16.0,CHEMBL612538,Providencia sp.,Providencia sp.,589.0,,MIC90,ug ml-1,UO_0000274,16.0
56390,,5220687,CHEMBL1675179,Antibacterial activity against ceftazidime-susceptible Providencia sp. by CLSI M7-A7 broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,>=,1,1,>=,MIC,ug.mL-1,0.03,CHEMBL612538,Providencia sp.,Providencia sp.,589.0,,MIC,ug ml-1,UO_0000274,0.03
56391,,5220698,CHEMBL1675182,Antibacterial activity against Bacteroides fragilis by by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,MIC,ug ml-1,UO_0000274,1.0
56392,,5220712,CHEMBL1675185,Antibacterial activity against beta-lactamase producing Bacteroides thetaiotaomicron by by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,>,1,1,>,MIC,ug.mL-1,2.0,CHEMBL614412,Bacteroides thetaiotaomicron,Bacteroides thetaiotaomicron,818.0,,MIC,ug ml-1,UO_0000274,2.0
56393,,5220726,CHEMBL1675182,Antibacterial activity against Bacteroides fragilis by by CLSI agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,MIC50,ug.mL-1,2.0,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,MIC50,ug ml-1,UO_0000274,2.0
56394,,5220740,CHEMBL1675185,Antibacterial activity against beta-lactamase producing Bacteroides thetaiotaomicron by by CLSI agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,MIC50,ug.mL-1,4.0,CHEMBL614412,Bacteroides thetaiotaomicron,Bacteroides thetaiotaomicron,818.0,,MIC50,ug ml-1,UO_0000274,4.0
56395,,5220754,CHEMBL1675182,Antibacterial activity against Bacteroides fragilis by by CLSI agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,MIC90,ug ml-1,UO_0000274,8.0
56396,,5220768,CHEMBL1675185,Antibacterial activity against beta-lactamase producing Bacteroides thetaiotaomicron by by CLSI agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL614412,Bacteroides thetaiotaomicron,Bacteroides thetaiotaomicron,818.0,,MIC90,ug ml-1,UO_0000274,8.0
56397,,5220834,CHEMBL1673478,Antibacterial activity against beta-lactamase producing Bacteroides vulgatus by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,>,1,1,>,MIC,ug.mL-1,0.5,CHEMBL612287,Phocaeicola vulgatus,Phocaeicola vulgatus,821.0,,MIC,ug ml-1,UO_0000274,0.5
56398,,5220846,CHEMBL1673478,Antibacterial activity against beta-lactamase producing Bacteroides vulgatus by CLSI agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,MIC50,ug.mL-1,2.0,CHEMBL612287,Phocaeicola vulgatus,Phocaeicola vulgatus,821.0,,MIC50,ug ml-1,UO_0000274,2.0
56399,,5220858,CHEMBL1673478,Antibacterial activity against beta-lactamase producing Bacteroides vulgatus by CLSI agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL612287,Phocaeicola vulgatus,Phocaeicola vulgatus,821.0,,MIC90,ug ml-1,UO_0000274,8.0
56400,,5220902,CHEMBL1673762,Antibacterial activity against beta-lactamase producing Bacteroides uniformis by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,>,1,1,>,MIC,ug.mL-1,0.5,CHEMBL612622,Bacteroides uniformis,Bacteroides uniformis,820.0,,MIC,ug ml-1,UO_0000274,0.5
56401,,5220914,CHEMBL1673762,Antibacterial activity against beta-lactamase producing Bacteroides uniformis by CLSI agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,MIC50,ug.mL-1,2.0,CHEMBL612622,Bacteroides uniformis,Bacteroides uniformis,820.0,,MIC50,ug ml-1,UO_0000274,2.0
56402,,5220926,CHEMBL1673762,Antibacterial activity against beta-lactamase producing Bacteroides uniformis by CLSI agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL612622,Bacteroides uniformis,Bacteroides uniformis,820.0,,MIC90,ug ml-1,UO_0000274,8.0
56403,,5220970,CHEMBL1673771,Antibacterial activity against beta-lactamase producing Bacteroides caccae by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,>,1,1,>,MIC,ug.mL-1,0.5,CHEMBL614749,Bacteroides caccae,Bacteroides caccae,47678.0,,MIC,ug ml-1,UO_0000274,0.5
56404,,5220982,CHEMBL1673771,Antibacterial activity against beta-lactamase producing Bacteroides caccae by CLSI agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,MIC50,ug.mL-1,2.0,CHEMBL614749,Bacteroides caccae,Bacteroides caccae,47678.0,,MIC50,ug ml-1,UO_0000274,2.0
56405,,5220994,CHEMBL1673771,Antibacterial activity against beta-lactamase producing Bacteroides caccae by CLSI agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL614749,Bacteroides caccae,Bacteroides caccae,47678.0,,MIC90,ug ml-1,UO_0000274,8.0
56406,,5222083,CHEMBL1673780,Antibacterial activity against Fusobacterium varium by by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL614416,Fusobacterium varium,Fusobacterium varium,856.0,,MIC,ug ml-1,UO_0000274,0.12
56407,,5222095,CHEMBL1673781,Antibacterial activity against Fusobacterium nucleatum by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL614609,Fusobacterium nucleatum,Fusobacterium nucleatum,851.0,,MIC,ug ml-1,UO_0000274,0.12
56408,,5222107,CHEMBL1673782,Antibacterial activity against Fusobacterium mortiferum by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL614415,Fusobacterium mortiferum,Fusobacterium mortiferum,850.0,,MIC,ug ml-1,UO_0000274,0.12
56409,,5222119,CHEMBL1673783,Antibacterial activity against Fusobacterium necrophorum by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL614417,Fusobacterium necrophorum,Fusobacterium necrophorum,859.0,,MIC,ug ml-1,UO_0000274,0.12
56410,,5222131,CHEMBL1673780,Antibacterial activity against Fusobacterium varium by by CLSI agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,MIC50,ug.mL-1,2.0,CHEMBL614416,Fusobacterium varium,Fusobacterium varium,856.0,,MIC50,ug ml-1,UO_0000274,2.0
56411,,5222143,CHEMBL1673781,Antibacterial activity against Fusobacterium nucleatum by CLSI agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,MIC50,ug.mL-1,2.0,CHEMBL614609,Fusobacterium nucleatum,Fusobacterium nucleatum,851.0,,MIC50,ug ml-1,UO_0000274,2.0
56412,,5222155,CHEMBL1673782,Antibacterial activity against Fusobacterium mortiferum by CLSI agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,MIC50,ug.mL-1,2.0,CHEMBL614415,Fusobacterium mortiferum,Fusobacterium mortiferum,850.0,,MIC50,ug ml-1,UO_0000274,2.0
56413,,5222167,CHEMBL1673783,Antibacterial activity against Fusobacterium necrophorum by CLSI agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,MIC50,ug.mL-1,2.0,CHEMBL614417,Fusobacterium necrophorum,Fusobacterium necrophorum,859.0,,MIC50,ug ml-1,UO_0000274,2.0
56414,,5222179,CHEMBL1673780,Antibacterial activity against Fusobacterium varium by by CLSI agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL614416,Fusobacterium varium,Fusobacterium varium,856.0,,MIC90,ug ml-1,UO_0000274,4.0
56415,,5222191,CHEMBL1673781,Antibacterial activity against Fusobacterium nucleatum by CLSI agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL614609,Fusobacterium nucleatum,Fusobacterium nucleatum,851.0,,MIC90,ug ml-1,UO_0000274,4.0
56416,,5222203,CHEMBL1673782,Antibacterial activity against Fusobacterium mortiferum by CLSI agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL614415,Fusobacterium mortiferum,Fusobacterium mortiferum,850.0,,MIC90,ug ml-1,UO_0000274,4.0
56417,,5222215,CHEMBL1673783,Antibacterial activity against Fusobacterium necrophorum by CLSI agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL614417,Fusobacterium necrophorum,Fusobacterium necrophorum,859.0,,MIC90,ug ml-1,UO_0000274,4.0
56418,,5222355,CHEMBL1674570,Antibacterial activity against Prevotella buccae by by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,>,1,1,>,MIC,ug.mL-1,0.25,CHEMBL612234,Prevotella buccae,Prevotella buccae,28126.0,,MIC,ug ml-1,UO_0000274,0.25
56419,,5222367,CHEMBL1674571,Antibacterial activity against Prevotella bivia by by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,>,1,1,>,MIC,ug.mL-1,0.25,CHEMBL612321,Prevotella bivia,Prevotella bivia,28125.0,,MIC,ug ml-1,UO_0000274,0.25
56420,,5222379,CHEMBL1674572,Antibacterial activity against Prevotella intermedia by by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,>,1,1,>,MIC,ug.mL-1,0.25,CHEMBL613261,Prevotella intermedia,Prevotella intermedia,28131.0,,MIC,ug ml-1,UO_0000274,0.25
56421,,5222391,CHEMBL1674573,Antibacterial activity against Prevotella melaninogenica by by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,>,1,1,>,MIC,ug.mL-1,0.25,CHEMBL612236,Prevotella melaninogenica,Prevotella melaninogenica,28132.0,,MIC,ug ml-1,UO_0000274,0.25
56422,,5222466,CHEMBL1674471,Antimicrobial activity against qnrS-positive Salmonella enterica serovar Corvallis isolate s2017 harboring ParC QRDR mutant gene by agar dilution method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332014,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,1.0
56423,,5222467,CHEMBL1674470,Antimicrobial activity against qnrS-positive Salmonella enterica serovar Stanley isolate s2018 harboring ParC QRDR mutant gene by agar dilution method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332014,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,1.0
56424,,5222468,CHEMBL1674469,Antimicrobial activity against qnrS-positive Salmonella enterica serovar Corvallis isolate s2052 harboring ParC QRDR mutant gene by agar dilution method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332014,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.5
56425,,5222469,CHEMBL1674468,Antimicrobial activity against qnrA-positive Salmonella enterica serovar Mbandaka isolate s2093 harboring ParC QRDR mutant gene by agar dilution method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332014,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,1.0
56426,,5222470,CHEMBL1674467,Antimicrobial activity against qnrS-positive Salmonella enterica serovar Montevideo isolate s2209 harboring ParC QRDR mutant gene by agar dilution method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332014,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,1.0
56427,,5222471,CHEMBL1674466,Antimicrobial activity against qnrS-positive Salmonella enterica serovar Virginia isolate s2219 harboring ParC QRDR mutant gene by agar dilution method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332014,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,1.0
56428,,5222472,CHEMBL1674465,Antimicrobial activity against qnrS-positive Salmonella enterica serovar Typhimurium isolate s2425 harboring wild type ParC gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332014,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC,ug ml-1,UO_0000274,1.0
56429,,5222473,CHEMBL1674464,Antimicrobial activity against qnrS-positive Salmonella enterica serovar Typhimurium isolate s2705 harboring wild type ParC gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332014,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC,ug ml-1,UO_0000274,1.0
56430,,5222474,CHEMBL1674463,Antimicrobial activity against qnrS-positive Salmonella enterica serovar Braenderup isolate s2856 harboring ParC QRDR mutant gene by agar dilution method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332014,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,1.0
56431,,5222475,CHEMBL1674462,Antimicrobial activity against qnrS-positive Salmonella enterica serovar Montevideo isolate s2944 harboring ParC QRDR mutant gene by agar dilution method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332014,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,1.0
56432,,5222476,CHEMBL1674461,Antimicrobial activity against Salmonella enterica serovar Stanley isolate s2043 harboring ParC QRDR mutant gene by agar dilution method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332014,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.06
56433,,5222477,CHEMBL1674340,Antimicrobial activity against Salmonella enterica serovar Corvallis isolate s2064 harboring ParC QRDR mutant gene by agar dilution method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332014,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.06
56434,,5222478,CHEMBL1674339,Antimicrobial activity against Salmonella enterica serovar Mbandaka isolate s2159 harboring ParC QRDR mutant gene by agar dilution method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332014,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.06
56435,,5222479,CHEMBL1674338,Antimicrobial activity against Salmonella enterica serovar Montevideo isolate s2317 harboring ParC QRDR mutant gene by agar dilution method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332014,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.06
56436,Not Determined,5222480,CHEMBL1674337,Antimicrobial activity against Salmonella enterica serovar Typhimurium isolate s2878 harboring wild type ParC gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1332014,,1,0,,MIC,,,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC,,,
56437,Not Determined,5222481,CHEMBL1674336,Antimicrobial activity against Salmonella enterica serovar Braenderup isolate s2906 harboring ParC QRDR mutant gene by agar dilution method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1332014,,1,0,,MIC,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,,,
56438,Not Determined,5222482,CHEMBL1674335,Antimicrobial activity against Salmonella enterica serovar Typhimurium isolate SL1344 harboring wild type ParC gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1332014,,1,0,,MIC,,,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC,,,
56439,,5223455,CHEMBL1674570,Antibacterial activity against Prevotella buccae by by CLSI agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL612234,Prevotella buccae,Prevotella buccae,28126.0,,MIC50,ug ml-1,UO_0000274,1.0
56440,,5223467,CHEMBL1674571,Antibacterial activity against Prevotella bivia by by CLSI agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL612321,Prevotella bivia,Prevotella bivia,28125.0,,MIC50,ug ml-1,UO_0000274,1.0
56441,,5223479,CHEMBL1674572,Antibacterial activity against Prevotella intermedia by by CLSI agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL613261,Prevotella intermedia,Prevotella intermedia,28131.0,,MIC50,ug ml-1,UO_0000274,1.0
56442,,5223491,CHEMBL1674573,Antibacterial activity against Prevotella melaninogenica by by CLSI agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL612236,Prevotella melaninogenica,Prevotella melaninogenica,28132.0,,MIC50,ug ml-1,UO_0000274,1.0
56443,,5223503,CHEMBL1674570,Antibacterial activity against Prevotella buccae by by CLSI agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,MIC90,ug.mL-1,16.0,CHEMBL612234,Prevotella buccae,Prevotella buccae,28126.0,,MIC90,ug ml-1,UO_0000274,16.0
56444,,5223515,CHEMBL1674571,Antibacterial activity against Prevotella bivia by by CLSI agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,MIC90,ug.mL-1,16.0,CHEMBL612321,Prevotella bivia,Prevotella bivia,28125.0,,MIC90,ug ml-1,UO_0000274,16.0
56445,,5223527,CHEMBL1674572,Antibacterial activity against Prevotella intermedia by by CLSI agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,MIC90,ug.mL-1,16.0,CHEMBL613261,Prevotella intermedia,Prevotella intermedia,28131.0,,MIC90,ug ml-1,UO_0000274,16.0
56446,,5223539,CHEMBL1674573,Antibacterial activity against Prevotella melaninogenica by by CLSI agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,MIC90,ug.mL-1,16.0,CHEMBL612236,Prevotella melaninogenica,Prevotella melaninogenica,28132.0,,MIC90,ug ml-1,UO_0000274,16.0
56447,,5223679,CHEMBL1674730,Antibacterial activity against Veillonella parvula by by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL612244,Veillonella parvula,Veillonella parvula,29466.0,,MIC,ug ml-1,UO_0000274,0.06
56448,,5223693,CHEMBL1674733,Antibacterial activity against beta-lactamase producing Clostridium perfringens by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL614967,Clostridium perfringens,Clostridium perfringens,1502.0,,MIC,ug ml-1,UO_0000274,0.25
56449,,5223705,CHEMBL1674734,Antibacterial activity against beta-lactamase producing Clostridium paraputrificum by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL615027,Clostridium paraputrificum,Clostridium paraputrificum,29363.0,,MIC,ug ml-1,UO_0000274,0.25
56450,,5223717,CHEMBL1674735,Antibacterial activity against beta-lactamase producing Clostridium septicum by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL614968,Clostridium septicum,Clostridium septicum,1504.0,,MIC,ug ml-1,UO_0000274,0.25
56451,,5223729,CHEMBL1674736,Antibacterial activity against beta-lactamase producing Clostridium tertium by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL613074,Clostridium tertium,Clostridium tertium,1559.0,,MIC,ug ml-1,UO_0000274,0.25
56452,,5223749,CHEMBL1674733,Antibacterial activity against beta-lactamase producing Clostridium perfringens by CLSI agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL614967,Clostridium perfringens,Clostridium perfringens,1502.0,,MIC50,ug ml-1,UO_0000274,0.5
56453,,5223761,CHEMBL1674734,Antibacterial activity against beta-lactamase producing Clostridium paraputrificum by CLSI agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL615027,Clostridium paraputrificum,Clostridium paraputrificum,29363.0,,MIC50,ug ml-1,UO_0000274,0.5
56454,,5223773,CHEMBL1674735,Antibacterial activity against beta-lactamase producing Clostridium septicum by CLSI agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL614968,Clostridium septicum,Clostridium septicum,1504.0,,MIC50,ug ml-1,UO_0000274,0.5
56455,,5223785,CHEMBL1674736,Antibacterial activity against beta-lactamase producing Clostridium tertium by CLSI agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL613074,Clostridium tertium,Clostridium tertium,1559.0,,MIC50,ug ml-1,UO_0000274,0.5
56456,,5224860,CHEMBL1674733,Antibacterial activity against beta-lactamase producing Clostridium perfringens by CLSI agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL614967,Clostridium perfringens,Clostridium perfringens,1502.0,,MIC90,ug ml-1,UO_0000274,4.0
56457,,5224872,CHEMBL1674734,Antibacterial activity against beta-lactamase producing Clostridium paraputrificum by CLSI agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL615027,Clostridium paraputrificum,Clostridium paraputrificum,29363.0,,MIC90,ug ml-1,UO_0000274,4.0
56458,,5224884,CHEMBL1674735,Antibacterial activity against beta-lactamase producing Clostridium septicum by CLSI agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL614968,Clostridium septicum,Clostridium septicum,1504.0,,MIC90,ug ml-1,UO_0000274,4.0
56459,,5224896,CHEMBL1674736,Antibacterial activity against beta-lactamase producing Clostridium tertium by CLSI agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL613074,Clostridium tertium,Clostridium tertium,1559.0,,MIC90,ug ml-1,UO_0000274,4.0
56460,,5225012,CHEMBL1675645,Antibacterial activity against beta-lactamase producing Peptostreptococcus anaerobius by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,>,1,1,>,MIC,ug.mL-1,0.03,CHEMBL614420,Peptostreptococcus anaerobius,Peptostreptococcus anaerobius,1261.0,,MIC,ug ml-1,UO_0000274,0.03
56461,,5225026,CHEMBL1675645,Antibacterial activity against beta-lactamase producing Peptostreptococcus anaerobius by CLSI agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL614420,Peptostreptococcus anaerobius,Peptostreptococcus anaerobius,1261.0,,MIC50,ug ml-1,UO_0000274,0.5
56462,,5225040,CHEMBL1675645,Antibacterial activity against beta-lactamase producing Peptostreptococcus anaerobius by CLSI agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,MIC90,ug.mL-1,32.0,CHEMBL614420,Peptostreptococcus anaerobius,Peptostreptococcus anaerobius,1261.0,,MIC90,ug ml-1,UO_0000274,32.0
56463,,5225078,CHEMBL1675654,Antibacterial activity against beta-lactamase producing Micromonas micros by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,>,1,1,>,MIC,ug.mL-1,0.03,CHEMBL612380,Parvimonas micra,Parvimonas micra,33033.0,,MIC,ug ml-1,UO_0000274,0.03
56464,,5225090,CHEMBL1675654,Antibacterial activity against beta-lactamase producing Micromonas micros by CLSI agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL612380,Parvimonas micra,Parvimonas micra,33033.0,,MIC50,ug ml-1,UO_0000274,0.5
56465,,5225102,CHEMBL1675654,Antibacterial activity against beta-lactamase producing Micromonas micros by CLSI agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,MIC90,ug.mL-1,32.0,CHEMBL612380,Parvimonas micra,Parvimonas micra,33033.0,,MIC90,ug ml-1,UO_0000274,32.0
56466,,5225144,CHEMBL1675663,Antibacterial activity against beta-lactamase producing Peptoniphilus asaccharolyticus by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,>,1,1,>,MIC,ug.mL-1,0.03,CHEMBL614419,Peptoniphilus asaccharolyticus,Peptoniphilus asaccharolyticus,1258.0,,MIC,ug ml-1,UO_0000274,0.03
56467,,5225156,CHEMBL1675663,Antibacterial activity against beta-lactamase producing Peptoniphilus asaccharolyticus by CLSI agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL614419,Peptoniphilus asaccharolyticus,Peptoniphilus asaccharolyticus,1258.0,,MIC50,ug ml-1,UO_0000274,0.5
56468,,5225168,CHEMBL1675663,Antibacterial activity against beta-lactamase producing Peptoniphilus asaccharolyticus by CLSI agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,MIC90,ug.mL-1,32.0,CHEMBL614419,Peptoniphilus asaccharolyticus,Peptoniphilus asaccharolyticus,1258.0,,MIC90,ug ml-1,UO_0000274,32.0
56469,,5225345,CHEMBL1680543,Antibacterial activity against Enterobacter cloacae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.25 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,90.3,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,Activity,%,UO_0000187,90.3
56470,,5225353,CHEMBL1679664,Antibacterial activity against methicillin-resistant Staphylococcus aureus by CLSI M7-A7 broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332069,>=,1,1,>=,MIC50,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,32.0
56471,,5225358,CHEMBL1679789,Antibacterial activity against Staphylococcus aureus by CLSI M7-A7 broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332069,>=,1,1,>=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
56472,,5225365,CHEMBL1679794,Antibacterial activity against Enterobacteriaceae by CLSI M7-A7 broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332069,<=,1,1,<=,MIC90,ug.mL-1,0.06,CHEMBL614436,Enterobacteriaceae,Enterobacteriaceae,543.0,,MIC90,ug ml-1,UO_0000274,0.06
56473,,5225380,CHEMBL1679806,Antibacterial activity against methicillin-susceptible Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.06 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,0.5
56474,,5225384,CHEMBL1679807,Antibacterial activity against methicillin-susceptible Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.12 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,13.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,13.4
56475,,5225388,CHEMBL1679808,Antibacterial activity against methicillin-susceptible Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.25 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,81.8,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,81.8
56476,,5225392,CHEMBL1679809,Antibacterial activity against methicillin-susceptible Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.5 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,88.8,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,88.8
56477,,5225395,CHEMBL1679810,Antibacterial activity against methicillin-susceptible Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 1 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,91.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,91.4
56478,,5225402,CHEMBL1679812,Antibacterial activity against methicillin-susceptible Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 4 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,92.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,92.0
56479,,5225405,CHEMBL1679813,Antibacterial activity against methicillin-susceptible Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 8 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,93.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,93.6
56480,,5225411,CHEMBL1679815,Antibacterial activity against methicillin-susceptible Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 32 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,100.0
56481,,5225416,CHEMBL1679820,Antibacterial activity against methicillin-resistant Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.12 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,0.8,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,0.8
56482,,5225420,CHEMBL1679821,Antibacterial activity against methicillin-resistant Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.25 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,8.7,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,8.7
56483,,5225425,CHEMBL1679961,Antibacterial activity against methicillin-resistant Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 1 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,9.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,9.4
56484,,5225432,CHEMBL1679964,Antibacterial activity against methicillin-resistant Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 8 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,22.8,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,22.8
56485,,5225436,CHEMBL1679965,Antibacterial activity against methicillin-resistant Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 16 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,24.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,24.4
56486,,5225438,CHEMBL1679966,Antibacterial activity against methicillin-resistant Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 32 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,100.0
56487,,5225473,CHEMBL1680856,Antibacterial activity against community-associated methicillin-resistant Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.12 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,4.0
56488,,5225477,CHEMBL1680857,Antibacterial activity against community-associated methicillin-resistant Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.25 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,24.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,24.0
56489,,5225481,CHEMBL1680859,Antibacterial activity against community-associated methicillin-resistant Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 1 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,32.0
56490,,5225485,CHEMBL1680862,Antibacterial activity against community-associated methicillin-resistant Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 8 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,96.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,96.0
56491,,5225487,CHEMBL1680863,Antibacterial activity against community-associated methicillin-resistant Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 16 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,100.0
56492,,5225492,CHEMBL1680967,Antibacterial activity against hospital-associated methicillin-resistant Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.25 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,3.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,3.0
56493,,5225500,CHEMBL1680972,Antibacterial activity against hospital-associated methicillin-resistant Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 8 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,4.0
56494,,5225504,CHEMBL1680973,Antibacterial activity against hospital-associated methicillin-resistant Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 16 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,5.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,5.1
56495,,5225506,CHEMBL1680974,Antibacterial activity against hospital-associated methicillin-resistant Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 32 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,100.0
56496,,5225515,CHEMBL1680979,Antibacterial activity against methicillin-susceptible Staphylococcus epidermidis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.12 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,11.6,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Activity,%,UO_0000187,11.6
56497,,5225519,CHEMBL1680980,Antibacterial activity against methicillin-susceptible Staphylococcus epidermidis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.25 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,53.5,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Activity,%,UO_0000187,53.5
56498,,5225526,CHEMBL1679336,Antibacterial activity against methicillin-susceptible Staphylococcus epidermidis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 2 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,55.8,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Activity,%,UO_0000187,55.8
56499,,5225530,CHEMBL1679337,Antibacterial activity against methicillin-susceptible Staphylococcus epidermidis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 4 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,62.8,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Activity,%,UO_0000187,62.8
56500,,5225533,CHEMBL1679338,Antibacterial activity against methicillin-susceptible Staphylococcus epidermidis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 8 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,76.7,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Activity,%,UO_0000187,76.7
56501,,5225536,CHEMBL1679339,Antibacterial activity against methicillin-susceptible Staphylococcus epidermidis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 16 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,88.4,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Activity,%,UO_0000187,88.4
56502,,5225538,CHEMBL1679340,Antibacterial activity against methicillin-susceptible Staphylococcus epidermidis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 32 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,100.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Activity,%,UO_0000187,100.0
56503,,5225543,CHEMBL1679345,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 4 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,11.1,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Activity,%,UO_0000187,11.1
56504,,5225547,CHEMBL1679347,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 16 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,33.3,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Activity,%,UO_0000187,33.3
56505,,5225549,CHEMBL1679348,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 32 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,100.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Activity,%,UO_0000187,100.0
56506,,5225555,CHEMBL1679352,Antibacterial activity against Streptococcus pneumoniae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.06 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,0.5
56507,,5226185,CHEMBL1674838,Antimicrobial activity against Escherichia coli isolate GZ3 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1331644,=,1,0,=,FC,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,FC,,,2.0
56508,,5226186,CHEMBL1674839,Antimicrobial activity against Escherichia coli isolate GZ4 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1331644,=,1,0,=,FC,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,FC,,,2.0
56509,,5226187,CHEMBL1674840,Antimicrobial activity against Escherichia coli isolate GZ5 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1331644,=,1,0,=,FC,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,FC,,,2.0
56510,,5226188,CHEMBL1674841,Antimicrobial activity against Escherichia coli isolate GZ6 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1331644,=,1,0,=,FC,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,FC,,,4.0
56511,,5226189,CHEMBL1674842,Antimicrobial activity against Escherichia coli isolate GZ8 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1331644,=,1,0,=,FC,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,FC,,,1.0
56512,,5226190,CHEMBL1674843,Antimicrobial activity against Escherichia coli isolate GZ9 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1331644,=,1,0,=,FC,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,FC,,,2.0
56513,,5226191,CHEMBL1674844,Antimicrobial activity against Escherichia coli isolate GZ11 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1331644,=,1,0,=,FC,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,FC,,,2.0
56514,,5226192,CHEMBL1674845,Antimicrobial activity against Escherichia coli isolate GZ12 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1331644,=,1,0,=,FC,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,FC,,,8.0
56515,,5226193,CHEMBL1674846,Antimicrobial activity against Escherichia coli isolate GZ13 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1331644,=,1,0,=,FC,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,FC,,,2.0
56516,,5226194,CHEMBL1674847,Antimicrobial activity against Escherichia coli isolate GZ14 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1331644,=,1,0,=,FC,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,FC,,,4.0
56517,,5226195,CHEMBL1674848,Antimicrobial activity against Escherichia coli isolate GZ15 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1331644,=,1,0,=,FC,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,FC,,,2.0
56518,,5226196,CHEMBL1674849,Antimicrobial activity against Escherichia coli isolate GZ16 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1331644,=,1,0,=,FC,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,FC,,,4.0
56519,,5226197,CHEMBL1674850,Antimicrobial activity against Escherichia coli isolate CQ15 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1331644,=,1,0,=,FC,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,FC,,,1.0
56520,,5226198,CHEMBL1674851,Antimicrobial activity against Escherichia coli isolate CQ18 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1331644,=,1,0,=,FC,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,FC,,,1.0
56521,,5226199,CHEMBL1674852,Antimicrobial activity against Escherichia coli isolate CQ2 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1331644,=,1,0,=,FC,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,FC,,,4.0
56522,,5226200,CHEMBL1674853,Antimicrobial activity against Escherichia coli isolate CQ5 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1331644,=,1,0,=,FC,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,FC,,,1.0
56523,,5226201,CHEMBL1674854,Antimicrobial activity against Escherichia coli isolate CQ4 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1331644,=,1,0,=,FC,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,FC,,,1.0
56524,,5226202,CHEMBL1674855,Antimicrobial activity against Escherichia coli isolate CQ20 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1331644,=,1,0,=,FC,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,FC,,,2.0
56525,,5226203,CHEMBL1674856,Antimicrobial activity against Escherichia coli isolate CQ26 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1331644,=,1,0,=,FC,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,FC,,,1.0
56526,,5226204,CHEMBL1674857,Antimicrobial activity against Escherichia coli isolate CQ10 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1331644,=,1,0,=,FC,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,FC,,,2.0
56527,,5226205,CHEMBL1674972,Antimicrobial activity against Escherichia coli isolate CQ14 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1331644,=,1,0,=,FC,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,FC,,,2.0
56528,,5226206,CHEMBL1674973,Antimicrobial activity against Escherichia coli isolate GZ7 transconjugant harboring 16S rRNA methylase RmtB and qepA and qnrS1 by agar dilution method relative to recipient strain,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1331644,=,1,0,=,FC,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,FC,,,1.0
56529,,5226207,CHEMBL1674974,Antimicrobial activity against Escherichia coli isolate GZ1 transconjugant harboring 16S rRNA methylase RmtB and qnrS1 by agar dilution method relative to recipient strain,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1331644,=,1,0,=,FC,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,FC,,,4.0
56530,,5226208,CHEMBL1674975,Antimicrobial activity against Escherichia coli isolate GZ2 transconjugant harboring 16S rRNA methylase RmtB and qnrS1 by agar dilution method relative to recipient strain,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1331644,=,1,0,=,FC,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,FC,,,2.0
56531,,5226209,CHEMBL1674976,Antimicrobial activity against Escherichia coli isolate CQ22 transconjugant harboring 16S rRNA methylase RmtB and qnrS1 by agar dilution method relative to recipient strain,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1331644,=,1,0,=,FC,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,FC,,,1.0
56532,,5226210,CHEMBL1674977,Antimicrobial activity against Escherichia coli isolate CQ13 transconjugant harboring 16S rRNA methylase RmtB and qnrS1 by agar dilution method relative to recipient strain,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1331644,=,1,0,=,FC,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,FC,,,4.0
56533,,5226211,CHEMBL1674978,"Antimicrobial activity against Escherichia coli isolate CQ6 transconjugant harboring 16S rRNA methylase RmtB and qepA, qnrS2, aac(6')-Ib-cr gene by agar dilution method relative to recipient strain",F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1331644,=,1,0,=,FC,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,FC,,,4.0
56534,,5226212,CHEMBL1674979,"Antimicrobial activity against Escherichia coli isolate CQ7 transconjugant harboring 16S rRNA methylase RmtB and qepA, qnrS2, aac(6')-Ib-cr gene by agar dilution method relative to recipient strain",F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1331644,=,1,0,=,FC,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,FC,,,1.0
56535,,5226213,CHEMBL1674980,"Antimicrobial activity against Escherichia coli isolate CQ12 transconjugant harboring 16S rRNA methylase RmtB and qepA, qnrS2, aac(6')-Ib-cr gene by agar dilution method relative to recipient strain",F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1331644,=,1,0,=,FC,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,FC,,,2.0
56536,,5226214,CHEMBL1674981,"Antimicrobial activity against Escherichia coli isolate CQ16 transconjugant harboring 16S rRNA methylase RmtB and qepA, qnrS2, aac(6')-Ib-cr gene by agar dilution method relative to recipient strain",F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1331644,=,1,0,=,FC,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,FC,,,2.0
56537,,5226215,CHEMBL1674982,"Antimicrobial activity against Escherichia coli isolate GZ10 transconjugant harboring 16S rRNA methylase RmtB and qepA, aac(6')-Ib-cr gene by agar dilution method relative to recipient strain",F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1331644,=,1,0,=,FC,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,FC,,,4.0
56538,,5226216,CHEMBL1674983,"Antimicrobial activity against Escherichia coli isolate CQ19 transconjugant harboring 16S rRNA methylase RmtB and qepA, aac(6')-Ib-cr gene by agar dilution method relative to recipient strain",F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1331644,=,1,0,=,FC,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,FC,,,1.0
56539,,5226217,CHEMBL1674984,Antimicrobial activity against Escherichia coli isolate CQ1 transconjugant harboring 16S rRNA methylase RmtB and qnrB6 by agar dilution method relative to recipient strain,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1331644,=,1,0,=,FC,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,FC,,,1.0
56540,,5226337,CHEMBL1675672,Antibacterial activity against beta-lactamase producing Finegoldia magna by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,>,1,1,>,MIC,ug.mL-1,0.03,CHEMBL614615,Finegoldia magna,Finegoldia magna,1260.0,,MIC,ug ml-1,UO_0000274,0.03
56541,,5226349,CHEMBL1675672,Antibacterial activity against beta-lactamase producing Finegoldia magna by CLSI agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL614615,Finegoldia magna,Finegoldia magna,1260.0,,MIC50,ug ml-1,UO_0000274,0.5
56542,,5226361,CHEMBL1675672,Antibacterial activity against beta-lactamase producing Finegoldia magna by CLSI agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,MIC90,ug.mL-1,32.0,CHEMBL614615,Finegoldia magna,Finegoldia magna,1260.0,,MIC90,ug ml-1,UO_0000274,32.0
56543,,5226683,CHEMBL1679353,Antibacterial activity against Streptococcus pneumoniae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.12 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,1.2,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,1.2
56544,,5226687,CHEMBL1679354,Antibacterial activity against Streptococcus pneumoniae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.25 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,10.2,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,10.2
56545,,5226690,CHEMBL1679355,Antibacterial activity against Streptococcus pneumoniae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.5 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,69.3,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,69.3
56546,,5226693,CHEMBL1679356,Antibacterial activity against Streptococcus pneumoniae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 1 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,96.3,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,96.3
56547,,5226695,CHEMBL1679357,Antibacterial activity against Streptococcus pneumoniae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 2 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,99.4,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,99.4
56548,,5226700,CHEMBL1679511,Antibacterial activity against Streptococcus pneumoniae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 8 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,99.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,99.5
56549,,5226703,CHEMBL1679512,Antibacterial activity against Streptococcus pneumoniae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 16 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,99.8,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,99.8
56550,,5226704,CHEMBL1679513,Antibacterial activity against Streptococcus pneumoniae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 32 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,100.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,100.0
56551,,5226710,CHEMBL1679518,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.25 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,3.1,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,3.1
56552,,5226713,CHEMBL1679519,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.5 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,53.1,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,53.1
56553,,5226715,CHEMBL1679520,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 1 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,90.6,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,90.6
56554,,5226717,CHEMBL1679521,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 2 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,100.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,100.0
56555,,5226725,CHEMBL1679527,Antibacterial activity against Enterococcus faecalis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.25 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,2.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Activity,%,UO_0000187,2.5
56556,,5226732,CHEMBL1679529,Antibacterial activity against Enterococcus faecalis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 1 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,35.8,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Activity,%,UO_0000187,35.8
56557,,5226736,CHEMBL1679530,Antibacterial activity against Enterococcus faecalis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 2 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,67.9,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Activity,%,UO_0000187,67.9
56558,,5226743,CHEMBL1679534,Antibacterial activity against Enterococcus faecalis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 32 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,100.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Activity,%,UO_0000187,100.0
56559,,5226751,CHEMBL1680375,Antibacterial activity against Enterococcus faecium assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 1 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,10.5,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,Activity,%,UO_0000187,10.5
56560,,5226755,CHEMBL1680376,Antibacterial activity against Enterococcus faecium assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 2 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,23.7,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,Activity,%,UO_0000187,23.7
56561,,5226758,CHEMBL1680377,Antibacterial activity against Enterococcus faecium assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 4 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,28.9,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,Activity,%,UO_0000187,28.9
56562,,5226767,CHEMBL1680380,Antibacterial activity against Enterococcus faecium assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 32 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,100.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,Activity,%,UO_0000187,100.0
56563,,5226774,CHEMBL1680385,Antibacterial activity against Escherichia coli assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.06 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,66.4,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,66.4
56564,,5226778,CHEMBL1680386,Antibacterial activity against Escherichia coli assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.12 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,67.8,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,67.8
56565,,5226782,CHEMBL1680387,Antibacterial activity against Escherichia coli assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.25 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,70.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,70.0
56566,,5226786,CHEMBL1680388,Antibacterial activity against Escherichia coli assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.5 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,73.6,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,73.6
56567,,5226790,CHEMBL1680389,Antibacterial activity against Escherichia coli assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 1 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,75.1,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,75.1
56568,,5226797,CHEMBL1680391,Antibacterial activity against Escherichia coli assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 4 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,75.6,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,75.6
56569,,5226800,CHEMBL1680392,Antibacterial activity against Escherichia coli assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 8 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,78.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,78.5
56570,,5226804,CHEMBL1680393,Antibacterial activity against Escherichia coli assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 16 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,92.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,92.5
56571,,5226807,CHEMBL1680394,Antibacterial activity against Escherichia coli assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 32 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,100.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,100.0
56572,,5226816,CHEMBL1680524,Antibacterial activity against Klebsiella pneumoniae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.06 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,69.8,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,Activity,%,UO_0000187,69.8
56573,,5226820,CHEMBL1680525,Antibacterial activity against Klebsiella pneumoniae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.12 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,77.4,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,Activity,%,UO_0000187,77.4
56574,,5226824,CHEMBL1680526,Antibacterial activity against Klebsiella pneumoniae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.25 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,78.4,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,Activity,%,UO_0000187,78.4
56575,,5226828,CHEMBL1680527,Antibacterial activity against Klebsiella pneumoniae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.5 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,87.4,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,Activity,%,UO_0000187,87.4
56576,,5226832,CHEMBL1680528,Antibacterial activity against Klebsiella pneumoniae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 1 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,92.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,Activity,%,UO_0000187,92.5
56577,,5226836,CHEMBL1680529,Antibacterial activity against Klebsiella pneumoniae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 2 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,93.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,Activity,%,UO_0000187,93.0
56578,,5226840,CHEMBL1680530,Antibacterial activity against Klebsiella pneumoniae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 4 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,96.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,Activity,%,UO_0000187,96.0
56579,,5226847,CHEMBL1680532,Antibacterial activity against Klebsiella pneumoniae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 16 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,98.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,Activity,%,UO_0000187,98.5
56580,,5226850,CHEMBL1680533,Antibacterial activity against Klebsiella pneumoniae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 32 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,100.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,Activity,%,UO_0000187,100.0
56581,,5226855,CHEMBL1680536,Antibacterial activity against Klebsiella oxytoca assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.06 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,93.8,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,Activity,%,UO_0000187,93.8
56582,,5226862,CHEMBL1680538,Antibacterial activity against Klebsiella oxytoca assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.25 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,100.0,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,Activity,%,UO_0000187,100.0
56583,,5226868,CHEMBL1680541,Antibacterial activity against Enterobacter cloacae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.06 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,87.5,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,Activity,%,UO_0000187,87.5
56584,,5226879,CHEMBL1680545,Antibacterial activity against Enterobacter cloacae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 1 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,91.7,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,Activity,%,UO_0000187,91.7
56585,,5226880,CHEMBL1680546,Antibacterial activity against Enterobacter cloacae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 2 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,93.1,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,Activity,%,UO_0000187,93.1
56586,,5226884,CHEMBL1681164,Antibacterial activity against Enterobacter cloacae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 4 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,97.2,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,Activity,%,UO_0000187,97.2
56587,,5226888,CHEMBL1679398,Antibacterial activity against Enterobacter cloacae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 8 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,98.6,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,Activity,%,UO_0000187,98.6
56588,,5226894,CHEMBL1679400,Antibacterial activity against Enterobacter cloacae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 32 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,100.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,Activity,%,UO_0000187,100.0
56589,,5226896,CHEMBL1679401,Antibacterial activity against Proteus mirabilis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.06 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,33.3,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,Activity,%,UO_0000187,33.3
56590,,5226898,CHEMBL1679402,Antibacterial activity against Proteus mirabilis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.12 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,63.6,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,Activity,%,UO_0000187,63.6
56591,,5226902,CHEMBL1679403,Antibacterial activity against Proteus mirabilis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.25 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,75.8,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,Activity,%,UO_0000187,75.8
56592,,5226906,CHEMBL1679404,Antibacterial activity against Proteus mirabilis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.5 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,78.8,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,Activity,%,UO_0000187,78.8
56593,,5226913,CHEMBL1679406,Antibacterial activity against Proteus mirabilis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 2 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,84.8,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,Activity,%,UO_0000187,84.8
56594,,5226915,CHEMBL1679407,Antibacterial activity against Proteus mirabilis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 4 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,93.9,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,Activity,%,UO_0000187,93.9
56595,,5226917,CHEMBL1679541,Antibacterial activity against Proteus mirabilis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 8 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,97.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,Activity,%,UO_0000187,97.0
56596,,5226922,CHEMBL1679543,Antibacterial activity against Proteus mirabilis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 32 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,100.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,Activity,%,UO_0000187,100.0
56597,,5226926,CHEMBL1679545,Antibacterial activity against Pseudomonas aeruginosa assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.06 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,2.2,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,%,UO_0000187,2.2
56598,,5226930,CHEMBL1679546,Antibacterial activity against Pseudomonas aeruginosa assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.12 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,5.1,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,%,UO_0000187,5.1
56599,,5226933,CHEMBL1679547,Antibacterial activity against Pseudomonas aeruginosa assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.25 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,10.2,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,%,UO_0000187,10.2
56600,,5226937,CHEMBL1679548,Antibacterial activity against Pseudomonas aeruginosa assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.5 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,42.3,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,%,UO_0000187,42.3
56601,,5226941,CHEMBL1679549,Antibacterial activity against Pseudomonas aeruginosa assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 1 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,59.9,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,%,UO_0000187,59.9
56602,,5226945,CHEMBL1679550,Antibacterial activity against Pseudomonas aeruginosa assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 2 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,70.1,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,%,UO_0000187,70.1
56603,,5226949,CHEMBL1679551,Antibacterial activity against Pseudomonas aeruginosa assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 4 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,78.8,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,%,UO_0000187,78.8
56604,,5226953,CHEMBL1679552,Antibacterial activity against Pseudomonas aeruginosa assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 8 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,84.7,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,%,UO_0000187,84.7
56605,,5226957,CHEMBL1679553,Antibacterial activity against Pseudomonas aeruginosa assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 16 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,90.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,%,UO_0000187,90.5
56606,,5226960,CHEMBL1679554,Antibacterial activity against Pseudomonas aeruginosa assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 32 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,100.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,%,UO_0000187,100.0
56607,,5226966,CHEMBL1679559,Antibacterial activity against Stenotrophomonas maltophilia assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.06 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,3.8,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,Activity,%,UO_0000187,3.8
56608,,5226970,CHEMBL1679562,Antibacterial activity against Stenotrophomonas maltophilia assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.5 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,7.7,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,Activity,%,UO_0000187,7.7
56609,,5226974,CHEMBL1679563,Antibacterial activity against Stenotrophomonas maltophilia assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 1 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,46.2,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,Activity,%,UO_0000187,46.2
56610,,5226978,CHEMBL1679564,Antibacterial activity against Stenotrophomonas maltophilia assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 2 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,69.2,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,Activity,%,UO_0000187,69.2
56611,,5226982,CHEMBL1679565,Antibacterial activity against Stenotrophomonas maltophilia assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 4 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,84.6,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,Activity,%,UO_0000187,84.6
56612,,5226985,CHEMBL1679566,Antibacterial activity against Stenotrophomonas maltophilia assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 8 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,92.3,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,Activity,%,UO_0000187,92.3
56613,,5226989,CHEMBL1679567,Antibacterial activity against Stenotrophomonas maltophilia assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 16 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,100.0,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,Activity,%,UO_0000187,100.0
56614,,5226992,CHEMBL1679570,Antibacterial activity against Acinetobacter baumannii assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.06 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,6.7,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,Activity,%,UO_0000187,6.7
56615,,5226996,CHEMBL1679571,Antibacterial activity against Acinetobacter baumannii assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.12 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,40.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,Activity,%,UO_0000187,40.0
56616,,5227000,CHEMBL1679572,Antibacterial activity against Acinetobacter baumannii assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.25 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,80.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,Activity,%,UO_0000187,80.0
56617,,5227004,CHEMBL1679704,Antibacterial activity against Acinetobacter baumannii assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.5 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,86.7,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,Activity,%,UO_0000187,86.7
56618,,5227008,CHEMBL1679705,Antibacterial activity against Acinetobacter baumannii assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 1 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,93.3,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,Activity,%,UO_0000187,93.3
56619,,5227012,CHEMBL1679708,Antibacterial activity against Acinetobacter baumannii assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 16 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,Activity,%,100.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,Activity,%,UO_0000187,100.0
56620,,5227016,CHEMBL1679789,Antibacterial activity against Staphylococcus aureus by CLSI M7-A7 broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332069,=,1,1,=,MIC90,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,16.0
56621,,5228587,CHEMBL1678027,Antimicrobial activity against Haemophilus influenzae by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332500,=,1,1,=,MIC,ug.mL-1,0.08,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug ml-1,UO_0000274,0.08
56622,,5228589,CHEMBL1678027,Antimicrobial activity against Haemophilus influenzae by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332500,=,1,1,=,MIC90,ug.mL-1,0.06,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC90,ug ml-1,UO_0000274,0.06
56623,,5228591,CHEMBL1678027,Antimicrobial activity against Haemophilus influenzae by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332500,=,1,1,=,MIC50,ug.mL-1,0.015,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC50,ug ml-1,UO_0000274,0.015
56624,,5228597,CHEMBL1678042,"Half life in common marmoset at 40 mg/kg, po measured on day 1 by LS/MS/MS analysis",A,BAO_0002115,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671723,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1332502,=,1,1,=,T1/2,hr,3.9,CHEMBL613924,Callithrix jacchus,Callithrix jacchus,9483.0,,t1/2,hr,UO_0000032,3.9
56625,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,5228598,CHEMBL1678043,"Cmax in common marmoset at 40 mg/kg, po measured on day 1 by LS/MS/MS analysis",A,BAO_0002119,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671723,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,1332502,=,1,1,=,Cmax,nM,52024.24,CHEMBL613924,Callithrix jacchus,Callithrix jacchus,9483.0,,Cmax,ug ml-1,UO_0000065,18.8
56626,,5228599,CHEMBL1678041,"AUC in common marmoset at 40 mg/kg, po measured on day 1 by LS/MS/MS analysis",A,BAO_0002120,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671723,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1332502,=,1,1,=,AUC,ng.hr.mL-1,112400.0,CHEMBL613924,Callithrix jacchus,Callithrix jacchus,9483.0,,AUC,ug/ml/hr,,112.4
56627,,5228600,CHEMBL1678040,"Half life in common marmoset at 40 mg/kg, po BID measured on day 1 by LS/MS/MS analysis",A,BAO_0002115,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671723,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1332502,=,1,1,=,T1/2,hr,2.4,CHEMBL613924,Callithrix jacchus,Callithrix jacchus,9483.0,,t1/2,hr,UO_0000032,2.4
56628,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,5228601,CHEMBL1678039,"Cmax in common marmoset at 40 mg/kg, po BID measured on day 1 by LS/MS/MS analysis",A,BAO_0002119,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671723,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,1332502,=,1,1,=,Cmax,nM,45659.57,CHEMBL613924,Callithrix jacchus,Callithrix jacchus,9483.0,,Cmax,ug ml-1,UO_0000065,16.5
56629,,5228602,CHEMBL1678038,"AUC in common marmoset at 40 mg/kg, po BID measured on day 1 by LS/MS/MS analysis",A,BAO_0002120,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671723,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1332502,=,1,1,=,AUC,ng.hr.mL-1,63600.0,CHEMBL613924,Callithrix jacchus,Callithrix jacchus,9483.0,,AUC,ug/ml/hr,,63.6
56630,,5228603,CHEMBL1678037,"Half life in common marmoset at 40 mg/kg, po BID measured on day 7 by LS/MS/MS analysis",A,BAO_0002115,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671723,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1332502,=,1,1,=,T1/2,hr,2.3,CHEMBL613924,Callithrix jacchus,Callithrix jacchus,9483.0,,t1/2,hr,UO_0000032,2.3
56631,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,5228604,CHEMBL1678036,"Cmax in common marmoset at 40 mg/kg, po BID measured on day 7 by LS/MS/MS analysis",A,BAO_0002119,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671723,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,1332502,=,1,1,=,Cmax,nM,57835.46,CHEMBL613924,Callithrix jacchus,Callithrix jacchus,9483.0,,Cmax,ug ml-1,UO_0000065,20.9
56632,,5228605,CHEMBL1678035,"AUC in common marmoset at 40 mg/kg, po BID measured on day 7 by LS/MS/MS analysis",A,BAO_0002120,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671723,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1332502,=,1,1,=,AUC,ng.hr.mL-1,81400.0,CHEMBL613924,Callithrix jacchus,Callithrix jacchus,9483.0,,AUC,ug/ml/hr,,81.4
56633,Active,5228606,CHEMBL1678056,Antimicrobial activity against Francisella tularensis SCHU S4 infected in common marmoset assessed as survival of marmoset at 16.5 mg/kg BID for 10 days measured on day 24,F,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671723,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1332502,,1,0,,Activity,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,Activity,,,
56634,,5228616,CHEMBL1678048,Half life in Rhesus monkey at 15 mg/kg followed by 4 mg/kg in 12 hrs dosing interval by LS/MS/MS analysis,A,BAO_0002115,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671723,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1332502,=,1,1,=,T1/2,hr,3.4,CHEMBL614875,Macaca mulatta,Rhesus monkey,9544.0,,t1/2,hr,UO_0000032,3.4
56635,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,5228618,CHEMBL1678050,Cmax in Rhesus monkey at 15 mg/kg followed by 4 mg/kg in 12 hrs dosing interval by LS/MS/MS analysis,A,BAO_0002119,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671723,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,1332502,=,1,1,=,Cmax,nM,14666.41,CHEMBL614875,Macaca mulatta,Rhesus monkey,9544.0,,Cmax,ug ml-1,UO_0000065,5.3
56636,,5228619,CHEMBL1678051,AUC (0 to infinity) in Rhesus monkey at 15 mg/kg followed by 4 mg/kg in 12 hrs dosing interval by LS/MS/MS analysis,A,BAO_0002120,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671723,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1332502,=,1,1,=,AUC,ng.hr.mL-1,33.4,CHEMBL614875,Macaca mulatta,Rhesus monkey,9544.0,,AUC,ug/L/h,,33.4
56637,,5228620,CHEMBL1678052,Half life in Rhesus monkey at 15 mg/kg by LS/MS/MS analysis,A,BAO_0002115,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671723,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1332502,=,1,1,=,T1/2,hr,2.0,CHEMBL614875,Macaca mulatta,Rhesus monkey,9544.0,,t1/2,hr,UO_0000032,2.0
56638,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,5228622,CHEMBL1678054,Cmax in Rhesus monkey at 15 mg/kg by LS/MS/MS analysis,A,BAO_0002119,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671723,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,1332502,=,1,1,=,Cmax,nM,14112.96,CHEMBL614875,Macaca mulatta,Rhesus monkey,9544.0,,Cmax,ug ml-1,UO_0000065,5.1
56639,,5228623,CHEMBL1678055,AUC (0 to infinity) in Rhesus monkey at 15 mg/kg by LS/MS/MS analysis,A,BAO_0002120,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671723,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1332502,=,1,1,=,AUC,ng.hr.mL-1,21.3,CHEMBL614875,Macaca mulatta,Rhesus monkey,9544.0,,AUC,ug/L/h,,21.3
56640,,5229242,CHEMBL1679882,Ratio of MIC for Escherichia coli K-12 3-AG300 harboring acrB::rpsLneo mutant gene to MIC for Escherichia coli K-12 3-AG300,F,BAO_0000193,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671642,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1331917,=,1,0,=,Ratio,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Ratio,,,4.0
56641,,5229256,CHEMBL1679881,Antimicrobial activity against Escherichia coli K-12 3-AG300 harboring AcrB-N623S-Q624S mutant gene,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671642,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331917,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.0
56642,,5229270,CHEMBL1679880,Antimicrobial activity against Escherichia coli K-12 3-AG300 harboring AcrB-G616N mutant gene,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671642,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331917,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.0
56643,,5229284,CHEMBL1679174,Antimicrobial activity against Escherichia coli K-12 3-AG300 harboring AcrB-I626M mutant gene,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671642,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331917,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.0
56644,,5229298,CHEMBL1679173,Antimicrobial activity against Escherichia coli K-12 3-AG300 harboring AcrB-615-628MexB-M626I mutant gene,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671642,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331917,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.0
56645,,5229312,CHEMBL1679172,Antimicrobial activity against Escherichia coli K-12 3-AG300 harboring AcrB-615-628MexB-N616 mutant gene,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671642,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331917,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.0
56646,,5229326,CHEMBL1679171,Antimicrobial activity against Escherichia coli K-12 3-AG300 harboring AcrB-615-628MexB mutant gene,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671642,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331917,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.0
56647,,5229340,CHEMBL1679170,Antimicrobial activity against Escherichia coli K-12 3-AG300 harboring acrB::rpsLneo mutant gene,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671642,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331917,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.06
56648,,5229354,CHEMBL1679169,Antimicrobial activity against Escherichia coli K-12 3-AG300 harboring AcrB-F628F mutant gene,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671642,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331917,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.0
56649,,5229357,CHEMBL1679886,Antimicrobial activity against Escherichia coli K-12 3-AG300 harboring AcrB-615-628MexB-S623N mutant gene,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671642,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331917,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.0
56650,,5229661,CHEMBL1678266,Antimicrobial activity against erythromycin-resistant Streptococcus pneumoniae assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671681,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332114,=,1,0,=,Activity,%,0.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,0.0
56651,,5229680,CHEMBL1678264,Antimicrobial activity against erythromycin-resistant Streptococcus pneumoniae assessed as susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671681,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1332114,=,1,0,=,Activity,%,100.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,100.0
56652,,5229694,CHEMBL1678262,Antimicrobial activity against erythromycin-resistant Streptococcus pneumoniae by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671681,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332114,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
56653,,5229703,CHEMBL1678262,Antimicrobial activity against erythromycin-resistant Streptococcus pneumoniae by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671681,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332114,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,1.0
56654,,5229715,CHEMBL1678262,Antimicrobial activity against erythromycin-resistant Streptococcus pneumoniae by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671681,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332114,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,1.0
56655,,5230118,CHEMBL1676244,Antimicrobial activity against Staphylococcus aureus RDN1 harboring cloned pTZN10 containing cat and bla genes by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671731,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332571,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
56656,,5230119,CHEMBL1676245,Antimicrobial activity against Staphylococcus aureus RDN1 harboring cloned pTZ2396-encoded QacA gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671731,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332571,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
56657,,5230120,CHEMBL1676246,Antimicrobial activity against Staphylococcus aureus RDN1 harboring cloned pTZ2182-encoded QacBII gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671731,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332571,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
56658,,5230121,CHEMBL1676247,Antimicrobial activity against Staphylococcus aureus RDN1 harboring cloned pTZ2162-encoded QacBIII gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671731,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332571,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
56659,,5230122,CHEMBL1676248,Antimicrobial activity against Staphylococcus aureus RDN1 harboring cloned pTZ2162-encoded QacBIII E320A mutant gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671731,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332571,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
56660,,5230123,CHEMBL1676249,Antimicrobial activity against Staphylococcus aureus RDN1 harboring cloned pTZ2238-encoded QacBIV gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671731,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332571,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
56661,Not Determined,5230124,CHEMBL1676250,Antimicrobial activity against Staphylococcus aureus RDN1 harboring cloned pTZ2238-encoded QacBIV A19T mutant gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671731,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1332571,,1,0,,MIC,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,,,
56662,Not Determined,5230125,CHEMBL1676251,Antimicrobial activity against Staphylococcus aureus RDN1 harboring cloned pTZ2238-encoded QacBIV S151I mutant gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671731,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1332571,,1,0,,MIC,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,,,
56663,Not Determined,5230126,CHEMBL1676252,Antimicrobial activity against Staphylococcus aureus RDN1 harboring cloned pTZ2238-encoded QacBIV A184V mutant gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671731,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1332571,,1,0,,MIC,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,,,
56664,Not Determined,5230127,CHEMBL1676253,Antimicrobial activity against Staphylococcus aureus RDN1 harboring cloned pTZ2238-encoded QacBIV E377G mutant gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1671731,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1332571,,1,0,,MIC,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,,,
56665,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,5294972,CHEMBL1697194,"Cmax in Escherichia coli ATCC 35218 infected Wistar rat tissue cage fluid at 100 mg/kg/day, ip measured on day 4",A,BAO_0002119,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687713,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,1337257,=,1,1,=,Cmax,nM,33206.96,CHEMBL612558,,ADMET,,,Cmax,mg/L,UO_0000065,12.0
56666,,5294974,CHEMBL1697196,"AUC in Escherichia coli ATCC 35218 infected Wistar rat serum at 100 mg/kg/day, ip measured on day 4",A,BAO_0002120,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687713,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1337257,=,1,1,=,AUC,ng.hr.mL-1,106000.0,CHEMBL613658,Rattus norvegicus,Serum,10116.0,,AUC,microg.hr/mL,,106.0
56667,,5294975,CHEMBL1697197,"AUC in Escherichia coli ATCC 35218 infected Wistar rat tissue cage fluid at 100 mg/kg/day, ip measured on day 4",A,BAO_0002120,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687713,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1337257,=,1,1,=,AUC,ng.hr.mL-1,117000.0,CHEMBL612558,,ADMET,,,AUC,microg.hr/mL,,117.0
56668,,5294976,CHEMBL1697198,"Ratio of AUC in Wistar rat tissue cage fluid to MIC for Escherichia coli ATCC 35218 at 100 mg/kg/day, ip measured on day 4",F,BAO_0000193,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687713,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1337257,=,1,0,=,Ratio,,234.0,CHEMBL612545,,Unchecked,,,Ratio,,,234.0
56669,,5294977,CHEMBL1697199,"Ratio of Cmax in Wistar rat tissue cage fluid to MIC for Escherichia coli ATCC 35218 at 100 mg/kg/day, ip measured on day 4",F,BAO_0000193,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687713,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1337257,=,1,0,=,Ratio,,24.0,CHEMBL612545,,Unchecked,,,Ratio,,,24.0
56670,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,5294978,CHEMBL1697200,"Cmax in Escherichia coli ATCC 35218 infected Wistar rat tissue cage fluid at 50 mg/kg/day, ip measured on day 4",A,BAO_0002119,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687713,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,1337257,=,1,1,=,Cmax,nM,16603.48,CHEMBL612558,,ADMET,,,Cmax,mg/L,UO_0000065,6.0
56671,,5294980,CHEMBL1697202,"AUC in Escherichia coli ATCC 35218 infected Wistar rat serum at 50 mg/kg/day, ip measured on day 4",A,BAO_0002120,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687713,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1337257,=,1,1,=,AUC,ng.hr.mL-1,77000.0,CHEMBL613658,Rattus norvegicus,Serum,10116.0,,AUC,microg.hr/mL,,77.0
56672,,5294981,CHEMBL1697203,"AUC in Escherichia coli ATCC 35218 infected Wistar rat tissue cage fluid at 50 mg/kg/day, ip measured on day 4",A,BAO_0002120,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687713,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1337257,=,1,1,=,AUC,ng.hr.mL-1,68000.0,CHEMBL612558,,ADMET,,,AUC,microg.hr/mL,,68.0
56673,,5294982,CHEMBL1697204,"Ratio of AUC in Wistar rat tissue cage fluid to MIC for Escherichia coli ATCC 35218 at 50 mg/kg/day, ip measured on day 4",F,BAO_0000193,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687713,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1337257,=,1,0,=,Ratio,,136.0,CHEMBL612545,,Unchecked,,,Ratio,,,136.0
56674,,5294983,CHEMBL1697205,"Ratio of Cmax in Wistar rat tissue cage fluid to MIC for Escherichia coli ATCC 35218 at 50 mg/kg/day, ip measured on day 4",F,BAO_0000193,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687713,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1337257,=,1,0,=,Ratio,,13.0,CHEMBL612545,,Unchecked,,,Ratio,,,13.0
56675,,5294991,CHEMBL1697192,Antimicrobial activity against log phase culture of methicillin-resistant Staphylococcus aureus ATCC 29213 by macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687713,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337257,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
56676,,5294992,CHEMBL1697192,Antimicrobial activity against log phase culture of methicillin-resistant Staphylococcus aureus ATCC 29213 by macrodilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687713,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337257,=,1,0,=,MBC,ug ml-1,0.015,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,ug ml-1,UO_0000274,0.015
56677,,5294994,CHEMBL1697190,Antimicrobial activity against stationary phase culture of methicillin-resistant Staphylococcus aureus ATCC 29213 by macrodilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687713,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337257,>,1,0,>,MBC,ug ml-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,ug ml-1,UO_0000274,8.0
56678,Not Active,5294998,CHEMBL1697193,Antimicrobial activity against methicillin-resistant Staphylococcus aureus ATCC 29213 at 2 times MIC in presence of rifampin,F,BAO_0000201,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687713,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1337257,,1,0,,Inhibition,%,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,INH,,UO_0000187,
56679,,5294999,CHEMBL1697187,"Antimicrobial activity against methicillin-resistant Staphylococcus aureus ATCC 29213 tissue cage Wistar rat infected model assessed as bacterial load reduction at 100 mg/kg/day, ip treated for 7 days measured 24 hrs after last dose (Rvb = 6.8 +/-0.8 logCFU/ml)",F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687713,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1337257,=,1,0,=,log10CFU/ml,,6.74,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,log10CFU/ml,,,6.74
56680,,5295000,CHEMBL1697186,"Antimicrobial activity against methicillin-resistant Staphylococcus aureus ATCC 29213 tissue cage Wistar rat infected model assessed as bacterial load reduction at 50 mg/kg/day, ip treated for 7 days measured 24 hrs after last dose (Rvb = 6.8 +/-0.8 logCFU/ml)",F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687713,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1337257,=,1,0,=,log10CFU/ml,,6.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,log10CFU/ml,,,6.4
56681,,5295001,CHEMBL1697336,"Antimicrobial activity against methicillin-resistant Staphylococcus aureus ATCC 29213 tissue cage Wistar rat infected model assessed as bacterial load reduction at 100 mg/kg/day, ip treated for 7 days measured 24 hrs after last dose (Rvb = 6.8 +/-0.8 logCFU/ml) co-treated with 25 mg/kg rifampin, ip bid",F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687713,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1337257,=,1,0,=,log10CFU/ml,,6.74,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,log10CFU/ml,,,6.74
56682,,5295002,CHEMBL1697337,"Antimicrobial activity against methicillin-resistant Staphylococcus aureus ATCC 29213 tissue cage Wistar rat infected model assessed as bacterial load reduction at 50 mg/kg/day, ip treated for 7 days measured 24 hrs after last dose (Rvb = 6.8 +/-0.8 logCFU/ml) co-treated with 25 mg/kg rifampin, ip bid",F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687713,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1337257,=,1,0,=,log10CFU/ml,,6.7,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,log10CFU/ml,,,6.7
56683,,5295003,CHEMBL1697338,"Antimicrobial activity against methicillin-resistant Staphylococcus aureus ATCC 29213 tissue cage Wistar rat infected model assessed as bacterial load reduction at 100 mg/kg/day, ip treated for 14 days measured 24 hrs after last dose (Rvb = 7.2 +/- 0.6 logCFU/ml) co-treated with 25 mg/kg rifampin, ip bid",F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687713,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1337257,=,1,0,=,log10CFU/ml,,3.37,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,log10CFU/ml,,,3.37
56684,,5295004,CHEMBL1697185,"Antimicrobial activity against methicillin-resistant Staphylococcus aureus ATCC 29213 tissue cage Wistar rat infected model assessed as bacterial load reduction at 100 mg/kg/day, ip treated for 14 days measured 24 hrs after last dose (Rvb = 7.2 +/- 0.6 logCFU/ml)",F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687713,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1337257,=,1,0,=,log10CFU/ml,,2.9,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,log10CFU/ml,,,2.9
56685,,5295005,CHEMBL1697184,"Antimicrobial activity against methicillin-resistant Staphylococcus aureus ATCC 29213 coverslip Wistar rat infected model assessed as bacterial load reduction at 100 mg/kg/day, ip treated for 14 days measured 24 hrs after last dose (Rvb = 5.4 +/- 1 logCFU/ml)",F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687713,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1337257,=,1,0,=,log10CFU/ml,,2.24,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,log10CFU/ml,,,2.24
56686,,5295006,CHEMBL1697339,"Antimicrobial activity against methicillin-resistant Staphylococcus aureus ATCC 29213 coverslip Wistar rat infected model assessed as bacterial load reduction at 100 mg/kg/day, ip treated for 14 days measured 24 hrs after last dose (Rvb = 5.4 +/- 1 logCFU/ml) co-treated with 25 mg/kg rifampin, ip bid",F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687713,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1337257,=,1,0,=,log10CFU/ml,,3.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,log10CFU/ml,,,3.3
56687,,5296292,CHEMBL1691259,Bacteriostatic activity against Escherichia coli K-12 DM4100,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687807,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338187,=,1,1,=,MIC,ug.mL-1,0.2,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.2
56688,,5296322,CHEMBL1691261,Ratio of LD99 for Escherichia coli K-12 DM4100 to MIC for Escherichia coli K-12 DM4100,F,BAO_0000193,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687807,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1338187,=,1,0,=,Ratio,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Ratio,,,4.0
56689,,5297846,CHEMBL1690705,Antimicrobial activity against Acinetobacter lwoffii isolate A expressing beta-lactamase OXA-164 isolated from tracheal secretion of patient by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687815,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338301,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,MIC,ug ml-1,UO_0000274,8.0
56690,,5297847,CHEMBL1690706,Antimicrobial activity against Acinetobacter lwoffii isolate B expressing beta-lactamase OXA-164 isolated from tracheal secretion of patient by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687815,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338301,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,MIC,ug ml-1,UO_0000274,8.0
56691,,5297848,CHEMBL1690707,Antimicrobial activity against Acinetobacter lwoffii isolate C expressing beta-lactamase OXA-164 isolated from tracheal secretion of patient by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687815,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338301,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,MIC,ug ml-1,UO_0000274,8.0
56692,,5297849,CHEMBL1690708,Antimicrobial activity against Acinetobacter lwoffii isolate D expressing beta-lactamase OXA-164 isolated from tracheal secretion of patient by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687815,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338301,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,MIC,ug ml-1,UO_0000274,8.0
56693,,5297850,CHEMBL1690709,Antimicrobial activity against Acinetobacter lwoffii isolate E expressing beta-lactamase OXA-164 isolated from tracheal secretion of patient by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687815,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338301,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,MIC,ug ml-1,UO_0000274,16.0
56694,,5297851,CHEMBL1690710,Antimicrobial activity against Acinetobacter lwoffii isolate F expressing beta-lactamase OXA-164 isolated from tracheostoma of patient by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687815,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338301,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,MIC,ug ml-1,UO_0000274,8.0
56695,,5297852,CHEMBL1690711,Antimicrobial activity against Acinetobacter lwoffii isolate G expressing beta-lactamase OXA-58 isolated from tracheal secretion of patient by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687815,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338301,>=,1,1,>=,MIC,ug.mL-1,64.0,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,MIC,ug ml-1,UO_0000274,64.0
56696,,5297853,CHEMBL1690712,Antimicrobial activity against Acinetobacter lwoffii isolate H expressing beta-lactamase OXA-58 isolated from tracheal secretion of patient by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687815,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338301,>=,1,1,>=,MIC,ug.mL-1,64.0,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,MIC,ug ml-1,UO_0000274,64.0
56697,,5298585,CHEMBL1690713,Antimicrobial activity against Acinetobacter lwoffii isolate I expressing beta-lactamase OXA-58 isolated from tracheal secretion of patient by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687815,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338301,>=,1,1,>=,MIC,ug.mL-1,64.0,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,MIC,ug ml-1,UO_0000274,64.0
56698,,5298586,CHEMBL1690714,Antimicrobial activity against Acinetobacter lwoffii isolate J expressing beta-lactamase OXA-58 isolated from bedsore by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687815,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338301,>=,1,1,>=,MIC,ug.mL-1,64.0,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,MIC,ug ml-1,UO_0000274,64.0
56699,,5298587,CHEMBL1690715,Antimicrobial activity against Acinetobacter lwoffii isolate K expressing beta-lactamase OXA-58 isolated from blood culture of patient by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687815,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338301,>=,1,1,>=,MIC,ug.mL-1,64.0,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,MIC,ug ml-1,UO_0000274,64.0
56700,,5298588,CHEMBL1690716,Antimicrobial activity against Acinetobacter lwoffii isolate L expressing beta-lactamase OXA-58 isolated from tracheal secretion of patient by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687815,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338301,>=,1,1,>=,MIC,ug.mL-1,64.0,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,MIC,ug ml-1,UO_0000274,64.0
56701,,5298589,CHEMBL1690717,Antimicrobial activity against Acinetobacter lwoffii isolate M expressing beta-lactamase OXA-58 isolated from tracheal secretion of patient by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687815,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338301,>=,1,1,>=,MIC,ug.mL-1,64.0,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,MIC,ug ml-1,UO_0000274,64.0
56702,,5305664,CHEMBL1690402,"Antibacterial activity against porin, OmpA positive Klebsiella pneumoniae ATCC 138821 by disk agar diffusion method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687777,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337863,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,mg/L,UO_0000274,0.03
56703,,5305665,CHEMBL1690403,"Antibacterial activity against porin, OmpA positive Klebsiella pneumoniae KPBj1 expressing efflux system by disk agar diffusion method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687777,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337863,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,mg/L,UO_0000274,1.0
56704,,5305666,CHEMBL1690404,"Antibacterial activity against porin, OmpA positive Klebsiella pneumoniae KPBj1 revertant by disk agar diffusion method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687777,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337863,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,mg/L,UO_0000274,0.03
56705,,5305667,CHEMBL1690405,Antibacterial activity against porin deficient OmpA positive Klebsiella pneumoniae KPBj1 expressing efflux system by disk agar diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687777,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337863,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,mg/L,UO_0000274,1.0
56706,,5305668,CHEMBL1690406,Antibacterial activity against porin deficient OmpA positive Klebsiella pneumoniae KPBj1 revertant by disk agar diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687777,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337863,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,mg/L,UO_0000274,0.06
56707,,5305669,CHEMBL1690407,"Antibacterial activity against porin, OmpA positive extended-spectrum beta-lactamase producing Klebsiella pneumoniae KPBj1 by disk agar diffusion method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687777,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337863,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,mg/L,UO_0000274,0.5
56708,,5305670,CHEMBL1690408,"Antibacterial activity against porin, OmpA positive extended-spectrum beta-lactamase producing Klebsiella pneumoniae KPBj1 revertant by disk agar diffusion method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687777,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337863,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,mg/L,UO_0000274,0.03
56709,,5305671,CHEMBL1690409,Antibacterial activity against porin deficient OmpA positive extended-spectrum beta-lactamase producing Klebsiella pneumoniae KPBj1 expressing efflux system by disk agar diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687777,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337863,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,mg/L,UO_0000274,1.0
56710,,5305672,CHEMBL1690410,Antibacterial activity against porin deficient OmpA positive extended-spectrum beta-lactamase producing Klebsiella pneumoniae KPBj1 revertant by disk agar diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687777,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337863,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,mg/L,UO_0000274,0.06
56711,,5305673,CHEMBL1690411,"Antibacterial activity against porin, OmpA positive Klebsiella pneumoniae KPBj3 expressing efflux system by disk agar diffusion method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687777,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337863,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,mg/L,UO_0000274,0.5
56712,,5305674,CHEMBL1690412,"Antibacterial activity against porin, OmpA positive Klebsiella pneumoniae KPBj3 revertant by disk agar diffusion method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687777,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337863,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,mg/L,UO_0000274,0.03
56713,,5305675,CHEMBL1690413,Antibacterial activity against porin deficient OmpA positive Klebsiella pneumoniae KPBj3 expressing efflux system by disk agar diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687777,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337863,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,mg/L,UO_0000274,0.5
56714,,5305676,CHEMBL1690414,Antibacterial activity against porin deficient OmpA positive Klebsiella pneumoniae KPBj3 revertant by disk agar diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687777,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337863,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,mg/L,UO_0000274,0.015
56715,,5305677,CHEMBL1690415,"Antibacterial activity against porin, OmpA positive Klebsiella pneumoniae KPBj5 expressing efflux system by disk agar diffusion method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687777,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337863,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,mg/L,UO_0000274,0.125
56716,,5305678,CHEMBL1690416,"Antibacterial activity against porin, OmpA positive Klebsiella pneumoniae KPBj5 revertant by disk agar diffusion method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687777,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337863,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,mg/L,UO_0000274,0.06
56717,,5305679,CHEMBL1690417,Antibacterial activity against porin deficient OmpA positive Klebsiella pneumoniae KPBj5 expressing efflux system by disk agar diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687777,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337863,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,mg/L,UO_0000274,0.125
56718,,5305680,CHEMBL1690418,Antibacterial activity against porin deficient OmpA positive Klebsiella pneumoniae KPBj5 revertant by disk agar diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687777,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337863,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,mg/L,UO_0000274,0.06
56719,,5307391,CHEMBL1694333,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrA gene and pBK-QnrA1 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,1,=,MIC,ug.mL-1,0.008,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.008
56720,,5307392,CHEMBL1694334,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrB gene and pBK-QnrB1 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.5
56721,,5307393,CHEMBL1694335,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrS gene and pBK-QnrS1 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.125
56722,,5307394,CHEMBL1694336,Antibacterial activity against Escherichia coli ATCC 25922 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.5
56723,,5307395,CHEMBL1694337,Antibacterial activity against Escherichia coli ATCC 25922 harboring GyrA S83L mutant by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.125
56724,,5307396,CHEMBL1694221,Antibacterial activity against qnrA gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrA1 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.5
56725,,5307397,CHEMBL1694220,Antibacterial activity against qnrB gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrB1 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.25
56726,,5307398,CHEMBL1694219,Antibacterial activity against qnrS gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrS1 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.0
56727,,5307399,CHEMBL1694218,Antibacterial activity against Escherichia coli ATCC 25922 harboring ParC S80R mutant by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,1,=,MIC,ug.mL-1,0.008,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.008
56728,,5307400,CHEMBL1694332,Antibacterial activity against qnrA gene expressing Escherichia coli ATCC 25922 harboring ParC S80R mutant and pBK-QnrA1 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.25
56729,,5307401,CHEMBL1694223,Antibacterial activity against qnrB gene expressing Escherichia coli ATCC 25922 harboring ParC S80R mutant and pBK-QnrB1 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.25
56730,,5307402,CHEMBL1694217,Antibacterial activity against qnrS gene expressing Escherichia coli ATCC 25922 harboring ParC S80R mutant and pBK-QnrS1 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.25
56731,,5307403,CHEMBL1694338,Antibacterial activity against Escherichia coli ATCC 25922 harboring GyrA S83L mutant and ParC S80R mutant by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.25
56732,,5307404,CHEMBL1694339,"Antibacterial activity against qnrA gene expressing Escherichia coli ATCC 25922 harboring ParC S80R mutant, ParC S80R mutant and pBK-QnrA1 by broth microdilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,2.0
56733,,5307405,CHEMBL1694340,"Antibacterial activity against qnrB gene expressing Escherichia coli ATCC 25922 harboring ParC S80R mutant, ParC S80R mutant and pBK-QnrB1 by broth microdilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.0
56734,,5307406,CHEMBL1694341,"Antibacterial activity against qnrS gene expressing Escherichia coli ATCC 25922 harboring ParC S80R mutant, ParC S80R mutant and pBK-QnrS1 by broth microdilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,4.0
56735,,5307407,CHEMBL1694346,Antibacterial activity against Escherichia coli ATCC 25922 assessed as mutant prevention concentration,F,BAO_0000181,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,0,=,Activity,ug ml-1,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,ug ml-1,UO_0000274,2.0
56736,,5307408,CHEMBL1694347,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrA gene and pBK-QnrA1 assessed as mutant prevention concentration,F,BAO_0000181,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,0,=,Activity,ug ml-1,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,ug ml-1,UO_0000274,8.0
56737,,5307409,CHEMBL1694348,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrB gene and pBK-QnrB1 assessed as mutant prevention concentration,F,BAO_0000181,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,0,=,Activity,ug ml-1,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,ug ml-1,UO_0000274,4.0
56738,,5307410,CHEMBL1694527,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrS gene and pBK-QnrS1 assessed as mutant prevention concentration,F,BAO_0000181,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,0,=,Activity,ug ml-1,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,ug ml-1,UO_0000274,4.0
56739,,5307411,CHEMBL1694528,Antibacterial activity against Escherichia coli ATCC 25922 harboring GyrA S83L mutant assessed as mutant prevention concentration,F,BAO_0000181,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,0,=,Activity,ug ml-1,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,ug ml-1,UO_0000274,4.0
56740,,5307412,CHEMBL1694624,Antibacterial activity against qnrA gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrA1 assessed as mutant prevention concentration,F,BAO_0000181,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,0,=,Activity,ug ml-1,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,ug ml-1,UO_0000274,32.0
56741,,5307413,CHEMBL1694625,Antibacterial activity against qnrB gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrB1 assessed as mutant prevention concentration,F,BAO_0000181,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,0,=,Activity,ug ml-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,ug ml-1,UO_0000274,16.0
56742,,5307414,CHEMBL1694626,Antibacterial activity against qnrS gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrS1 assessed as mutant prevention concentration,F,BAO_0000181,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,0,=,Activity,ug ml-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,ug ml-1,UO_0000274,16.0
56743,,5307415,CHEMBL1694627,Ratio of mutant prevention concentration to MIC for Escherichia coli ATCC 25922,F,BAO_0000193,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1338561,=,1,0,=,Ratio,,250.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Ratio,,,250.0
56744,,5307416,CHEMBL1694628,Ratio of mutant prevention concentration to MIC for Escherichia coli ATCC 25922 expressing qnrA gene and pBK-QnrA1,F,BAO_0000193,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1338561,=,1,0,=,Ratio,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Ratio,,,16.0
56745,,5307417,CHEMBL1694629,Ratio of mutant prevention concentration to MIC for Escherichia coli ATCC 25922 expressing qnrB gene and pBK-QnrB1,F,BAO_0000193,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1338561,=,1,0,=,Ratio,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Ratio,,,32.0
56746,,5307418,CHEMBL1694630,Ratio of mutant prevention concentration to MIC for Escherichia coli ATCC 25922 expressing qnrS gene and pBK-QnrS1,F,BAO_0000193,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1338561,=,1,0,=,Ratio,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Ratio,,,8.0
56747,,5307419,CHEMBL1694631,Ratio of mutant prevention concentration to MIC for Escherichia coli ATCC 25922 harboring GyrA S83L mutant,F,BAO_0000193,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1338561,=,1,0,=,Ratio,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Ratio,,,32.0
56748,,5307420,CHEMBL1694632,Ratio of mutant prevention concentration to MIC for qnrA gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrA1,F,BAO_0000193,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1338561,=,1,0,=,Ratio,,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Ratio,,,64.0
56749,,5307421,CHEMBL1694633,Ratio of mutant prevention concentration to MIC for qnrB gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrB1,F,BAO_0000193,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1338561,=,1,0,=,Ratio,,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Ratio,,,64.0
56750,,5307422,CHEMBL1694634,Ratio of mutant prevention concentration to MIC for qnrS gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrS1,F,BAO_0000193,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1338561,=,1,0,=,Ratio,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Ratio,,,16.0
56751,,5307423,CHEMBL1694635,Antibacterial activity against Escherichia coli ATCC 25922 assessed as earliest time required to resistant colonies visible one step below mutant prevention concentration,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1338561,=,1,1,=,TIME,hr,48.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Time,hr,UO_0000032,48.0
56752,,5307424,CHEMBL1694636,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrA gene and pBK-QnrA1 assessed as earliest time required to resistant colonies visible one step below mutant prevention concentration,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1338561,=,1,1,=,TIME,hr,24.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Time,hr,UO_0000032,24.0
56753,,5307425,CHEMBL1694637,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrB gene and pBK-QnrB1 assessed as earliest time required to resistant colonies visible one step below mutant prevention concentration,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1338561,=,1,1,=,TIME,hr,48.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Time,hr,UO_0000032,48.0
56754,,5307426,CHEMBL1694638,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrS gene and pBK-QnrS1 assessed as earliest time required to resistant colonies visible one step below mutant prevention concentration,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1338561,=,1,1,=,TIME,hr,24.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Time,hr,UO_0000032,24.0
56755,,5307427,CHEMBL1694639,Antibacterial activity against Escherichia coli ATCC 25922 harboring GyrA S83L mutant assessed as earliest time required to resistant colonies visible one step below mutant prevention concentration,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1338561,=,1,1,=,TIME,hr,24.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Time,hr,UO_0000032,24.0
56756,,5307428,CHEMBL1694640,Antibacterial activity against qnrA gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrA1 assessed as earliest time required to resistant colonies visible one step below mutant prevention concentration,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1338561,=,1,1,=,TIME,hr,24.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Time,hr,UO_0000032,24.0
56757,,5307429,CHEMBL1694641,Antibacterial activity against qnrB gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrB1 assessed as earliest time required to resistant colonies visible one step below mutant prevention concentration,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1338561,=,1,1,=,TIME,hr,72.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Time,hr,UO_0000032,72.0
56758,,5307430,CHEMBL1694642,Antibacterial activity against qnrS gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrS1 assessed as earliest time required to resistant colonies visible one step below mutant prevention concentration,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1338561,=,1,1,=,TIME,hr,96.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Time,hr,UO_0000032,96.0
56759,,5307431,CHEMBL1694643,Antibacterial activity against Escherichia coli ATCC 25922 assessed as resistant colonies recovered one step below mutant prevention concentration,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.125
56760,,5307432,CHEMBL1694644,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrA gene and pBK-QnrA1 assessed as resistant colonies recovered one step below mutant prevention concentration,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.0
56761,,5307433,CHEMBL1694646,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrB gene and pBK-QnrB1 assessed as resistant colonies recovered one step below mutant prevention concentration,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.5
56762,,5307434,CHEMBL1694647,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrS gene and pBK-QnrS1 assessed as resistant colonies recovered one step below mutant prevention concentration,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.0
56763,,5307435,CHEMBL1694648,Antibacterial activity against Escherichia coli ATCC 25922 harboring GyrA S83L mutant assessed as resistant colonies recovered one step below mutant prevention concentration,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,2.0
56764,,5307436,CHEMBL1694649,Antibacterial activity against qnrA gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrA1 assessed as resistant colonies recovered one step below mutant prevention concentration,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,2.0
56765,,5307437,CHEMBL1694650,Antibacterial activity against qnrB gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrB1 assessed as resistant colonies recovered one step below mutant prevention concentration,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.0
56766,,5307438,CHEMBL1694651,Antibacterial activity against qnrS gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrS1 assessed as resistant colonies recovered one step below mutant prevention concentration,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,4.0
56767,,5307439,CHEMBL1694333,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrA gene and pBK-QnrA1 by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,0,=,MBC,ug ml-1,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MBC,ug ml-1,UO_0000274,0.03
56768,,5307440,CHEMBL1694334,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrB gene and pBK-QnrB1 by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,0,=,MBC,ug ml-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MBC,ug ml-1,UO_0000274,0.5
56769,,5307441,CHEMBL1694335,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrS gene and pBK-QnrS1 by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,0,=,MBC,ug ml-1,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MBC,ug ml-1,UO_0000274,0.25
56770,,5307442,CHEMBL1694336,Antibacterial activity against Escherichia coli ATCC 25922 by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,0,=,MBC,ug ml-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MBC,ug ml-1,UO_0000274,0.5
56771,,5307443,CHEMBL1694337,Antibacterial activity against Escherichia coli ATCC 25922 harboring GyrA S83L mutant by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,0,=,MBC,ug ml-1,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MBC,ug ml-1,UO_0000274,0.25
56772,,5307444,CHEMBL1694221,Antibacterial activity against qnrA gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrA1 by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,0,=,MBC,ug ml-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MBC,ug ml-1,UO_0000274,0.5
56773,,5307445,CHEMBL1694220,Antibacterial activity against qnrB gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrB1 by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,0,=,MBC,ug ml-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MBC,ug ml-1,UO_0000274,0.5
56774,,5307446,CHEMBL1694219,Antibacterial activity against qnrS gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrS1 by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,0,=,MBC,ug ml-1,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MBC,ug ml-1,UO_0000274,2.0
56775,,5307447,CHEMBL1694218,Antibacterial activity against Escherichia coli ATCC 25922 harboring ParC S80R mutant by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,0,=,MBC,ug ml-1,0.008,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MBC,ug ml-1,UO_0000274,0.008
56776,,5307448,CHEMBL1694332,Antibacterial activity against qnrA gene expressing Escherichia coli ATCC 25922 harboring ParC S80R mutant and pBK-QnrA1 by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,0,=,MBC,ug ml-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MBC,ug ml-1,UO_0000274,0.5
56777,,5307449,CHEMBL1694223,Antibacterial activity against qnrB gene expressing Escherichia coli ATCC 25922 harboring ParC S80R mutant and pBK-QnrB1 by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,0,=,MBC,ug ml-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MBC,ug ml-1,UO_0000274,0.5
56778,,5307450,CHEMBL1694217,Antibacterial activity against qnrS gene expressing Escherichia coli ATCC 25922 harboring ParC S80R mutant and pBK-QnrS1 by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,0,=,MBC,ug ml-1,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MBC,ug ml-1,UO_0000274,0.25
56779,,5307451,CHEMBL1694338,Antibacterial activity against Escherichia coli ATCC 25922 harboring GyrA S83L mutant and ParC S80R mutant by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,0,=,MBC,ug ml-1,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MBC,ug ml-1,UO_0000274,0.25
56780,,5307452,CHEMBL1694339,"Antibacterial activity against qnrA gene expressing Escherichia coli ATCC 25922 harboring ParC S80R mutant, ParC S80R mutant and pBK-QnrA1 by broth microdilution method",F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,0,=,MBC,ug ml-1,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MBC,ug ml-1,UO_0000274,4.0
56781,,5307453,CHEMBL1694340,"Antibacterial activity against qnrB gene expressing Escherichia coli ATCC 25922 harboring ParC S80R mutant, ParC S80R mutant and pBK-QnrB1 by broth microdilution method",F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,0,=,MBC,ug ml-1,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MBC,ug ml-1,UO_0000274,1.0
56782,,5307454,CHEMBL1694341,"Antibacterial activity against qnrS gene expressing Escherichia coli ATCC 25922 harboring ParC S80R mutant, ParC S80R mutant and pBK-QnrS1 by broth microdilution method",F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,0,=,MBC,ug ml-1,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MBC,ug ml-1,UO_0000274,4.0
56783,,5310849,CHEMBL1694724,Antibacterial activity against levofloxacin-resistant Pseudomonas aeruginosa,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687743,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337509,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,32.0
56784,,5310850,CHEMBL1694723,Antibacterial activity against levofloxacin-resistant Proteus mirabilis,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687743,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337509,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,MIC,ug ml-1,UO_0000274,32.0
56785,,5310851,CHEMBL1694722,Antibacterial activity against levofloxacin-resistant Escherichia coli,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687743,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337509,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,32.0
56786,,5310852,CHEMBL1694721,Antibacterial activity against levofloxacin-resistant Enterococcus faecalis,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687743,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337509,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,16.0
56787,,5310854,CHEMBL1694719,"Antibacterial activity against Pseudomonas aeruginosa isolated from patient with urinary tract infection receiving drug at 250 mg, iv qd for 10 days measured after post drug therapy",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687743,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337509,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.25
56788,,5310855,CHEMBL1694718,"Antibacterial activity against Proteus mirabilis isolated from patient with urinary tract infection receiving drug at 250 mg, iv qd for 10 days measured after post drug therapy",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687743,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337509,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,MIC,ug ml-1,UO_0000274,0.25
56789,,5310856,CHEMBL1694717,"Antibacterial activity against Klebsiella pneumoniae isolated from patient with urinary tract infection receiving drug at 250 mg, iv qd for 10 days measured after post drug therapy",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687743,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337509,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,2.0
56790,,5310857,CHEMBL1694716,"Antibacterial activity against Escherichia coli isolated from patient with urinary tract infection receiving drug at 250 mg, iv qd for 10 days measured after post drug therapy",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687743,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337509,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.25
56791,,5310860,CHEMBL1694713,"Antibacterial activity against Proteus mirabilis infected in microbiologically evaluable patient with UTI assessed as cure rate at 250 mg, iv qd for 10 days measured at test-of-cure visit",F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687743,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1337509,=,1,0,=,Activity,%,86.7,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,Activity,%,UO_0000187,86.7
56792,,5310862,CHEMBL1694711,"Antibacterial activity against Klebsiella pneumoniae infected in microbiologically evaluable patient with UTI assessed as cure rate at 250 mg, iv qd for 10 days measured at test-of-cure visit",F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687743,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1337509,=,1,0,=,Activity,%,62.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,Activity,%,UO_0000187,62.5
56793,,5310864,CHEMBL1694709,"Antibacterial activity against levofloxacin-resistant Escherichia coli infected in clinically evaluable patient with UTI assessed as cure rate at 250 mg, iv qd for 10 days measured at test-of-cure visit",F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687743,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1337509,=,1,0,=,Activity,%,33.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,33.0
56794,,5310866,CHEMBL1694707,"Antibacterial activity against levofloxacin-resistant Escherichia coli infected in microbiologically evaluable patient with UTI assessed as cure rate at 250 mg, iv qd for 10 days measured at test-of-cure visit",F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687743,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1337509,=,1,0,=,Activity,%,29.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,29.0
56795,,5310868,CHEMBL1694705,"Antibacterial activity against Escherichia coli infected in microbiologically evaluable patient with UTI assessed as cure rate at 250 mg, iv qd for 10 days measured at test-of-cure visit",F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1687743,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1337509,=,1,0,=,Activity,%,87.2,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,87.2
56796,WE: Weak evidence (<10 case reports) of human hepatotoxicity,5316449,CHEMBL1697722,Literature-mined public compounds from Greene et al multi-species hepatotoxicity modelling dataset,A,BAO_0000179,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1697692,Chem Res Toxicol,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1340272,,1,0,,Hepatotoxicity,,,CHEMBL1697861,,Hepatotoxicity,,,Hepatotoxicity,,,
56797,DILI negative (training set),5316663,CHEMBL1697730,Human drug-induced liver injury (DILI) modelling dataset from Ekins et al,A,BAO_0000179,BAO_0000221,tissue-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1697723,Drug Metab Dispos,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1340481,,1,0,,Hepatotoxicity,,,CHEMBL1697861,,Hepatotoxicity,,,Hepatotoxicity,,,
56798,drug-induced liver injury reported,5317522,CHEMBL1697778,"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in humans",A,BAO_0000179,BAO_0000221,tissue-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1697731,Chem Res Toxicol,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1341308,,1,0,,Hepatotoxicity,,,CHEMBL1697861,,Hepatotoxicity,,,Hepatotoxicity,,,
56799,no drug-induced liver injury reported,5318473,CHEMBL1697779,"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in rodents",A,BAO_0000179,BAO_0000221,tissue-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1697731,Chem Res Toxicol,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1341308,,1,0,,Hepatotoxicity,,,CHEMBL1697861,,Hepatotoxicity,,,Hepatotoxicity,,,
56800,no drug-induced liver injury reported,5319424,CHEMBL1697780,"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in non-rodents",A,BAO_0000179,BAO_0000221,tissue-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1697731,Chem Res Toxicol,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1341308,,1,0,,Hepatotoxicity,,,CHEMBL1697861,,Hepatotoxicity,,,Hepatotoxicity,,,
56801,,6172601,CHEMBL1767999,Antimicrobial activity against Bacillus cereus ATCC 11778 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1765022,Bioorg Med Chem,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418180,=,1,1,=,MIC,ug.mL-1,0.15,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,MIC,ug ml-1,UO_0000274,0.15
56802,,6172610,CHEMBL1768000,Antimicrobial activity against Bacillus megaterium ATCC 19213 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1765022,Bioorg Med Chem,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418180,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL613071,Priestia megaterium,Priestia megaterium,1404.0,,MIC,ug ml-1,UO_0000274,0.03
56803,,6172619,CHEMBL1768001,Antimicrobial activity against Bacillus subtilis ATCC 6633 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1765022,Bioorg Med Chem,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418180,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,0.03
56804,,6172628,CHEMBL1768002,Antimicrobial activity against Bacillus thuringiensis var.kurstaki BGSC 4D1 by broth dilution method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1765022,Bioorg Med Chem,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418180,=,1,1,=,MIC,ug.mL-1,0.07,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.07
56805,,6172637,CHEMBL1768003,Antimicrobial activity against Staphylococcus aureus ATCC 6538 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1765022,Bioorg Med Chem,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418180,=,1,1,=,MIC,ug.mL-1,0.07,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.07
56806,,6172646,CHEMBL1768004,Antimicrobial activity against quinilone-pencillin-resistant Staphylococcus aureus isolate SAR 72 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1765022,Bioorg Med Chem,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418180,=,1,1,=,MIC,ug.mL-1,25.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,25.0
56807,,6172655,CHEMBL1768005,Antimicrobial activity against quinilone-pencillin-resistant Staphylococcus aureus isolate SAR 4790 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1765022,Bioorg Med Chem,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418180,=,1,1,=,MIC,ug.mL-1,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,100.0
56808,,6172664,CHEMBL1768006,Antimicrobial activity against Staphylococcus epidermidis ATCC 12228 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1765022,Bioorg Med Chem,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418180,=,1,1,=,MIC,ug.mL-1,0.15,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.15
56809,,6172673,CHEMBL1768007,Antimicrobial activity against quinilone-pencillin-resistant Staphylococcus epidermidis clinical isolate by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1765022,Bioorg Med Chem,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418180,>,1,1,>,MIC,ug.mL-1,100.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,100.0
56810,,6172682,CHEMBL1768008,Antimicrobial activity against Acinetobacter baumannii ATCC 19606 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1765022,Bioorg Med Chem,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418180,=,1,1,=,MIC,ug.mL-1,0.15,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,0.15
56811,,6172691,CHEMBL1768009,Antimicrobial activity against quinilone-pencillin-resistant Acinetobacter baumannii clinical isolate by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1765022,Bioorg Med Chem,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418180,>,1,1,>,MIC,ug.mL-1,100.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,100.0
56812,,6172700,CHEMBL1768010,Antimicrobial activity against Escherichia coli ATCC 8739 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1765022,Bioorg Med Chem,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418180,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.03
56813,,6172709,CHEMBL1768011,Antimicrobial activity against quinilone-pencillin-resistant Escherichia coli clinical isolate by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1765022,Bioorg Med Chem,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418180,=,1,1,=,MIC,ug.mL-1,25.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,25.0
56814,,6172718,CHEMBL1768012,Antimicrobial activity against Haemophilus influenzae ATCC 19418 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1765022,Bioorg Med Chem,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418180,=,1,1,=,MIC,ug.mL-1,0.15,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug ml-1,UO_0000274,0.15
56815,,6172727,CHEMBL1768013,Antimicrobial activity against Pseudomonas aeruginosa ATCC 9027 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1765022,Bioorg Med Chem,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418180,=,1,1,=,MIC,ug.mL-1,0.3,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.3
56816,,6172736,CHEMBL1768014,Antimicrobial activity against Saccharomyces cerevisiae ATCC 9763 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1765022,Bioorg Med Chem,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418180,>,1,1,>,MIC,ug.mL-1,100.0,CHEMBL361,Saccharomyces cerevisiae,Saccharomyces cerevisiae,4932.0,,MIC,ug ml-1,UO_0000274,100.0
56817,,6172746,CHEMBL1768015,Antimicrobial activity against Candida tropicalis ATCC 1369 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1765022,Bioorg Med Chem,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418180,>,1,1,>,MIC,ug.mL-1,100.0,CHEMBL612870,Candida tropicalis,Candida tropicalis,5482.0,,MIC,ug ml-1,UO_0000274,100.0
56818,,6172756,CHEMBL1768201,Antimicrobial activity against Aspergillus niger ATCC 6275 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1765022,Bioorg Med Chem,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418180,>,1,1,>,MIC,ug.mL-1,100.0,CHEMBL358,Aspergillus niger,Aspergillus niger,5061.0,,MIC,ug ml-1,UO_0000274,100.0
56819,,6184781,CHEMBL1775356,Antibacterial activity against methicillin-resistant Staphylococcus aureus clinical isolate after 24 hrs by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1772978,J Med Chem,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1422183,>,1,1,>,MIC,ug.mL-1,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.12
56820,,6184787,CHEMBL1775356,Antibacterial activity against methicillin-resistant Staphylococcus aureus clinical isolate after 24 hrs by microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1772978,J Med Chem,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1422183,=,1,1,=,MIC50,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,16.0
56821,,6184793,CHEMBL1775356,Antibacterial activity against methicillin-resistant Staphylococcus aureus clinical isolate after 24 hrs by microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1772978,J Med Chem,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1422183,>,1,1,>,MIC90,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,16.0
56822,,6208995,CHEMBL1781603,Antibacterial activity against Staphylococcus aureus ATCC 13709,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424190,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.06
56823,,6208996,CHEMBL1781602,Antibacterial activity against methicillin-sensitive Staphylococcus aureus 08-49,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424190,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.06
56824,,6208997,CHEMBL1781604,Antibacterial activity against methicillin-resistant Staphylococcus aureus 08-52,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424190,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
56825,,6208998,CHEMBL1781605,Antibacterial activity against Staphylococcus epidermidis ATCC 12228,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424190,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.125
56826,,6208999,CHEMBL1781606,Antibacterial activity against methicillin-sensitive Staphylococcus epidermidis 08-17,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424190,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,1.0
56827,,6209000,CHEMBL1781746,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis 08-18,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424190,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.125
56828,,6209001,CHEMBL1781747,Antibacterial activity against Streptococcus pneumoniae ATCC 6301,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424190,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
56829,,6209002,CHEMBL1781748,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae 08-2,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424190,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
56830,,6209003,CHEMBL1781749,Antibacterial activity against Enterococcus faecalis ATCC 51299,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424190,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,0.25
56831,,6209004,CHEMBL1781750,Antibacterial activity against vancomycin-resistant Enterococcus faecalis EFL1004,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424190,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,2.0
56832,,6209005,CHEMBL1781751,Antibacterial activity against Streptococcus pyogenes 556,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424190,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,1.0
56833,,6209006,CHEMBL1781752,Antibacterial activity against Escherichia coli ATCC 25922,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424190,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.03
56834,,6209007,CHEMBL1781753,Antibacterial activity against Extended spectrum beta-lactamase producing Escherichia coli 08-5,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424190,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,32.0
56835,,6209008,CHEMBL1781754,Antibacterial activity against Klebsiella pneumoniae ATCC 700603,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424190,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.5
56836,,6209009,CHEMBL1781755,Antibacterial activity against Pseudomonas aeruginosa 17,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424190,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,8.0
56837,,6209010,CHEMBL1781756,Antibacterial activity against Shigella sonnei 51592,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424190,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL614595,Shigella sonnei,Shigella sonnei,624.0,,MIC,ug ml-1,UO_0000274,0.03
56838,,6209011,CHEMBL1781757,Antibacterial activity against Bacillus typhi 50035,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424190,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL614448,Salmonella enterica subsp. enterica serovar Typhi,Salmonella typhi,90370.0,,MIC,ug ml-1,UO_0000274,0.03
56839,,6209012,CHEMBL1781758,Antibacterial activity against Enterobacter cloacae 45301,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424190,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,0.06
56840,,6209013,CHEMBL1781759,Antibacterial activity against Acinetobacter calcoaceticus 25001,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424190,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL614426,Acinetobacter calcoaceticus,Acinetobacter calcoaceticus,471.0,,MIC,ug ml-1,UO_0000274,0.25
56841,,6209014,CHEMBL1781760,Antibacterial activity against Enterobacter aerogenes 45102,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424190,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,0.03
56842,,6209015,CHEMBL1781761,Antibacterial activity against Serratia marcescens 41002,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424190,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,MIC,ug ml-1,UO_0000274,0.25
56843,,6209016,CHEMBL1781762,Antibacterial activity against Morganella morganii 49086,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424190,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,MIC,ug ml-1,UO_0000274,0.03
56844,,6209017,CHEMBL1781763,Antibacterial activity against Proteus rettgeri 49006,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424190,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL612537,Providencia rettgeri,Providencia rettgeri,587.0,,MIC,ug ml-1,UO_0000274,0.25
56845,,6209018,CHEMBL1781764,Antibacterial activity against Proteus vulgaris 56,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424190,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,MIC,ug ml-1,UO_0000274,0.03
56846,,6229804,CHEMBL1785609,Antibacterial activity against 10'4 CFU Staphylococcus aureus ATCC 25923 after 18 hrs by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1781961,Eur J Med Chem,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427625,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
56847,,6229805,CHEMBL1785610,Antibacterial activity against 10'4 CFU methicillin-sensitive Staphylococcus aureus 08-1 after 18 hrs by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1781961,Eur J Med Chem,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427625,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.125
56848,,6229806,CHEMBL1785772,Antibacterial activity against 10'4 CFU methicillin-resistant Staphylococcus aureus 08-1 after 18 hrs by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1781961,Eur J Med Chem,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427625,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.125
56849,,6229807,CHEMBL1785773,Antibacterial activity against 10'4 CFU methicillin-sensitive Staphylococcus epidermidis 09-6 after 18 hrs by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1781961,Eur J Med Chem,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427625,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,4.0
56850,,6229808,CHEMBL1785774,Antibacterial activity against 10'4 CFU methicillin-resistant Staphylococcus epidermidis 09-2 after 18 hrs by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1781961,Eur J Med Chem,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427625,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.25
56851,,6229809,CHEMBL1785775,Antibacterial activity against 10'4 CFU Streptococcus pneumoniae 08-4 after 18 hrs by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1781961,Eur J Med Chem,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427625,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
56852,,6229810,CHEMBL1785776,Antibacterial activity against 10'4 CFU Enterococcus faecalis 08-10 after 18 hrs by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1781961,Eur J Med Chem,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427625,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,8.0
56853,,6229811,CHEMBL1785777,Antibacterial activity against 10'4 CFU Enterococcus faecalis 08-12 after 18 hrs by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1781961,Eur J Med Chem,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427625,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,8.0
56854,,6229812,CHEMBL1785778,Antibacterial activity against 10'4 CFU Enterococcus faecium 08-2 after 18 hrs by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1781961,Eur J Med Chem,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427625,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,4.0
56855,,6229813,CHEMBL1785779,Antibacterial activity against 10'4 CFU Enterococcus faecium 06-7 after 18 hrs by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1781961,Eur J Med Chem,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427625,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,16.0
56856,,6229814,CHEMBL1785780,Antibacterial activity against 10'4 CFU Escherichia coli ATCC 25922 after 18 hrs by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1781961,Eur J Med Chem,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427625,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,2.0
56857,,6229815,CHEMBL1785781,Antibacterial activity against 10'4 CFU Escherichia coli 08-21 after 18 hrs by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1781961,Eur J Med Chem,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427625,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,16.0
56858,,6229816,CHEMBL1785782,Antibacterial activity against 10'4 CFU Klebsiella pneumoniae 09-22 after 18 hrs by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1781961,Eur J Med Chem,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427625,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,16.0
56859,,6229817,CHEMBL1785783,Antibacterial activity against 10'4 CFU Klebsiella pneumoniae 09-23 after 18 hrs by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1781961,Eur J Med Chem,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427625,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,16.0
56860,,6229818,CHEMBL1785784,Antibacterial activity against 10'4 CFU Pseudomonas aeruginosa ATCC 27853 after 18 hrs by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1781961,Eur J Med Chem,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427625,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,4.0
56861,,6229819,CHEMBL1785785,Antibacterial activity against 10'4 CFU Pseudomonas aeruginosa 09-32 after 18 hrs by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1781961,Eur J Med Chem,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427625,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,16.0
56862,,6262266,CHEMBL1798464,Fraction unbound in Sprague-Dawley rat plasma administered in casettes of 2/3 drugs at 4 hr constant rate intravenous infusions using flow rate of 1 (ml/kg)/hr corresponding to dosage rate of 2 (umol/kg)/hr by LC-MS/MS method,A,BAO_0000179,BAO_0000366,cell-free format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1795238,J Med Chem,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1438387,=,1,1,=,Fu,,0.82,CHEMBL613652,Rattus norvegicus,Plasma,10116.0,,Fu,,,0.82
56863,,6268566,CHEMBL1803851,Antibacterial activity against Staphylococcus aureus ATCC 25923 after 24 hrs by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1799937,J Nat Prod,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1441251,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.12
56864,,6268567,CHEMBL1803852,Antibacterial activity against Enterococcus faecalis ATCC 29212 after 24 hrs by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1799937,J Nat Prod,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1441251,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,0.5
56865,,6268568,CHEMBL1803853,Antibacterial activity against Bacillus subtilis ATCC 6633 after 24 hrs by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1799937,J Nat Prod,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1441251,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,0.12
56866,,6268569,CHEMBL1803854,Antibacterial activity against Mycobacterium smegmatis MC2 155 after 24 hrs by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1799937,J Nat Prod,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1441251,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,MIC,ug ml-1,UO_0000274,1.0
56867,,6268570,CHEMBL1803855,Antibacterial activity against Mycobacterium tuberculosis H37Rv after 14 days by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1799937,J Nat Prod,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1441251,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,0.5
56868,,6268571,CHEMBL1804001,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 24 hrs by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1799937,J Nat Prod,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1441251,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.25
56869,,6268572,CHEMBL1804002,Antibacterial activity against multidrug-resistant Morganella morganii 07-09 after 24 hrs by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1799937,J Nat Prod,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1441251,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,MIC,ug ml-1,UO_0000274,16.0
56870,,6268573,CHEMBL1804003,Antibacterial activity against Escherichia coli ATCC 25922 after 24 hrs by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1799937,J Nat Prod,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1441251,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.12
56871,,6268574,CHEMBL1804004,Antifungal activity against Candida albicans ATCC 10231 after 24 hrs by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1799937,J Nat Prod,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1441251,>,1,1,>,MIC,ug.mL-1,128.0,CHEMBL366,Candida albicans,Candida albicans,5476.0,,MIC,ug ml-1,UO_0000274,128.0
56872,,6328875,CHEMBL1820177,Antimicrobial activity against multidrug-resistant Vibrio parahaemolyticus 7001 after 24 hrs by microtiter plate based MIC assay,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1817603,J Nat Prod,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1450333,=,1,1,=,MIC,ug.mL-1,0.156,CHEMBL614403,Vibrio parahaemolyticus,Vibrio parahaemolyticus,670.0,,MIC,ug ml-1,UO_0000274,0.156
56873,,6332451,CHEMBL1820556,Antibacterial activity against Staphylococcus aureus ATCC 25923 after 18 to 24 hrs by NCCLS M100-S11 two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1817648,Eur J Med Chem,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1451020,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
56874,,6332452,CHEMBL1820557,Antibacterial activity against methicillin-resistant Staphylococcus aureus 08-1 after 18 to 24 hrs by NCCLS M100-S11 two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1817648,Eur J Med Chem,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1451020,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.06
56875,,6332453,CHEMBL1820558,Antibacterial activity against methicillin-sensitive Staphylococcus aureus 08-1 after 18 to 24 hrs by NCCLS M100-S11 two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1817648,Eur J Med Chem,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1451020,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
56876,,6332454,CHEMBL1820559,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis 09-4 after 18 to 24 hrs by NCCLS M100-S11 two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1817648,Eur J Med Chem,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1451020,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.5
56877,,6332455,CHEMBL1820560,Antibacterial activity against methicillin-sensitive Staphylococcus epidermidis 09-3 after 18 to 24 hrs by NCCLS M100-S11 two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1817648,Eur J Med Chem,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1451020,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.06
56878,,6332456,CHEMBL1820561,Antibacterial activity against methicillin-sensitive Staphylococcus epidermidis 09-6 after 18 to 24 hrs by NCCLS M100-S11 two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1817648,Eur J Med Chem,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1451020,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,2.0
56879,,6332457,CHEMBL1820562,Antibacterial activity against Streptococcus pneumoniae 08-2 after 18 to 24 hrs by NCCLS M100-S11 two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1817648,Eur J Med Chem,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1451020,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,16.0
56880,,6332458,CHEMBL1820563,Antibacterial activity against Streptococcus pneumoniae 08-4 after 18 to 24 hrs by NCCLS M100-S11 two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1817648,Eur J Med Chem,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1451020,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,4.0
56881,,6332459,CHEMBL1820564,Antibacterial activity against Enterococcus faecium 08-2 after 18 to 24 hrs by NCCLS M100-S11 two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1817648,Eur J Med Chem,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1451020,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,4.0
56882,,6332460,CHEMBL1820565,Antibacterial activity against Enterococcus faecium 08-7 after 18 to 24 hrs by NCCLS M100-S11 two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1817648,Eur J Med Chem,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1451020,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,8.0
56883,,6332461,CHEMBL1820566,Antibacterial activity against Enterococcus faecalis 08-10 after 18 to 24 hrs by NCCLS M100-S11 two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1817648,Eur J Med Chem,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1451020,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,8.0
56884,,6332462,CHEMBL1820567,Antibacterial activity against Enterococcus faecalis 08-12 after 18 to 24 hrs by NCCLS M100-S11 two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1817648,Eur J Med Chem,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1451020,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,8.0
56885,,6332463,CHEMBL1820568,Antibacterial activity against Escherichia coli ATCC 25922 after 18 to 24 hrs by NCCLS M100-S11 two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1817648,Eur J Med Chem,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1451020,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,2.0
56886,,6332464,CHEMBL1820569,Antibacterial activity against Escherichia coli 08-21 after 18 to 24 hrs by NCCLS M100-S11 two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1817648,Eur J Med Chem,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1451020,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,8.0
56887,,6332465,CHEMBL1820570,Antibacterial activity against Escherichia coli 08-22 after 18 to 24 hrs by NCCLS M100-S11 two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1817648,Eur J Med Chem,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1451020,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,4.0
56888,,6332466,CHEMBL1820571,Antibacterial activity against Klebsiella pneumoniae 09-22 after 18 to 24 hrs by NCCLS M100-S11 two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1817648,Eur J Med Chem,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1451020,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,16.0
56889,,6332467,CHEMBL1820597,Antibacterial activity against Klebsiella pneumoniae 09-23 after 18 to 24 hrs by NCCLS M100-S11 two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1817648,Eur J Med Chem,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1451020,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,8.0
56890,,6332468,CHEMBL1820572,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 18 to 24 hrs by NCCLS M100-S11 two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1817648,Eur J Med Chem,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1451020,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,4.0
56891,,6332469,CHEMBL1820573,Antibacterial activity against Pseudomonas aeruginosa 09-32 after 18 to 24 hrs by NCCLS M100-S11 two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1817648,Eur J Med Chem,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1451020,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,16.0
56892,,6332470,CHEMBL1820574,Antibacterial activity against Pseudomonas aeruginosa 09-33 after 18 to 24 hrs by NCCLS M100-S11 two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1817648,Eur J Med Chem,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1451020,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,8.0
56893,,6332471,CHEMBL1820575,Antibacterial activity against Pseudomonas aeruginosa 09-34 after 18 to 24 hrs by NCCLS M100-S11 two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1817648,Eur J Med Chem,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1451020,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,1.0
56894,inactive,7468762,CHEMBL1794440,PUBCHEM_BIOASSAY: qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488771],F,BAO_0000186,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1201862,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,1212704,,7,1,,Potency,nM,56234.1,CHEMBL6035,Rattus norvegicus,"Thioredoxin reductase 1, cytoplasmic",10116.0,,Potency,uM,UO_0000065,56.2341
56895,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768007,CHEMBL1909084,DRUGMATRIX: Sodium/nucleoside co-transporter radioligand binding (ligand: nitrobenzylthioinosine),B,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1909046,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1539888,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
56896,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768008,CHEMBL1909084,DRUGMATRIX: Sodium/nucleoside co-transporter radioligand binding (ligand: nitrobenzylthioinosine),B,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1909046,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1539888,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
56897,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768009,CHEMBL1909085,DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin),B,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1909046,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1539888,,15,0,,IC50,,,CHEMBL319,Rattus norvegicus,Alpha-1a adrenergic receptor,10116.0,,IC50,,,
56898,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768010,CHEMBL1909085,DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin),B,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1909046,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1539888,,15,0,,Ki,,,CHEMBL319,Rattus norvegicus,Alpha-1a adrenergic receptor,10116.0,,Ki,,,
56899,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768011,CHEMBL1909086,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),B,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1909046,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1539888,,15,0,,IC50,,,CHEMBL315,Rattus norvegicus,Alpha-1b adrenergic receptor,10116.0,,IC50,,,
56900,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768012,CHEMBL1909086,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),B,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1909046,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1539888,,15,0,,Ki,,,CHEMBL315,Rattus norvegicus,Alpha-1b adrenergic receptor,10116.0,,Ki,,,
56901,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768029,CHEMBL1909095,DRUGMATRIX: Aldose Reductase enzyme inhibition (substrate: DL-Glyceraldehyde),B,BAO_0000190,BAO_0000221,tissue-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1909046,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1539888,,15,0,,IC50,,,CHEMBL2622,Rattus norvegicus,Aldose reductase,10116.0,,IC50,,,
56902,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768030,CHEMBL1909095,DRUGMATRIX: Aldose Reductase enzyme inhibition (substrate: DL-Glyceraldehyde),B,BAO_0000192,BAO_0000221,tissue-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1909046,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1539888,,15,0,,Ki,,,CHEMBL2622,Rattus norvegicus,Aldose reductase,10116.0,,Ki,,,
56903,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768033,CHEMBL1909097,"DRUGMATRIX: ATPase, Na+/K+ enzyme inhibition (substrate: ATP)",B,BAO_0000190,BAO_0000221,tissue-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1909046,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1539888,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
56904,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768034,CHEMBL1909097,"DRUGMATRIX: ATPase, Na+/K+ enzyme inhibition (substrate: ATP)",B,BAO_0000192,BAO_0000221,tissue-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1909046,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1539888,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
56905,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768035,CHEMBL1909098,DRUGMATRIX: Atrial Natriuretic Factor (ANF) radioligand binding (ligand: [125I] ANF (rat)),B,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1909046,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1539888,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
56906,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768036,CHEMBL1909098,DRUGMATRIX: Atrial Natriuretic Factor (ANF) radioligand binding (ligand: [125I] ANF (rat)),B,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1909046,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1539888,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
56907,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768037,CHEMBL1909099,DRUGMATRIX: beta-Lactamase enzyme inhibition (substrate: Nitrocefin),B,BAO_0000190,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1909046,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1539888,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
56908,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768038,CHEMBL1909099,DRUGMATRIX: beta-Lactamase enzyme inhibition (substrate: Nitrocefin),B,BAO_0000192,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1909046,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1539888,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
56909,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768043,CHEMBL1909102,"DRUGMATRIX: Calcium Channel Type L, Benzothiazepine radioligand binding (ligand: [3H] Diltiazem)",B,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1909046,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1539888,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
56910,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768044,CHEMBL1909102,"DRUGMATRIX: Calcium Channel Type L, Benzothiazepine radioligand binding (ligand: [3H] Diltiazem)",B,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1909046,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1539888,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
56911,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768045,CHEMBL1909103,"DRUGMATRIX: Calcium Channel Type L, Dihydropyridine radioligand binding (ligand: [3H] Nitrendipine)",B,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1909046,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1539888,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
56912,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768046,CHEMBL1909103,"DRUGMATRIX: Calcium Channel Type L, Dihydropyridine radioligand binding (ligand: [3H] Nitrendipine)",B,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1909046,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1539888,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
56913,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768047,CHEMBL1909121,"DRUGMATRIX: Calcium Channel Type L, Phenylalkylamine radioligand binding (ligand: [3H] (-)-Desmethoxyverapamil (D-888))",B,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1909046,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1539888,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
56914,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768048,CHEMBL1909121,"DRUGMATRIX: Calcium Channel Type L, Phenylalkylamine radioligand binding (ligand: [3H] (-)-Desmethoxyverapamil (D-888))",B,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1909046,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1539888,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
56915,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768099,CHEMBL1909147,"DRUGMATRIX: GABAA, Muscimol, Central radioligand binding (ligand: [3H] Muscimol)",B,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1909046,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1539888,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
56916,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768100,CHEMBL1909147,"DRUGMATRIX: GABAA, Muscimol, Central radioligand binding (ligand: [3H] Muscimol)",B,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1909046,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1539888,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
56917,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768101,CHEMBL1909148,"DRUGMATRIX: GABAA, Flunitrazepam, Central radioligand binding (ligand: [3H] Flunitrazepam)",B,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1909046,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1539888,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
56918,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768102,CHEMBL1909148,"DRUGMATRIX: GABAA, Flunitrazepam, Central radioligand binding (ligand: [3H] Flunitrazepam)",B,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1909046,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1539888,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
56919,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768103,CHEMBL1909149,"DRUGMATRIX: GABAA, Chloride Channel, TBOB radioligand binding (ligand: [3H] TBOB)",B,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1909046,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1539888,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
56920,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768104,CHEMBL1909149,"DRUGMATRIX: GABAA, Chloride Channel, TBOB radioligand binding (ligand: [3H] TBOB)",B,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1909046,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1539888,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
56921,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768107,CHEMBL1909151,"DRUGMATRIX: Glutamate, AMPA radioligand binding (ligand: [3H] AMPA)",B,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1909046,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1539888,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
56922,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768108,CHEMBL1909151,"DRUGMATRIX: Glutamate, AMPA radioligand binding (ligand: [3H] AMPA)",B,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1909046,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1539888,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
56923,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768109,CHEMBL1909152,"DRUGMATRIX: Glutamate, Kainate radioligand binding (ligand: [3H] Kainic acid)",B,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1909046,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1539888,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
56924,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770122,CHEMBL1909152,"DRUGMATRIX: Glutamate, Kainate radioligand binding (ligand: [3H] Kainic acid)",B,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1909046,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1539888,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
56925,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770123,CHEMBL1909153,"DRUGMATRIX: Glutamate, NMDA, Agonism radioligand binding (ligand: [3H] CGP-39653)",B,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1909046,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1539888,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
56926,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770124,CHEMBL1909153,"DRUGMATRIX: Glutamate, NMDA, Agonism radioligand binding (ligand: [3H] CGP-39653)",B,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1909046,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1539888,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
56927,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770125,CHEMBL1909154,"DRUGMATRIX: Glutamate, NMDA, Phencyclidine radioligand binding (ligand: [3H] TCP)",B,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1909046,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1539888,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
56928,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770126,CHEMBL1909154,"DRUGMATRIX: Glutamate, NMDA, Phencyclidine radioligand binding (ligand: [3H] TCP)",B,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1909046,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1539888,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
56929,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770127,CHEMBL1909155,"DRUGMATRIX: Glycine, Strychnine-Sensitive radioligand binding (ligand: [3H] Strychnine)",B,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1909046,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1539888,,15,0,,IC50,,,CHEMBL3392921,Rattus norvegicus,Glycine receptor,10116.0,,IC50,,,
56930,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770128,CHEMBL1909155,"DRUGMATRIX: Glycine, Strychnine-Sensitive radioligand binding (ligand: [3H] Strychnine)",B,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1909046,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1539888,,15,0,,Ki,,,CHEMBL3392921,Rattus norvegicus,Glycine receptor,10116.0,,Ki,,,
56931,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770135,CHEMBL1909159,"DRUGMATRIX: Imidazoline I2, Central radioligand binding (ligand: [3H] Idazoxan)",B,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1909046,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1539888,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
56932,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770136,CHEMBL1909159,"DRUGMATRIX: Imidazoline I2, Central radioligand binding (ligand: [3H] Idazoxan)",B,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1909046,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1539888,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
56933,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770137,CHEMBL1909160,DRUGMATRIX: Insulin radioligand binding (ligand: [125I] Insulin),B,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1909046,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1539888,,15,0,,IC50,,,CHEMBL5486,Rattus norvegicus,Insulin receptor,10116.0,,IC50,,,
56934,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770138,CHEMBL1909160,DRUGMATRIX: Insulin radioligand binding (ligand: [125I] Insulin),B,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1909046,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1539888,,15,0,,Ki,,,CHEMBL5486,Rattus norvegicus,Insulin receptor,10116.0,,Ki,,,
56935,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770139,CHEMBL1909161,DRUGMATRIX: Interleukin IL-1 radioligand binding (ligand: [125I] interleukin 1beta),B,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1909046,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1539888,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
56936,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770140,CHEMBL1909161,DRUGMATRIX: Interleukin IL-1 radioligand binding (ligand: [125I] interleukin 1beta),B,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1909046,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1539888,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
56937,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770141,CHEMBL1909162,"DRUGMATRIX: Leukotriene, BLT (LTB4) radioligand binding (ligand: [3H]LTB4)",B,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1909046,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1539888,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
56938,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770142,CHEMBL1909162,"DRUGMATRIX: Leukotriene, BLT (LTB4) radioligand binding (ligand: [3H]LTB4)",B,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1909046,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1539888,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
56939,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770143,CHEMBL1909163,DRUGMATRIX: Leukotriene LTC4 Synthase enzyme inhibition (substrate: LTA4),B,BAO_0000190,BAO_0000221,tissue-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1909046,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1539888,,15,0,,IC50,,,CHEMBL1909043,Cavia porcellus,Leukotriene C4 synthase,10141.0,,IC50,,,
56940,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770144,CHEMBL1909163,DRUGMATRIX: Leukotriene LTC4 Synthase enzyme inhibition (substrate: LTA4),B,BAO_0000192,BAO_0000221,tissue-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1909046,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1539888,,15,0,,Ki,,,CHEMBL1909043,Cavia porcellus,Leukotriene C4 synthase,10141.0,,Ki,,,
56941,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770147,CHEMBL1909165,DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid),B,BAO_0000190,BAO_0000221,tissue-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1909046,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1539888,,15,0,,IC50,,,CHEMBL4358,Oryctolagus cuniculus,Arachidonate 15-lipoxygenase,9986.0,,IC50,,,
56942,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770148,CHEMBL1909165,DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid),B,BAO_0000192,BAO_0000221,tissue-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1909046,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1539888,,15,0,,Ki,,,CHEMBL4358,Oryctolagus cuniculus,Arachidonate 15-lipoxygenase,9986.0,,Ki,,,
56943,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770171,CHEMBL1909177,DRUGMATRIX: Nicotinic Acetylcholine radioligand binding (ligand: [125I] Epibatidine),B,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1909046,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1539888,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
56944,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770172,CHEMBL1909177,DRUGMATRIX: Nicotinic Acetylcholine radioligand binding (ligand: [125I] Epibatidine),B,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1909046,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1539888,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
56945,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770173,CHEMBL1909178,"DRUGMATRIX: Nitric Oxide Synthase, Neuronal (nNOS) radioligand binding (ligand: [3H]L-Arginine)",B,BAO_0000190,BAO_0000221,tissue-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1909046,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1539888,,15,0,,IC50,,,CHEMBL3048,Rattus norvegicus,"Nitric-oxide synthase, brain",10116.0,,IC50,,,
56946,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770174,CHEMBL1909178,"DRUGMATRIX: Nitric Oxide Synthase, Neuronal (nNOS) radioligand binding (ligand: [3H]L-Arginine)",B,BAO_0000192,BAO_0000221,tissue-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1909046,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1539888,,15,0,,Ki,,,CHEMBL3048,Rattus norvegicus,"Nitric-oxide synthase, brain",10116.0,,Ki,,,
56947,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770183,CHEMBL1909183,DRUGMATRIX: Phorbol Ester radioligand binding (ligand: [3H] PDBu),B,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1909046,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1539888,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
56948,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770184,CHEMBL1909183,DRUGMATRIX: Phorbol Ester radioligand binding (ligand: [3H] PDBu),B,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1909046,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1539888,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
56949,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770185,CHEMBL1909184,DRUGMATRIX: Phosphodiesterase PDE3 enzyme inhibition (substrate: [3H]cAMP + cAMP),B,BAO_0000190,BAO_0000221,tissue-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1909046,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1539888,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
56950,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770186,CHEMBL1909184,DRUGMATRIX: Phosphodiesterase PDE3 enzyme inhibition (substrate: [3H]cAMP + cAMP),B,BAO_0000192,BAO_0000221,tissue-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1909046,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1539888,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
56951,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770187,CHEMBL1909185,DRUGMATRIX: Phosphodiesterase PDE4 enzyme inhibition (substrate: [3H]cAMP + cAMP),B,BAO_0000190,BAO_0000219,cell-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1909046,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1539888,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
56952,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770188,CHEMBL1909185,DRUGMATRIX: Phosphodiesterase PDE4 enzyme inhibition (substrate: [3H]cAMP + cAMP),B,BAO_0000192,BAO_0000219,cell-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1909046,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1539888,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
56953,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770193,CHEMBL1909188,DRUGMATRIX: Platelet-Derived Growth Factor (PDGF) radioligand binding (ligand: [125I] PDGF),B,BAO_0000190,BAO_0000219,cell-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1909046,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1539888,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
56954,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770194,CHEMBL1909188,DRUGMATRIX: Platelet-Derived Growth Factor (PDGF) radioligand binding (ligand: [125I] PDGF),B,BAO_0000192,BAO_0000219,cell-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1909046,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1539888,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
56955,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770195,CHEMBL1909189,DRUGMATRIX: Potassium Channel [KATP] radioligand binding (ligand: [3H] Glyburide),B,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1909046,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1539888,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
56956,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770196,CHEMBL1909189,DRUGMATRIX: Potassium Channel [KATP] radioligand binding (ligand: [3H] Glyburide),B,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1909046,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1539888,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
56957,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770199,CHEMBL1909191,DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020),B,BAO_0000190,BAO_0000221,tissue-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1909046,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1539888,,15,0,,IC50,,,CHEMBL1909044,Bos taurus,Progesterone receptor,9913.0,,IC50,,,
56958,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770200,CHEMBL1909191,DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020),B,BAO_0000192,BAO_0000221,tissue-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1909046,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1539888,,15,0,,Ki,,,CHEMBL1909044,Bos taurus,Progesterone receptor,9913.0,,Ki,,,
56959,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770201,CHEMBL1909192,"DRUGMATRIX: Peptidase, Angiotensin Converting Enzyme enzyme inhibition (substrate: FAPGG)",B,BAO_0000190,BAO_0000221,tissue-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1909046,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1539888,,15,0,,IC50,,,CHEMBL4074,Oryctolagus cuniculus,Angiotensin-converting enzyme,9986.0,,IC50,,,
56960,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770202,CHEMBL1909192,"DRUGMATRIX: Peptidase, Angiotensin Converting Enzyme enzyme inhibition (substrate: FAPGG)",B,BAO_0000192,BAO_0000221,tissue-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1909046,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1539888,,15,0,,Ki,,,CHEMBL4074,Oryctolagus cuniculus,Angiotensin-converting enzyme,9986.0,,Ki,,,
56961,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770233,CHEMBL1909208,"DRUGMATRIX: Purinergic P2X radioligand binding (ligand: [3H] alpha, beta-Methylene-ATP)",B,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1909046,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1539888,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
56962,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770234,CHEMBL1909208,"DRUGMATRIX: Purinergic P2X radioligand binding (ligand: [3H] alpha, beta-Methylene-ATP)",B,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1909046,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1539888,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
56963,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770235,CHEMBL1909209,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT),B,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1909046,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1539888,,15,0,,IC50,,,CHEMBL273,Rattus norvegicus,Serotonin 1a (5-HT1a) receptor,10116.0,,IC50,,,
56964,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770236,CHEMBL1909209,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT),B,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1909046,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1539888,,15,0,,Ki,,,CHEMBL273,Rattus norvegicus,Serotonin 1a (5-HT1a) receptor,10116.0,,Ki,,,
56965,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770237,CHEMBL1909210,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol),B,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1909046,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1539888,,15,0,,IC50,,,CHEMBL3459,Rattus norvegicus,Serotonin 1b (5-HT1b) receptor,10116.0,,IC50,,,
56966,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770238,CHEMBL1909210,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol),B,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1909046,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1539888,,15,0,,Ki,,,CHEMBL3459,Rattus norvegicus,Serotonin 1b (5-HT1b) receptor,10116.0,,Ki,,,
56967,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770245,CHEMBL1909106,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT3 radioligand binding (ligand: [3H] GR-65630),B,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1909046,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1539888,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
56968,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770246,CHEMBL1909106,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT3 radioligand binding (ligand: [3H] GR-65630),B,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1909046,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1539888,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
56969,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770247,CHEMBL1909107,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT4 radioligand binding (ligand: [3H] GR-113808),B,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1909046,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1539888,,15,0,,IC50,,,CHEMBL5017,Cavia porcellus,Serotonin 4 (5-HT4) receptor,10141.0,,IC50,,,
56970,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770248,CHEMBL1909107,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT4 radioligand binding (ligand: [3H] GR-113808),B,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1909046,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1539888,,15,0,,Ki,,,CHEMBL5017,Cavia porcellus,Serotonin 4 (5-HT4) receptor,10141.0,,Ki,,,
56971,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7772262,CHEMBL1909111,DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil),B,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1909046,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1539888,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
56972,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7772263,CHEMBL1909111,DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil),B,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1909046,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1539888,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
56973,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7772264,CHEMBL1909112,"DRUGMATRIX: Sodium Channel, Site 2 radioligand binding (ligand: [3H] Batrachotoxin)",B,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1909046,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1539888,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
56974,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7772265,CHEMBL1909112,"DRUGMATRIX: Sodium Channel, Site 2 radioligand binding (ligand: [3H] Batrachotoxin)",B,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1909046,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1539888,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
56975,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7772270,CHEMBL1909115,DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone),B,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1909046,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1539888,,15,0,,IC50,,,CHEMBL3072,Rattus norvegicus,Androgen Receptor,10116.0,,IC50,,,
56976,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7772271,CHEMBL1909115,DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone),B,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1909046,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1539888,,15,0,,Ki,,,CHEMBL3072,Rattus norvegicus,Androgen Receptor,10116.0,,Ki,,,
56977,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7772274,CHEMBL1909117,"DRUGMATRIX: Tumor Necrosis Factor (TNF), Non-Selective radioligand binding (ligand: [125I] TNF-alpha)",B,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1909046,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1539888,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
56978,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7772275,CHEMBL1909117,"DRUGMATRIX: Tumor Necrosis Factor (TNF), Non-Selective radioligand binding (ligand: [125I] TNF-alpha)",B,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1909046,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1539888,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
56979,,7939926,CHEMBL1921187,Antiproliferative activity against human U373MG cells after 120 hrs by MTT asasy,F,BAO_0000190,BAO_0000219,cell-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1914411,Eur J Med Chem,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,1557962,=,1,1,=,IC50,nM,67000.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,IC50,uM,UO_0000065,67.0
56980,,7940153,CHEMBL1919919,"Antibacterial activity against Staphylococcus aureus ARC516 infected in CD1 mouse neutropenic thigh infection model assessed as 1 log reduction in colony forming unit per lung at 20 mg/kg, ip qd administered 2 hrs post-infection measured 24 hrs post-treatment relative to vehicle treated control",F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1914454,J Med Chem,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1559001,=,1,0,=,FC,,1.46,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,FC,,,1.46
56981,,7940305,CHEMBL1921192,Antimicrobial activity against Staphylococcus aureus CIP 4.83 after 18 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1914411,Eur J Med Chem,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,1557962,<=,1,1,<=,MIC,nM,970.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,0.97
56982,,7940367,CHEMBL1921192,Antimicrobial activity against Staphylococcus aureus CIP 4.83 after 18 to 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1914411,Eur J Med Chem,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Micromolar,1557962,<=,1,0,<=,MBC,uM,0.97,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,uM,UO_0000064,0.97
56983,,7940429,CHEMBL1921193,Antimicrobial activity against Enterococcus hirae CIP 5855 after 18 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1914411,Eur J Med Chem,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,1557962,<=,1,1,<=,MIC,nM,970.0,CHEMBL614623,Enterococcus hirae,Enterococcus hirae,1354.0,,MIC,uM,UO_0000065,0.97
56984,,7940491,CHEMBL1921193,Antimicrobial activity against Enterococcus hirae CIP 5855 after 18 to 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1914411,Eur J Med Chem,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Micromolar,1557962,=,1,0,=,MBC,uM,1.9,CHEMBL614623,Enterococcus hirae,Enterococcus hirae,1354.0,,MBC,uM,UO_0000064,1.9
56985,,7940553,CHEMBL1921194,Antimicrobial activity against Pseudomonas aeruginosa CIP 82.118 after 18 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1914411,Eur J Med Chem,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,1557962,<=,1,1,<=,MIC,nM,970.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,uM,UO_0000065,0.97
56986,,7940903,CHEMBL1921194,Antimicrobial activity against Pseudomonas aeruginosa CIP 82.118 after 18 to 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1914411,Eur J Med Chem,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Micromolar,1557962,<=,1,0,<=,MBC,uM,0.97,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MBC,uM,UO_0000064,0.97
56987,,7940965,CHEMBL1921195,Antimicrobial activity against Escherichia coli CIP 53126 after 18 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1914411,Eur J Med Chem,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,1557962,<=,1,1,<=,MIC,nM,970.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,uM,UO_0000065,0.97
56988,,7941027,CHEMBL1921195,Antimicrobial activity against Escherichia coli CIP 53126 after 18 to 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1914411,Eur J Med Chem,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Micromolar,1557962,<=,1,0,<=,MBC,uM,0.97,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MBC,uM,UO_0000064,0.97
56989,,7941045,CHEMBL1921196,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 6 days by MTT colorimetric microassay,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1914411,Eur J Med Chem,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,1557962,=,1,1,=,MIC,nM,2500.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,2.5
56990,,7941058,CHEMBL1921196,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 6 days by MTT colorimetric microassay,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1914411,Eur J Med Chem,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,1557962,=,1,1,=,IC50,nM,800.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,IC50,uM,UO_0000065,0.8
56991,,7941630,CHEMBL1921267,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as growth inhibition at 10 uM after 6 days by MTT colorimetric microassay,F,BAO_0000096,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1914411,Eur J Med Chem,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1557962,=,1,0,=,GI,%,96.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,GI,%,UO_0000187,96.0
56992,,7941652,CHEMBL1921268,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as growth inhibition at 1 uM after 6 days by MTT colorimetric microassay,F,BAO_0000096,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1914411,Eur J Med Chem,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1557962,=,1,0,=,GI,%,85.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,GI,%,UO_0000187,85.0
56993,Not Active,7941707,CHEMBL1921269,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as growth inhibition at 0.1 uM after 6 days by MTT colorimetric microassay,F,BAO_0000181,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1914411,Eur J Med Chem,2011.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1557962,,1,0,,GI,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,GI,,,
56994,,10958755,CHEMBL2061328,Antibacterial activity against Streptococcus pneumoniae ARC548,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL2057070,Bioorg Med Chem Lett,2012.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,1657556,=,1,1,=,MIC,nM,3130.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,uM,UO_0000065,3.13
56995,,10958769,CHEMBL2061327,Antibacterial activity against methicillin-sensitive Staphylococcus aureus,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL2057070,Bioorg Med Chem Lett,2012.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,1657556,=,1,1,=,MIC,nM,780.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,0.78
56996,,10958783,CHEMBL2061326,"Antibacterial activity against methicillin-, quinolone-resistant Staphylococcus aureus",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL2057070,Bioorg Med Chem Lett,2012.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,1657556,>,1,1,>,MIC,nM,25000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,25.0
56997,,10963400,CHEMBL2060283,Antibacterial activity against Acinetobacter baumannii,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL2057101,J Med Chem,2012.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1655655,=,1,1,=,MIC50,ug.mL-1,4.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC50,ug ml-1,UO_0000274,4.0
56998,,10963403,CHEMBL2060283,Antibacterial activity against Acinetobacter baumannii,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL2057101,J Med Chem,2012.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1655655,=,1,1,=,MIC90,ug.mL-1,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC90,ug ml-1,UO_0000274,32.0
56999,,10963404,CHEMBL2060283,Antibacterial activity against Acinetobacter baumannii,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL2057101,J Med Chem,2012.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1655655,>,1,1,>,MIC,ug.mL-1,0.13,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,0.13
